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List of Acronyms and Abbreviations
3D three dimensional
Å Angstrom
β2AR β2 adrenergic receptor
β2AR-cpep β2 adrenergic receptor C-terminal fused to a peptided derived from
the C-terminus of the Gαs subunit
β2AR-T4L-GαsCT-CC β2AR fused to a T4 lysoyme (T4L) and the C-terminus of the Gαs
subunit and further stabilized by a disulfid bridge (CC)
µs microsecond
cryo-EM cryo-electron microscopy
FAIR Findability, Accessibility, Interoperability, Re-usability
fs femtoseconds
G protein guanosine triphosphate-binding protein
GαsCT / GαtCT C terminus of the G protein αs/t subunit
GB gigabyte
GUI graphical user interface
GPCR G protein-coupled receptor
Gsempty G protein with αs subunit without bound GDP/GTP
HPC center high performance computing center
kDa kilodaltons
MD molecular dynamics
NMR nuclear magnetic resonance
ps picoseconds





trajectory path of single molecules through space as a function of time
TM transmembrane
wwPDB world wide protein data bank
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In pharmacological science, characterization of drug binding and investigation of physiolog-
ical drug-responses are key tasks [1]. G protein-coupled receptors (GPCRs) are major drug
targets, which conduct a high variety of different signals into the cell through binding and
activation of heterotrimeric guanosine triphosphate-binding proteins (G proteins) through
catalyzing nucleotide exchange, resulting in defined cellular responses. During my time as
a doctoral student, I have focused on the study of β2-adrenergic receptor (β2AR) signaling,
which is activated by adrenaline, regulating blood pressure and heart rate. Understanding of
that key signaling event provides important insights into molecular mechanisms to promote
the understanding and treatment ofβ2AR-specific cardiac diseases. Moreover, theβ2ARhas
been used as amodel system to investigateGPCR signaling, as its coupling to different down-
stream signaling partners, such as Gs, Gi, or arrestins, can cause opposite cellular responses.
Three-dimensional (3D) structures obtained from classical structural biology methods
such as X-ray crystallography or single-particle cryo-electron microscopy (cryo-EM) provide
first insights into themolecular interactions at atomic detail. However, to understandGPCR
function, the dynamics has to be investigated [2, 3]. GPCRs are highly flexible proteins that
exist in a manifold of different inactive and active functional states with different signaling
properties. I have been usingmolecular dynamics (MD) simulations, a well-established com-
putational technique, to investigate the time-resolved motion of the β2AR and how it cou-
ples to theGs protein. There, our collaborators solved the structure of a peptide derived from
the C terminus of the Gαs protein (GαsCT) bound to the intracellular binding crevice of
the β2AR and fused for stabilization and crystallization to the receptor (ID: 6E67, see figure
1, panel A). We obtained this fusion-construct to investigate the dynamics and interactions
of the receptor and peptide in a more native, unrestrained setup. Therefore, I prepared the
structure to conduct MD simulations by removing stabilizing extensions which had been
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included in the experimental setup to promote crystallization. I further modeled missing
backbone residues of the intracellular loop three to obtain a more complete structure. In
general, experimentally derived structures often contain missing segments, which need to be
completed. Further, the receptorwas embedded in amembrane environment and completely
solvated, and subsequently the dynamics was calculated. After processing and analysis, ob-
servations are shared andmutations based on those dynamics are suggested for further exper-
imental studies, also to confirm structure-function hypothesis (see figure 1, panel B-C and for
further information on the conducted study, see appendix 4, [4]).
Along this process, I implemented tools to automate steps of the generation of receptor
dynamics and to allow the sharing of resulting simulations with collaboration partners, in
this case accompanyingmutational suggestions as input for further experimental verification
[6, 7]. This automation of steps generally facilitates recapitulation of workflows for other
systems and promotes applicability. A specific aim of my work was to implement those tools
into an automatedweb-service that allows to be approached by collaboration partners, which
are regularly no computational experts. A major advantage is that no software or data has
to be downloaded for usage. More generally, it promotes transparency, reproducibility, and
facilitates broad applicability. Finally, interactive analysis and visualization helps to foster
interdisciplinary research and collaboration [8].
1 GPCRs as a prime example in structural and pharma-
ceutical biology
An important interdisciplinary field in medical and pharmacological research is the study of
the 7 transmembrane (TM) spanning proteins, GPCRs. They constitute the largest family
of integral membrane receptors with over 800 proteins encoded within the human genome
that sense a manifold of extracellular signals such as ions, hormones, neurotransmitters, and
sensory stimuli. Upon their binding, the receptor is activated and transduces to only a few
intracellular macromolecules such as G proteins (e.g. Gs, Gi, Go, G11), GPCR kinases, and
arrestins which regulate distinct cellular downstream pathways leading to physiological re-
sponses [9–12]. Malfunction of GPCRs causes various diseases like obesity, cancer, cardiac
dysfunction, inflammation, and disorders in the central nervous system [13]. Yet in 2018, less
than 134 of the 800 GPCRs are targeted by already approximately 35% of the approved phar-
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Figure 1: Results from a collabora ve workflow: Structural and dynamical insights into the coupling of the β2AR to the
Gs protein. A) X-ray crystal structure of β2AR-T4L-GαsCT-CC. In efforts to crystallize the GαsCT (red) within its na ve
intracellular binding crevice of the β2AR (green), the structure was stabilized by fusing a T4-lysozyme (yellow) to TM5 and
the N-terminus of the pep de, which is C-terminally fused through a three amino acid linker to TM6. Addi onally, the
pep de was stabilized by including a disulfide bridge to the receptor (at residue posi on L394, not shown). B) Boxplot
showing Cα root-mean-square-fluctua on (RMSF) of single residues from the GαsCT obtained from MD simula ons of
the previously crystallized structure and plo ed for the na ve pep de and func onally important double point muta ons
R389A/E392A and R389T/E392T. Those residues were selected according to their stabilizing role in the na ve pep de.
Double point muta ons R389T/E392T cause a loss in the stability of the pep de, indicated by overall larger RMSF values.
They were accordingly suggested for muta onal analysis to probe func onal. C) Ligand (Isoproprenol) compe on curves
for double muta ons. Na ve pep de fused to C-terminus of the receptor (β2AR-cpep) binds and ac vates the receptor
by inducing a TM6 outward lt. As predicted byMD simula ons, muta ons of R389A/E392A and R389T/E392T decrease
pep de affinity toβ2AR. Panel A & Cwith permission extracted and adapted from Liu et al. [4], panel B shows unpublished
molecular dynamics data from Liu et al. [4]. The NGL viewer was used to prepare Panel A [5].
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maceuticals, whichmakes GPCRs the largest family of approved drug targeted proteins with
likely even more potential targets whose roles in therapeutics remains to be revealed [14–17].
To guide the rational design of novel drugs with fewer side effects, the molecular details
of GPCR function have to be elucidated. GPCRs exist in an equilibrium of different dy-
namic conformations and functional states. In order to investigate the function and signal-
ing of GPCRs, the 3D structure and dynamics has to be known. Classical structural biol-
ogymethods includeX-ray crystallography, cryo-EM, or nuclearmagnetic resonance (NMR)
spectroscopy. In 2000 the first GPCR structure of inactive rhodopsin was resolved using X-
ray crystallography [18]. In 2008, Klaus Peter Hofmann and colleagues determined the first
structures of an active GPCR, namely of opsin with (ID: 3DQB [19]) and without a GαtCT
derived peptide (ID: 3CAP [20]). The GαtCT is the key interaction side of the G protein
binding deeply into the intracellular binding crevice of the receptor and, thereby, stabilizing
its active conformation [10]. In the active state, the outward tilt of TM6opens up an intracel-
lular binding crevice for GαtCTbinding. In 2011 the first structure of a complete receptor-G
protein complex was resolved (β2AR-Gsempty, ID: 3SN6 [21]) by Brian K. Kobilka who sub-
sequently was awarded theNobel Prize inChemistry together withRobert Lefkowitz 1. This
complex illustrates how the β2AR interacts with a nucleotide free Gαs protein and reveals
the structural hallmarks following receptor catalyzed nucleotide release.
2 Modelingmissing segments into cryo-EMdensitymaps
X-ray crystallographyhas traditionally beenused to elucidate the structure of smaller tomedium-
sized proteins (15- to 50-kilodaltons (kDa) range [22]), while cryo-EMwas used to investigate
large molecular complexes and machines (150- to 200-kDa range [23]). Recent technical and
methodological advances like the generation ofmore sensitive direct electron detectors paired
with powerful maximum likelihood image processing routines and increased computational
power significantly improved the density map resolution. This resulted in a significant rise
in the number of GPCR complexes resolved by cryo-EM. Rich structural information on
receptors in complex with different G proteins and arrestins provides first hints on their spe-
cific binding and helps to investigate signaling specificity [24, 25]. At the same time, cryo-EM
structures cannowbe resolved at near-atomic resolution,which even allowsdenovomodeling
1MLA style: The Nobel Prize in Chemistry 2012. NobelPrize.org. Nobel Media AB 2019. Sun. 8 Sep 2019.
https://www.nobelprize.org/prizes/chemistry/2012/summary/
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of side chains within well-resolved parts [26–28]. Notwithstanding those technological de-
velopments, in many of those complexes, parts of the structure are not modeled due to low
local resolution or map fragmentation [29, 30]. These missing segments are often located
in flexible and presumably functional important regions such as loops or turns of proteins.
Those and other non-resolved regions, however, must bemodeled to obtain amore complete
structure for further analysis of their structure-function relationship and intrinsic dynamics
e.g. by MD simulations.
Many powerful standalone desktop programs, such as Pathwalking [31], EM-Fold [32],
HADDOCK [33],MDFF [34],MAINMAST [35], and others, recently discussed byCassidy
et al. [28], allow modeling of residues into experimentally derived maps by following force
field- or fragment-based approaches or combinations of both. These tools mostly require
expert knowledge to install and execute the algorithm/software, and to handle density maps.
Therefore, they are not easily accessible to and usable by non-expert users. In contrast, web-
tools have the advantage to be globally accessible without the requirement for download and
installation and are, thereby, despite their different perspectives and backgrounds applicable
for experts and non-experts alike. Only those algorithms or workflows, which run mostly
automated andprovide their results in a very fastmanner, can be translated into aweb service.
Additionally, results have to be made available in an efficient and intuitive way.
We previously introduced a fragment-based algorithm which allows to model segments
into cryo-EM density maps (see appendix 3, figure 2, [36]). In contrast to other methods
following a force field-based approach [37], which allows direct de novo prediction of poly-
peptide folds, fragment-based methods are less computationally expensive [38] and, there-
fore, applicable to be translated into a web-service. For more information about different
modeling methods, also in the context of modeling into cryo-EM densities, be referred to
[39–41]. Our fragment-based algorithm consists of a search (FragSearch) and a fitting step
(FragFit) (see figure 2). In the first part (FragSearch), a fragment-database is searched ac-
cording to fragment length, sequence similarity, and geometrical fit of the stem residues of
the structure, flanking the missing segment, by using a hierarchical approach, which mini-
mizes calculation time. The database now consists ofmore than one billion fragments of 3-35
residue length obtained from experimentally derived structures deposited within the world
wide protein data bank (wwPDB) [42]. At time of publication, the algorithmperformed rea-
sonably well for modeling of fragments up to a length of 10 residues, outperforming promi-
nent tools such asMODELLER [41] with a mean difference of one Angstrom (Å) backbone
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Figure 2: Workflow of the fragment-
based method for modeling of pro-
tein segments into cryo-EM density
maps. FragFit workflow. FragSearch
(le panel) extracts fragments ac-
cording to their length, geometrical
fit and sequence similarity to the
input structure and sequence seg-
ment from a large database using
a hierarchical approach. For up to
1000 suitable fragments, simulated
density maps are generated. The
cryo-EM density map is preprocessed
(right panel) by extrac ng the min-
imal density map according to the
segment length and to non-occupied
densi es. Last, the simulated frag-
ment maps are compared to the
minimal cryo-EM density map using
pearson cross-correla on and ranked
accordingly to report the best fi ng
fragments. Figure with permission
adapted and extracted from Ismer et
al. 2017 [36].
root-mean-square-fluctuation (RMSD). Generally, prediction quality drops with increasing
fragment length [36, 43, 44] (also see appendix 3). Wepreviously implemented theFragSearch
algorithm into awebtool (SuperLooper [43] and SL2 [44], appendix 1). With this efficient al-
gorithm at hand, I integrated FragSearch into theGPCRhomologymodeling server SSFE2.0
(see appendix 2) [45], adapting the algorithm to allow automatedmodeling of all extracellular
and intracellular loops into the receptormodels and to search a sub-database containing only
fragments from GPCR structures.
We further implemented the FragFit step (see figure 2), which utilizes the cryo-EM den-
sity map of the corresponding structure to rank the database-derived FragSearch fragments
according to their fit into the density. Hence, the map is, first, preprocessed by extracting
the minimal density map estimated from the maximal fragment length in 3D space and the
deletion of already occupied densities, which reduces calculation load and false-positive pre-
dictions. Second, those resultingminimal cryo-EMdensitymaps are compared to each of the
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up to 1000 previously selected suitable FragSearch fragments. Therefore, a simulated map is
generated for eachof the fragments andfiltered to the resolutionof the experimental cryo-EM
density map using a Butterworth low pass filter. Those simulated maps are compared to the
experimentally determinedminimal density map using Pearson cross-correlation and ranked
accordingly. By utilizing the density maps for fitting, the prediction quality is increased by
up to two Å RMSD compared to FragSearch, especially for longer fragment length, whose
modeling has so far been much more challenging. For example the RMSD of a fragment
with length 11-13 lowers from 4.4 Å for FragSearch to 3.4 Å for FragFit and for fragments
with residue length 31-33 from 11.6 Å (FragSearch) to 9.9 Å (FragFit). Another remarkable
increase in prediction quality was obtained when not only the first but the best five top hits
are taken into account (improvement by two to three Å compared to FragFit top hit).
Depending on the fragment length, a complete run of the FragSearch and FragFit algo-
rithm may take from only a few seconds up to a few minutes. This allows the translation of
the standalone algorithm into a web-tool, which gives more researchers independent of their
background and knowledge levels the possibility tomodel fragments into density maps. The
workflow presented was successfully applied to the study of the initiation process of protein
translationbymodelingflexible and thus poorly resolved loop regions in the ribosome-bound
initiation factor-2 [46].
Furthermore,we could show that by visual inspectionof already thefirst 5-10 hits, the best
fitting solution (top hit) can be found within this range. Human-guided interference turns
out to be specifically useful for lower or inhomogeneous resolutions or map fragmentation
to select the top hit (see appendix 3, [36]). Therefore, we concluded that visualization should
be used for the final result selection.
Recent advances inbrowser technology, especially the access tohardware-accelerated graph-
ics through WebGL (reviewed by Mwalongo and others [47, 48]), opened up new possibili-
ties forwebmolecular graphics and rendering techniques, superseding plugin- and Java-based
viewers [49, 50] andmaking them compatiblewith desktop tools, such as PyMOL [51], VMD
[52], or UCSF Chimera [53]. A prominent example using WebGL and also embedded into
the research collaboratory for structural bioinformatics protein data bank (RCSBPDB) [54, 55]
is the in-house developed molecular viewer NGL [5, 56], focusing on scalability. Within the
RCSB PDB, the viewer allows researchers despite their different background knowledge or
research fields to inspect and easily validate structural features such as B factors or experimen-
tally derived density maps. The visualization of such experimental densities like cryo-EM
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maps was already a major milestone for highly specialized and powerful desktop programs,
as rendering techniques had to be improved to allow their visualization in a bright variety of
high-resolution and optimized representations and different depth cueing or aerial perspec-
tives [48]. Nevertheless, the visualization of suchmaps still remains highly complex, in terms
of file size and hardware/memory capacities.
3 Research goal I: Web service for modeling of missing
segments into cryo-EM density maps
Structures obtained from cryo-EMdensitymaps often contain flexible hinge regions ormiss-
ing segments, which need to be (re-) modeled. Easy usable tools to model proteins into den-
sity maps are sparse. Therefore, the aim of the first part of my dissertation was to translate
the fast and efficient in-house developed algorithm FragFit into a user-friendly web service
featuring a powerful web-visualization for interactive analysis and result selection.
4 From static to dynamics to investigate GPCR function
The elucidation of structures of different GPCRs in active and inactive states by classical
structural biologymethods is a huge achievement providing valuable starting points to inves-
tigate the intrinsic dynamics. Recent advances in the investigation of the sequence of events
of receptor-G protein coupling provide evidence that several structural intermediates with
limited lifetimes are passed along the process of signal transduction (see appendix 4, [4, 57]).
This multistep process leading to GDP release was recently investigated by labeling analy-
sis complemented by structural insights obtained through a fusion construct of the β2AR
with a peptide derived from the Gαs subunit C-terminus (GαsCT) (see figure 1, panel A)
[4, 57]. I appliedmolecular dynamics (MD) simulations to investigate the dynamic receptor-
G protein coupling interface of that structural intermediate, predicting key residues which
were subsequently confirmed by mutational analysis (see figure 1, panel B-C and appendix
4, [4]). Our analysis refers to an early coupling state, which is difficult to observe by classi-
cal structural biology methods such as X-ray crystallography or cryo-EM, due to its intrinsic
structural flexibility. This state, however, may be key to explain the specific recognition of G
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proteins by GPCRs that regularly only bind to a subset of available G proteins, in the case of
the β2AR to Gi and Gs.
To calculate the time resolvedmotions of macromolecules, MD simulations follow basic
physical laws. ClassicalMD simulation predicts themovement of atoms by solvingNewton’s
equations of motion, with Fi being the force that accelerates an atom i, m the mass of that
atom and a the directed acceleration.
Fi = mai (1)
A continuous, fully analytical calculation ofNewton’s equation ofmotion is due to the large
number of molecules not feasible. Therefore, the solution of the equation is approximated
by its calculation only at fixed time intervals [58]. Knowing the force Fi allows accelerating
the atoms, where the forces are given by the negative gradient of the potential energyUtotal.
Fi = −δUtotal/δri (2)
Thepotential energy is calculated frombonded (bonds, angles and torsions) andnon-bonded
(Lennard Jones and Coulomb) interactions.
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The interaction parameters of each individual atom used to solve the potential energy from
those interactions are specified in force fields. To reduce the computational calculation cost
and complexity, force fields contain simplified descriptions of those parameters. With the
masses (m) and initial velocities (simplified as ai) assigned, the simulation loop is entered.
Neighboring atoms are listed, their forces are calculated and the equation ofmotion is solved
including updating the atompositions and velocity. Next, pressure and temperature are con-
trolled and the data, like the coordinates of each atom over time, so-called trajectories, are
written out, starting the loop again until the final simulation time is reached.
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As those steps are calculated and written out in femtosecond (fs) to picosecond (ps)
timescales, MD simulations belong to the data-intensive sciences. For example, a simula-
tion box of 80.000 atoms, containing a GPCR structure embedded into a membrane and
surrounded by ions and water molecules, will be simulated for onemicrosecond (µs). There,
for every two fs, the forces of each atom are calculated by taking surrounding atoms within a
certain radius into account. The resulting positions of each atom are then written out every
10 ps, resulting in 80 ∗ 109 3D coordinates and file size of 80 gigabytes (GB), generated on a
desktop computer using a modern consumer graphics card within roughly 20 days. In com-
parison, amedium-sized complexGPCR-Gprotein system can contain up to 350.000 atoms,
which would in return use exponentially more time, capacities and space. This easily fills up
disk space within the range of hundreds of gigabytes or terabytes.
After a simulation is finished, the trajectory needs to be processed and analyzed. Pro-
cessing steps consist of the concatenation of simulation snippets, the removal of the periodic
boundary condition (PBC) in order to join split molecules again together, superpositioning
and centering for example on the proteins in order to obtain a noise-free simulation. With
those processed trajectories, excessive analysis is performed to identify functional relevant
dynamical observations. Visualization provides an intuitive, easy, quick and mutual com-
prehension of data and is, therefore, an essential part of the analysis of MD trajectories. The
most prominent and powerful standalone desktop tool to visualize and interactively analyze
MD data is VMD [52].
5 The complexity of sharing MD simulations
Dynamics obtained by MD simulations are expensive to generate and contain often much
more information not yet analyzed or beyond the current research scope. As they can explain
the intrinsic dynamics of a protein, MD results are of interest also for many experimental
researchers. This results in the urgent need to share these dynamic data (see appendix 5, [59]).
As MD belongs to the data-intensive sciences, sharing of the raw trajectories is hindered by
their huge file sizes. Cloud services for easy data sharing can only be used after truncation
and reduction of the trajectory data.
Furthermore, many different file formats are available. To use or even only to inspect
the trajectories, expert knowledge is needed. Additionally, even just to display their con-
tent, huge data files have to be transferred, specialized software needs to be installed and ex-
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ecuted. Therefore, the outcome of MD studies has so far along with publications mainly
been shared as text, tables, plots, figures, and, at the best, videos. This translates the dy-
namic nature of that valuable information obtained by simulations into a static, often very
focused, or non-interactive view on GPCR functional dynamics. Therefore, other interac-
tive and transparent ways to share MD simulations have to be found. An easy, intuitive, and
very efficient way to allow interactive inspection of MD simulations for experts and non-
experts likewise is via web-visualization. With the recent developments in web-visualization,
this comes into reach. The MegaMol Framework [60, 61] for Particle-Based Visualization
offers a client-server approach to view MD trajectories but is focused on visualization re-
search and prototyping rather than supplying software for life scientists. The JSmol viewer
(https://sourceforge.net/projects/jsmol/) can visualize only few specific and partly uncom-
mon trajectory file types (e.g. .xyz files). Similar to MegaMol, JSmol, however, demands
expert knowledge for usage and none of these viewers offers a solution to efficiently and eas-
ily view and share MD trajectories. Thus, the unavailability of easy usable sharing options
reduces GPCR dynamics again back to static proteins.
6 Research goal II: Interactive visual sharing of MD sim-
ulations
As MD belongs to the data-intensive sciences, cloud services for easy data sharing can only
be used after truncation and reduction of the trajectory data. Furthermore, many different
file formats are available. To use or even only to inspect the trajectories, up to a certain extent
expert knowledge is needed. Also, highly specialized visualization and analysis software need
to be installed, which further increases the barrier for non-experts to extract underlying in-
formation. Thus, easy usable and efficient tools to share, view, and analyze MD trajectories
are missing. The aim of this project was to develop a tool to allow easy visualization of MD
trajectories and the sharing of this visualization via the web. In collaborative settings, this
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ABSTRACT
Cryo-electron microscopy (cryo-EM) is a standard
method to determine the three-dimensional struc-
tures of molecular complexes. However, easy to use
tools for modeling of protein segments into cryo-EM
maps are sparse. Here, we present the FragFit web-
application, a web server for interactive modeling of
segments of up to 35 amino acids length into cryo-EM
density maps. The fragments are provided by a reg-
ularly updated database containing at the moment
about 1 billion entries extracted from PDB structures
and can be readily integrated into a protein struc-
ture. Fragments are selected based on geometric
criteria, sequence similarity and fit into a given cryo-
EM density map. Web-based molecular visualization
with the NGL Viewer allows interactive selection of
fragments. The FragFit web-application, accessible
at http://proteinformatics.de/FragFit, is free and open
to all users, without any login requirements.
INTRODUCTION
Due to recent technical advances in development of di-
rect electron detectors, cryo-electron microscopy (cryo-EM)
has become a key technology in structural biology (1) that
now even allows de novo modeling of side chains in well-
resolved parts (2,3). In cryo-EM density maps resolved at
sub-nanometer resolution (4), secondary structure elements
or backbone traces can be identified and modeled (5,6).
Therefore, fast and easy to use methods for modeling loops,
helices or sheets into cryo-EM density maps are in great de-
mand.
Here, we present the FragFit web-application for model-
ing of missing segments into cryo-EM density maps of pro-
teins. FragFit employs a classical fragment-based approach
for modeling of segments in proteins (7–9) and uses the lo-
cal fit to a given cryo-EM density map for re-scoring. Frag-
Fit works very well for a broad spectrum of resolutions, but
provides best results for maps with resolutions of at least
12 Å (10). Test cases are available for high (<4 Å), medium
(6 Å) and low resolution (8.9 Å). FragFit can be used to
model or remodel parts of proteins for which cryo-EM den-
sity maps are available. It has been proven to guide modeling
of poorly resolved flexible loops in ribosome bound initia-
tion factor-2, which cryo-EM density map was resolved at a
global map resolution of 3.7 Å (11). Moreover, FragFit can
be readily integrated into modeling approaches, where con-
formational changes of proteins only affect a substructure
of the protein or a single domain, while the general fold re-
mains unchanged (12). In these cases, flexible fitting of the
complete structure or complex is not required. Instead, the
structure can be dissembled into its different domains which
are rigidly fitted (13,14). FragFit can then be used to recon-
nect these domains or to re-model the hinge regions.
A great advantage of using FragFit compared to other
methods such as Coot (15), RosettaES (16), EM-Fold
(17,18), Segger (19) or VolRover (20) is ease of usage. While
the latter tools are powerful or even allow de novo model-
ing of backbone and side chains of regions resolved at high
resolution, they require specialized knowledge (21). In con-
trast, FragFit can be used instantly and no installation is
required.
The quality of the modeled structure depends on the type
of secondary structure, resolution and presence of fragmen-
tations or artifacts within a map. Since most maps feature
fragmentations and local variations in resolution, a fully
automated approach is challenging. Near native conforma-
tions are, however, regularly found in the top five results
list of FragFit (10) and the 100 top hits can be visualized
and selected in the FragFit web-application. Here, we use
the NGL Viewer (22,23) for integrated and interactive visu-
alization. The NGL Viewer adopts capabilities of modern
web browsers, such as WebGL for molecular graphics, al-
lowing comprehensive molecular visualization even of huge
trajectories derived from molecular dynamics simulations
without the need to install additional software. The user
*To whom correspondence should be addressed. Tel: +49 341 97 15 712; Fax: +49 30 450 524 138; Email: peter.hildebrand@medizin.uni-leipzig.de
†The authors wish to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
Present address: Alexander S. Rose, RCSB Protein Data Bank, San Diego Supercomputer Center, University of California, San Diego, CA 92093, USA.
C© The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.
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can directly upload the cryo-EM density map and avail-
able structure coordinates into the NGL Viewer, handle a
search and visually inspect and validate fragment candi-
dates. The fragment database used is regularly updated. The




The primary purpose of FragFit is to model missing seg-
ments such as loops, helices or -sheets of up to 35 amino
acids length into protein structures. The server employs a
fragment-based approach for modeling of fragments into
cryo-EM density maps. As a distinctive feature, FragFit
provides a powerful visualization to allow interactive val-
idation and selection by the user. A schematic of the work-
flow is shown in Figure 1. In the initial step, fragment-
based prediction (FragSearch) is performed by a fast hierar-
chical search algorithm to detect suitable fragments (7–9).
In the second step (FragFit), cross-correlation between the
simulated and the experimentally determined density map
is calculated for re-scoring to obtain fitting fragments. In-
teractive visualization and selection provided by the NGL
Viewer (22,23) is required to select suitable fragments espe-
cially for longer segments.
Template dataset
Two fragment database options are provided by FragFit:
LIP (‘Loops In Proteins’) contains all overlapping frag-
ments of 3–35 residues length extracted from all protein en-
tries of the PDB, while LIMP (‘Loops In Membrane Pro-
teins’) only composes from loops derived from membrane
proteins (7,8,24). The LIMP database takes into account
the specifics of the lipid bilayer (25) and is accordingly in-
tended for modeling of loops in membrane proteins. With
the latest regular update, the LIP database was extended
from 900 million (December 2015) to more than 1 billion
(November 2017) protein fragments. For each fragment the
amino acid sequence, PDB ID, PDB chain label, the residue
numbers of N- and C-terminal stem atoms and a geometri-
cal fingerprint is stored in the databases.
Implementation details
The FragFit server integrates two major steps––the frag-
ment search (FragSearch) and the fitting of these fragments
(FragFit) into cryo-EM density (see Figure 1).
FragSearch is based on the hierarchical approach imple-
mented by Superlooper and SL2, which allows fast and ef-
ficient searches of huge databases (7,8). Briefly, FragSearch
selects fragment candidates of the same length as the
queried segment and with a similar distance d of N- and
C-terminal stem residues as in the gap of the protein struc-
ture (d < 0.75 Å). The resulting candidate fragments are
ranked by a geometrical fingerprint score that takes geomet-
ric matching of stem residues of fragment and the protein
chain at the gap and sequence similarity into account. Frag-
ments of highly similar three dimensional structures are fil-
tered out from the top 1000 list to maximize the conforma-
tional space represented by this list (see (9)). The top 100 list
of ‘suitable fragments’ is finally provided and subsequently
re-ranked by the local fit to cryo-EM density maps (Frag-
Fit).
FragFit employs pre-processed cryo-EM density maps
for re-scoring of the top 100 list of suitable fragments. For
pre-processing a minimal box enclosing the density of the
queried segment is extracted from the uploaded cryo-EM
density map before densities occupied by other parts of the
structure are deleted. These pre-processing steps maximize
segment prediction quality and minimize calculation time
(10). Simulated density maps of the backbone of the frag-
ments are generated and filtered to the resolution of the ex-
perimental cryo-EM density map using a Butterworth low
pass filter. At last, to re-rank the top 100 list of suitable frag-
ments, the Pearson cross-correlation coefficient is calculated
between the simulated density maps and experimentally de-
termined cryo-EM density maps with SPIDER (26). Frag-
Fit applies well to high or medium resolution maps. Even
for resolutions above 12 Å, the overall shape of the map
can restrict the space of possible fragment conformations
sufficiently to guide modeling (10). In the latter case, visual
inspection and control is, however, obligatory.
Technical details
FragFit is free to access from http://proteinformatics.de/
FragFit and no login procedure is required. The web ap-
plication is written in JavaScript and compatible with any
modern web browser (Mozilla Firefox (>v.29), Google
Chrome (>v.27), Microsoft Internet Explorer (≥v.11), Ap-
ple Safari (≥v.8)) and requires no plug-ins to be installed.
The web server is implemented as a combination of sev-
eral Python modules running on a dedicated Linux server.
The job management and scheduling is handled by a Python
job server using the Flask framework (http://flask.pocoo.
org/). Each job is run as a Python script performing pre-
processing of the input, running external scripts and pro-
grams (Python, SPIDER and DELPHI) and preparing the
output. The structure and the top 100 list of fitting frag-
ments are visualized for interactive selection by the NGL
Viewer (22,23).
UTILITY AND WEB INTERFACE
The FragFit web application provides an intuitive graphical
user interface (GUI) integrated into the NGL GUI (Figure
1). In the following, the main GUI elements for input and
output are described in detail. A descriptive guide and fur-
ther information are provided in the online documentation,
including a method section, example results, documenta-
tion and a list of frequently asked questions.
Required server input and input modifications
The user has to provide a cryo-EM density map in MRC
or CCP4 (MAP) format and the atomic coordinates of a
protein structure in PDB format v3.x as input for the web
interface of FragFit. Both are automatically loaded into the
NGL Viewer for interactive inspection. Note that in or-
der to speed up upload to the server, huge maps should
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Figure 1. Workflow, input panel and result table of the FragFit web-application. The top part gives an overview about the FragFit workflow, the lower
part presents a screenshot of the web service with input panel (left), molecular visualization and result panel (right). As input, the PDB structure (‘PDB
file’), the cryo-EM density map (‘Density/MRC file’), its resolution (‘Map resolution’), the sequence of the queried segment (‘Fragment sequence’) and
the stem residues flanking the queried segment (Stem residue 1/2) must be provided. As soon as a search is initiated, suitable fragments are selected from
the database by geometric and sequence criteria (FragSearch). The list of suitable fragments is automatically re-scored by the cross-correlation coefficient
between the simulated map of the fragment and the minimal cryo-EM density map, which is extracted during pre-processing. The output (bottom right)
allows visual inspection and selection of the most appropriate fitting fragment by the NGL Viewer from the top-100 hit list (bottom center). A sortable
result table (bottom right) provides information about FragSearch and FragFit scores used for ranking, sequence similarity, sequence and origin of the
template and backbone clashes. If no appropriate fragment is found, the input data can be modified e.g. the search window can be extended in N- or
C-terminal directions. Finally, selected fragments are integrated into the protein structure and are available for download.
of missing fragments. The density map and the structure
file have to be aligned. Number and chain-ID of the stem
residues (where a fragment should be modeled in) must ei-
ther be typed into the respective form (Figure 1) or can be
selected by directly clicking onto the stem residues within
the viewer canvas. The sequence of the queried protein seg-
ment and the resolution of the cryo-EM density map need
to be specified as well. For membrane proteins, planes indi-
cating the lipid bilayer can be automatically obtained from
the TMDET (27) web-service to guide modeling of mem-
brane protein loops in the NGL Viewer (22,23).
After the job has been started, the input interface remains
open to provide the possibility for input modifications after
initial result inspection. If no suitable candidate is found, a
new search can be started with the search window extended
in N- or C-terminal directions. In this case, the amino acid
sequence of the queried segment is automatically expanded.
Server output
Depending on the fragment length, finishing a search may
take some seconds up to several minutes. The page is au-
tomatically updated (see Figure 1). Fitting fragments can
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the cryo-EM density map by the NGL Viewer. The interac-
tive result table is initially ranked according to the cross-
correlation score, which evaluates the local fit of a frag-
ment to the cryo-EM density map. For each candidate the
FragSearch and FragFit score, PDB ID, the origin and se-
quence of the template protein, the sequence identity and
the number of clashes is listed. Of note, the user can sort
the results list by each of these columns. A selected loop
candidate is automatically integrated into the structure with
its target sequence and side-chains (not energetically min-
imized) added and can be downloaded for further usage.
Since the fragments are taken from PDB structures which
have undergone several steps of quality control, the frag-
ments do not necessarily have to be refined, only the side
chain rotamers might have to be edited.
CONCLUSION
Using a hierarchical search algorithm and efficient pre-
processing of cryo-EM density maps, FragFit is able to
quickly and effectively model protein segments into cryo-
EM density maps. Providing visualization by an interactive
web application carried out by the NGL Viewer (22), loop
candidates can be inspected and controlled directly within
the same application. The utility of FragFit has been proven
to guide modeling of poorly resolved regions (11), but may
also serve for approaches where protein domains are recon-
nected after rigid fitting or more generally to re-model flex-
ible hinge regions. In summary, FragFit offers structural
biologists easy access to modeling of missing segments in
cryo-EM structures.
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MDsrv: viewing and sharing molecular 
dynamics simulations on the web
To the Editor: Molecular dynamics (MD) simulations are a well-
established technique to investigate time-resolved motions of 
biological macromolecules at atomic resolution1. Methodological 
advances, continued software optimization and hardware accel-
eration have broadened the applicability of MD simulations with 
respect to feasible system size, runtime and quality2. Coupled to 
these advances, availability of vast cloud storage is enabling the 
creation of MD trajectory databases3. However, accessing, viewing 
and sharing MD trajectories is restricted by large file sizes and the 
need for specialized software (e.g., VMD, Chimera, Schrodinger 
Suite Products), which greatly limits the audience to which the MD 
data are available. In light of increasingly interdisciplinary research 
and remote collaborations, it is desirable to make the atom trajec-
tories of MD simulations widely available to facilitate interactive 
exploration and collaborative visual analysis as well as to promote 
discussions. While some tools exist for analysis or visualization of 
trajectories, none of these offers a straightforward and easy solution 
for sharing and viewing MD trajectories online (for a comparison, 
see Supplementary Note 1).
Here, we present MDsrv, a tool to stream MD trajectories and 
show them interactively within web browsers without requir-
ing advanced knowledge in specialized MD software (Fig. 1). 
MDsrv is available as a software package (via PyPi and conda, 
Supplementary Software) that can be run locally or deployed 
to a dedicated web server to make data from MD simulations 
accessible to a wide audience of researchers, which helps to 
facilitate collaboration between computational and experimen-
tal researchers (see Supplementary Note 1). For interactive and 
remote exploration of trajectories, we used client-server archi-
tecture to create a web-based platform. MDsrv can be used for 
viewing or serving MD simulations. The latter usage offers two 
modes of operation—one is an easy-to-use command-line tool 
for local service (Supplementary Fig. 1a); the other deploys 
the tool on a server to provide a dedicated streaming service 
(see Supplementary Notes 2–4). MDsrv supports structures, 
topologies and trajectories from common MD packages includ-
ing Amber, Gromacs, NAMD, Tinker or Desmond. To aid visu-
alization and analysis of MD trajectories, a number of process-
ing steps can be performed on the structure and trajectory data 
(Supplementary Table 1). When analyzing MD simulations, the 
focus is generally on the internal motions of the macromolecule 
rather than on the diffusion movement in aqueous solution or 
lipid bilayers. To display unprocessed data from nascent simula-
tions, on-the-fly superposition to a reference structure, handling 
of simulations with periodic boundary conditions and second-
ary structure assignment can be performed. By applying these 
calculations only to displayed frames, no scalability issues arise 
when viewing large structures and very long trajectories. Finally, 
to reduce the amount of transferred data, coordinate frames can 
be retrieved individually, and atoms from solvent or other, non-
relevant molecules can be filtered out before transferring a frame.
Scalable molecular graphics for the MDsrv web application 
are provided by the NGL Viewer4. Accelerated 3D graphics are 
enabled by WebGL, a standard built directly into web browsers 
without requiring installation of plugins. NGL supports a wide 
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Figure 1 | VR using the Autodesk Molecule Viewer. (a) Screenshot of the 
Autodesk Molecule Viewer tool in its editing mode. (b) Exploring structures 
using a desktop-machine-linked VR headset through a web browser. 
(c) VR content loaded onto a smartphone web browser for exploration with 
an inexpensive cardboard VR device. (d) Audience members following a 
VR-based structural biology seminar.
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MDsrv is the next natural step in the sharing and visualization 
of MD simulations. Given the capabilities of MDsrv, we envision a 
number of use cases where it will prove helpful. Scientists perform-
ing MD simulations can benefit from MDsrv by remotely accessing 
MD trajectories. They can, for instance, use MDsrv to quickly share 
their simulations with collaborators without needing to completely 
transfer or process the data. In fact, the browser-based visualization 
gives experts, nonexperts or students easy access to MD simulation 
data for the first time. MDsrv thus supports collaborative visual 
analysis, peer review and teaching.
Life Sciences Reporting Summary. Further information on 
experimental design is available in the Life Sciences Reporting 
Summary.
Code availability. MDsrv is openly developed and available under 
the MIT License. The source code is provided as Supplementary 
Software. Updated versions, documentation and examples are avail-
able online at http://nglviewer.org/mdsrv/.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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array of molecular representations, including spacefill, ball and 
stick,  cartoon, and molecular surface. The appearance of the rep-
resentations can be fine tuned by various parameters, for example, 
to change the rendering quality, color or size. These parameters 
for molecular representations can also be scripted and stored for 
sharing MD trajectories (Supplementary Fig. 1b). MDsrv can be 
embedded into a website to provide scripted but interactive views 
of MD trajectories (see Supplementary Fig. 2 and tool’s website) 
or accessible via a graphical user interface (GUI) that allows the 
creation of complex molecular scenes (Supplementary Figs. 2–4). 
A set of controls is available for animating a trajectory, including 
playing and pausing, speed, frame increment and display of simu-
lation time. The GUI further provides controls to add new rep-
resentations or change parameters of molecular representations. 
Individual frames of a viewed MD trajectory can be saved as PDB-
formatted files directly from the web application for subsequent 
analysis. Further, the displayed molecular scene can be exported 
at any time as high-resolution images (Supplementary Fig. 4).
Figure 1 | Schematic display of MDsrv’s capabilities. Left, a rendering of 
cholesterol (red, orange, yellow) entering a G-protein-coupled receptor 
(steel-blue cartoon) as observed in an MD simulation5. The cholesterol 
molecule is shown for different stages of the process of entering. The 
receptor dynamics are indicated by showing several snapshots of the 
receptor (gray line traces). Right, the main components of the web 













Supplementary Figure 1 
MDsrv command-line usage and NGL scripting example. 
(A) Command-line usage of the 'mdsrv' tool. To open and view a MD trajectory in a browser, a structure and a trajectory file must be 
supplied. Optionally, a script file can be loaded to automate creation of complex molecular scenes (see B). Further arguments allow 
basic server configuration, such as setting port or host. (B) Example NGL script. The JavaScript-based code loads the md.gro structure 
file and adds the md.xtc trajectory to it. Display is limited to non-hydrogen protein atoms. A cartoon and a licorice representation are 
added. Finally the view is centered. 
Nature Methods: doi:10.1038/nmeth.4497
 
Supplementary Figure 2 




Supplementary Figure 3 
Graphical user interface (GUI) of the MDsrv web application.. 
(A) The main GUI. The sidebar on the right shows loaded files and added representations in collapsible panels with sub-elements 
including atom selection/filter (funnel symbol), trajectory (disk stack symbol) or menu (stacked bars symbol). The menu bar at the top 
provides access to general options. (B) By selecting 'File', (C) a submenu pops up from where structure files or NGL scripts can be 
loaded. (D) Trajectories can be loaded from the structure menu. (E) A “Remote Trajectory” is streamed by MDsrv whereas (E) a 
“Trajectory” import loads a file all at once. (F) Within the trajectory menu are options for handling superposition and periodic 
boundary conditions as well as playback settings. (G) By picking an atom or bond in any representation, their information is shown in 
the lower left of the GUI. 
Nature Methods: doi:10.1038/nmeth.4497
 
Supplementary Figure 4 
Snapshots of MD simulations viewed with MDsrv. 
(A) Self-assembly of three Bace1 transmembrane helices in a DPPC lipid bilayer obtained from coarse-grained MD simulations with 
carbons in grey, polar lipid head groups in red balls and water molecules in blue balls. (B) Cholesterol (green or grey hyperballs) 
enters the A2A receptor (violet cartoon) during MD simulations performed in a mixed lipid bilayer with carbons in grey, oxygens in 
red and nitrogens in blue19. (C) Simulations of a huge complex containing more than 550,000 atoms. The Gs protein (pink) is bound to 
the beta2 adrenoceptor (violet) within a phospholipid bilayer solvated in water (color code as in B, hydrogens in white) (D) Decisive 







Supplementary Note 1: Background on MDsrv: the 
next natural step in sharing and visualization of MD 
simulations in collaborative research networks. 
Software for molecular visualization was initially only available to 
specialists in the field, however, the large number of new protein 
structures deposited at the Protein Data Bank (PDB) over the last 15 
years has completely changed this picture. Nowadays, biologists, 
chemists, and biochemists visualize proteins and other macromolecules 
on a routine basis using a new plethora of easy-to-use visualization 
software (lately reviewed in 1) that is additionally benefiting from the high 
increase in computer power, particularly when it comes to Graphic 
Processing Unit (GPU) capabilities2. In addition, popular software for 
molecular visualization including VMD3, Chimera4 or PyMOL5 offer a wide 
range of tools that are typically used by rather advanced users to prepare, 
visualize and analyze MD simulations. These programs are distributed as 
stand-alone software and require pre-installation to function on a local 
computer, clearly limiting collaborative research due to their inability to 
offer quick or efficient sharing of MD simulation data. 
In contrast, web-based solutions facilitate immediate display of data 
without the need to install specialized software. A major advantage of 
web-based solutions is the spontaneous access of pre-processed MD 
trajectories from machines that have not previously been set-up for that 
purpose. Thus, instead of being loaded from a local file, MD trajectories 
can be loaded remotely from a web server and interactively be displayed 
in a web browser without previous installation of additional software. 
Another benefit from using web-based visualizations over locally 
installable solutions is that relevant aspects of MD trajectories can easily 
be highlighted through presets and sessions defined by the expert who 
performed the analysis and thus promoting direct access also by non-
expert users.  
Visualization of molecular structures in a web browser is extensively used 
but until recently, web browsers could not display 3D content without 
additional plug-ins. Therefore, programs like Jmol6 or the 
OpenAstexViewer7 were embedded within a web page as Java Applets, a 




browser technologies have lead to a surge of new developments of 
molecular viewers that leverage the increased speed of JavaScript and 
access to graphics cards through WebGL8. Browser-based viewers using 
WebGL include Glmol within mdtraj9, chemview, pv10, Jmol/Jsmol6, 
LiteMol, 3Dmol.js11and Molmil12. However, none of these viewers offers a 
solution to efficiently view MD trajectories. The MegaMol Framework for 
Particle-Based Visualization offers a client-server approach to view MD 
trajectories but is focused on visualization research and prototyping rather 
than supplying software for life scientists13,14. 
We previously introduced the NGL Viewer as a web application for the 
display of macromolecules with a focus on scalability15,16. This viewer has 
quickly become the default option to visualize macromolecules at the 
RCSB PDB (http://www.rcsb.org/) due to its fast and interactive web-
based capabilities. Therefore, to support viewing results from MD 
simulations we augmented the NGL Viewer with features to load and 
animate MD trajectories. Here, we introduce the MDsrv tool that provides 
fast access to MD trajectories and a web application for on-line 
visualization that is usable by life-scientists. MDsrv includes optimizations 
to handle large and unprocessed datasets. The web application displays 
macromolecular structures and animates their MD trajectories for 
interactive exploration and collaborative visual analysis. The project is 
openly developed and the software, documentation and examples are 
freely available from http://nglviewer.org/mdsrv/. 
 
Supplementary Note 2: Usage & scripting support 
(see MDsrv documentation for more details) 
Access to molecular dynamics (MD) trajectories and the web application is 
provided by the program 'mdsrv' as a command-line tool for local use or 
deployment on a dedicated server to provide an independent service. 
When used as a command-line tool, 'mdsrv' starts a local web-server and 
opens the web application within a browser. By default access is provided 
to all files and directories inside the execution directory. A number of 
command-line arguments are available for quick access of structures and 
trajectories (see Supplementary Figure 1A). Moreover, complex molecular 
scenes (see Supplementary Figure 1B) can be created programmatically 
through JavaScript-based scripting. For deployment on a server, Apache 
Server and mod_wsgi are used. A configuration file is needed to set up file 
access and to define hidden and password protected directories. The on-




(http://nglviewer.org/mdsrv). The ‘mdsrv’ program is available for easy 
installation from the Python package manager (https://pypi.python.org) 
and from the CONDA channel ‘conda-forge’ (https://conda-forge.org and 
https://anaconda.org). 
Supplementary Note 3: Implementation (see MDsrv 
documentation for more details) 
The server component is written in the Python programming language and 
uses the Flask framework to create a WSGI compliant web server. For 
production deployment, the server component can be run on top of the 
Apache HTTP Server through the mod_wsgi module. The server 
component fulfills four roles: (1) Serve static JavaScript, HTML, CSS, 
GLSL as well as font and image files needed by the browser application; 
(2) provide data files whose content should be displayed in the browser 
application, including structure/topology files in GRO, PDB, TOP, PSF or 
PARM7 format and NGL script files; (3) handle requests for trajectory 
frames; and (4) ensure basic access control to either the server in general 
or specific data directories. This is achieved through the HTTP basic-
access authentication method. Of note, to provide full security, the HTTPS 
encryption protocol must be used to serve the web application. 
 
The web application is written in JavaScript with some HTML and CSS for 
the graphical user interface (GUI) as previously described15. It can be 
divided into multiple task-specific areas: (1) Reading, processing and 
updating of molecular structures; (2) transforming molecular structures 
into display representations such as spheres for atoms, sticks for bonds or 
tubes tracing a protein backbone; (3) rendering of display representations 
on the GPU with WebGL; and (4) creating an interactive user interface 
that includes a GUI and scripting support. With a recent update, the NGL 
Viewer scales to large structures with millions of atoms16. For that WebGL 
is used efficiently by avoiding costly calls to the WebGL API and by 
rendering spheres and cylinders as ray-casted impostors. Further, Web 
Workers are employed to perform long running calculations, such as 
generating molecular surfaces, to leverage available CPUs and to not 
block the user interface. Modern web browser can perform 3D graphics 
acceleration though WebGL, a standard built directly into the browser 
without the need for installation of plug-ins. Support for WebGL is 
available in most of worldwide installed browsers (see 
http://caniuse.com/#feat=webgl). WebGL provides 3D web graphics based 




element. Bindings to JavaScript provide a flexible and low-level API to the 
GPU for web-based applications. Further, continuous work on JavaScript 
compilers has made the language suitable even for numerical 
calculations17.  
 
Supplementary Note 4: MD trajectory serving (see 
MDsrv documentation for more details) 
The key task of the server component is to provide access to vast 
amounts of MD trajectory data. For that purpose, access functions for the 
most common trajectory formats were derived from their corresponding 
implementations in the MDTraj9 and the MDAnalysis software package18, 
which allow fast, random access to any frame without reading the whole 
file into memory. The supported formats are currently XTC, TRR, 
NETCDF, LAMMPSTRJ, XYZ, BINPOS; HDF5, DTR, ARC, TNG and 
DCD. Together, these are the binary trajectory file formats used by the 
simulation packages Gromacs, CHARMM, Amber, NAMD, Tinker and 
ACEMD. This functionality gets automatically installed together with the 
main MDsrv tool. 
 
Molecular dynamics simulations are usually performed with periodic 
boundary conditions (PBC), meaning that an atom that is leaving the 
simulation box at one side enters the box on the opposing side. If not 
addressed by MD simulation programs when outputting the trajectory, it 
results in split molecules. To avoid this issue PBC-aware centering of the 
macromolecule is performed by NGL using the circular mean to calculate 
the real center of such split molecules. Using this approach, all 
coordinates are shifted to place a macromolecule in the center of the box. 
As only one molecule or group can be centered at a time, molecules not 
used for centering may still be split. To correct for this artifact an algorithm 
is performed on all atoms ensuring that consecutive atoms in bounding 
distance are placed on the same side of the box, so they are not split. 
After PBC handling, superposing is performed by standard least square fit 
of the backbone atoms using singular value decomposition. Additionally, 
structures from coarse grained simulations are detected and handled 
specially by taking missing or combined backbone and side-chain atoms 
into account when calculating backbone traces or assigning alpha-helical 





Supplementary Table 1: General comparison between MDsrv and the common 
standalone software VMD 
Feature VMD NGL + MDsrv 
Environments Standalone (desktop, server) Web browser (desktop, mobile), 
Installation Required No installation required 
Structure file formats mmCIF, PDB, PQR, GRO, SDF, MOL2 and more 
mmCIF, PDB, PQR, GRO, 
SDF, MOL2, MMTF 
File formats 
Structure: PSF, PRMTOP, TOP 
and more 
Structure: PSF, PRMTOP, 
TOP 
Trajectory (client-side loading): 
DCD, NCTRAJ, TRR, XTC and 
more* 
 
No server-side trajectory 
streaming. 
Trajectory (client-side loading): 




NCTRAJ/NetCDF, TRR, XTC, 
LAMMPSTRJ, XYZ, BINPOS, 
HDF5, DTR, ARC, TNG 
Volume: MRC/MAP/CCP4, 
DX/DXBIN, CUBE, BRIX/DSN6, 






Basic: depth cueing/fog, 
front/back cutting planes 
Basic: depth cueing/fog, 
front/back cutting planes 
Advanced: Raytracing, shadows, 
multiple lights, multiple materials, 
anti aliasing (MSAA), stereo 
modes 
Advanced: Anti aliasing 




Basic: cartoon, ball + stick, 
spacefill, surface, line, isosurface, 
slice and more 
Basic: cartoon, ball + stick, 
spacefill, surface, line, 
isosurface, slice and more 
Advanced: QuickSurf, HyperBall, 
Bendix, PaperChain and more Advanced: HyperBall, Rope 
On-the-fly trajectory 
processing Interpolation (linear, spline) 
Interpolation (linear, spline), 
centering, approximate PBC 
removal, super-positioning 
Operating systems Linux, MacOS, Windows Linux, MacOS, Android, Windows (under development). 
Analysis tools (basic) 
Basic: distance, angle, dihedral 
measurements, info about picked 
atom 
Basic: distance 




Advanced: a comprehensive set 
of tools is available**  
No advanced analysis tools 
available 
Scripting language Tcl/Tk and Python JavaScript 
 
* Complete list of file formats at http://www.ks.uiuc.edu/Research/vmd/plugins/molfile/ 
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Opinion
Bringing Molecular Dynamics Simulation Data
into View
Peter W. Hildebrand,1,2,3,* Alexander S. Rose,4,@ and Johanna K.S. Tiemann1,@
Molecular dynamics (MD) simulations monitor time-resolved motions of macromolecules. While
visualization of MD trajectories allows an instant and intuitive understanding of dynamics and
function, so far mainly static representations are provided in the published literature. Recent ad-
vances in browser technology may allow for the sharing of trajectories through interactive visu-
alization on theweb.We believe that providing intuitive and interactive visualization, alongwith
related protocols and analysis data, promotes understanding, reliability, and reusability of MD
simulations. Existing barriers for sharing MD simulations are discussed and emerging solutions
are highlighted.We predict that interactive visualization of MD trajectories will quickly be adop-
ted by researchers, research consortiums, journals, and funding agencies to gather and
distribute results from MD simulations via the web.
Dynamics Leads to Understanding Macromolecule Function
Molecular dynamics (MD, see Glossary) simulations are a well-established technique to investigate
time-resolved motions of biological macromolecules at atomic resolution [1,2]. Traditionally, macro-
molecules such as enzymes, channels, transporters, or receptors have been perceived as being rigid
entities mainly because structures obtained by X-ray crystallography are fixed in crystal lattices and
are therefore resolved as single, static snapshots. However, when compiled together, these snap-
shots often reveal that macromolecules exist in different substates and states, hinting that there is
dynamic fluctuations between substates and states [3]. Prominent examples are the G protein-
coupled receptors (GPCRs), which exist in multiple inactive and active states with different signaling
properties [4,5]. Complete understanding of the structural background of GPCR signaling and phar-
macological applications requires an in-depth knowledge of receptor and G protein dynamics [6–8].
To overcome these limitations, MD has been developed over several decades, becoming a cutting-
edge technology in the life sciences. Formally, the award of the Nobel Prize in Chemistry in 2013 to
Martin Karplus, Michael Levitt, and Ariel Warshel for the development of multiscale models for com-
plex chemical systems (https://www.nobelprize.org/prizes/chemistry/2013/press-release/) has af-
firmed the relevance and importance of MD [9]. Methodological advances, continued software opti-
mization, and hardware developments have broadened the applicability of MD simulations with
respect to feasible system size, runtime, and overall quality [10]. These developments are also re-
flected by the rising number of standardized and intuitive usable tools for automated setup and anal-
ysis, facilitating usage and enhancing reproducibility/replicability of MD simulations [11,12].
To bring MD into view for a broader audience, we believe the results of MD simulations now have to be
presented in a comprehensive and feasible way. So far, even accessing, viewing, and sharing ofMD trajec-
torieshasbeenhinderedby large file sizes formacromolecular structures and theneed for specializedsoft-
ware, limiting the audience towhich this technology has been available. However, recent developments in
web-based technology have allowed for efficient visualization of even large macromolecules such as
macromolecularmachines and virus capsids inwebbrowsers [13,14].Webelieve these advances areopen-
ing upnewpossibilities for sharing the visualization ofMDtrajectorieson theweb andwill foster interactive
collaborations, accessibility, and transparency (Box 1, Figure 1, Key Figure).
Visualization Is Timely and Necessary
Visualization facilitates and guides data analysis, and the complementary strengths of human andma-
chine analysis are potentiated when led by interactive visualization [15]. Advanced visual interfaces
that fuse analysis and visualization can combine human flexibility, creativity, and background
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MD simulations have become
routinely used over the past years
to investigate dynamic motions of
macromolecules at the atomic
level.
Interactive visualization of MD tra-
jectories may provide an instant,
transparent, and intuitive under-
standing of complex dynamics.
Sharing of MD trajectories may
generate transparency and trust,
allowing collaboration, knowledge
exchange, and data reuse.
Recent technological de-
velopments now allow visual
sharing of MD trajectories over the
web using tools such as the MDsrv
and HTMoL.
GPCRmd presents the first central-
ized special-purpose MD deposi-
tion platform featuring powerful
trajectory visualization.
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knowledge with storage and processing capacities of computers to gain insights into complex prob-
lems [16]. Taking into consideration that scientists trust results presented by visual analytics more
than other nonvisual media [17], we feel it is time to enable a comprehensive and detailed view on
MD trajectories.
Visual analysis has always guided pattern recognition along with other types of MD analysis [18]. For
analysis and visualization, tools installed on local machines such as Visual Molecular Dynamics (VMD)
[19] or Chimera [20] are used by experts to manipulate the perspective, zoom in on a certain structural
detail, or change the display mode of a trajectory. When MD data (Box 2) are prepared for publica-
tion, they are commonly translated into tables and static figures showing running averages of trajec-
tories with related statistics to describe the dynamic properties of a specific biophysical system. Fig-
ures visualize a predefined setting of those systems focusing the view of the reader to selected
aspects like the binding pocket of a receptor while hiding other features or regions due to their static
property. Videos provide a more dynamic but still limited glance on the simulations as they are also
predefined without allowing manipulation of the perspective.
The full potential of MD simulations, however, is only exploited through interactive visualization of
trajectory files; interactive visualizationmay strengthen and deepen the understanding of a character-
istic finding described in a publication [18]. For example, by zooming in on a certain structural and
dynamic feature of a trajectory that was not within the scope of the original analysis, novel ideas
and hypothesis can be generated and new lines of analysis may be triggered. This approach will
thus add new aspects to a published analysis, detect or explain unresolved issues, and complement
or update previous findings. In our opinion, interactive visualization of trajectories will, therefore, ul-
timately strengthen the perception of MD simulations as a reliable technique to monitor the dynamic
motion of macromolecules.
Visualizing MD Trajectories on the Web
The web has been developed into the primary resource to gather and distribute information in nearly
all areas of life [21,22]. When information is stored and presented in a sustainable way, the web pro-
motes discussion, education, and reputation [23]. To maximize its potential in science, data
Box 1. FAIR Principles
To deal with the growing amounts of large scientific datasets, discovery and innovation increasingly rely on
automation and computational support. In 2016, The FAIR Guiding Principles for Scientific Data Management
and Stewardship were established to endorse the reliability of data [52]. A special emphasis was, and is, put on
enhancing automated searchability and reusability of data. Reusability applies not only to deposition of (raw)
data, but also of algorithms, tools, and workflows for data generation and analysis. According to Wilkinson
et al. [52], using FAIR principles is beneficial for:
C researchers willing to share, credit, and reuse data;
C software/tool developers and data scientists providing processing, integrating, and analysis workflows to
enhance discoveries;
C professional data publishers selling their capabilities; and
C funding agencies in minimizing their rising concerns in long-term data handling.
To ensure that data are findable, a unique and persistent idem has to be assigned, connected to descriptive
keywords and registered in a searchable resource. Accessibility is obtained when (meta)data can be retrieved
by their identifiers using an open, free, and universally implementable protocol. This protocol allows for an
authentication and authorization procedure and keeps metadata accessible even when the data are no longer
available. To be interoperable, (meta)data have to use a specific, general, and consistent language for knowl-
edge representation including linked references. By ensuring an accurate and rich description with relevant at-




face (API): set of protocols/rou-
tines/software packages to facili-
tate development of programs.
Docker images: program that runs
software packages through con-
tainers within an operating system
similar to virtual machines. Docker
images can contain complete
program environments/servers
and can be shared.
DOI/idem: digital object identi-
fier, unique and permanent URL/
sequence/phrase linked to data.
Often used to find and access the
assigned data.
Findable, Accessible, Interoper-
able, Reusable (FAIR): see Box 1.
Graphics processing unit (GPU):
single-chip processor often
embedded on a video card,
motherboard, or mobile phone to
efficiently perform graphical
rendering.
Graphical user interface (GUI):
allowing the user to interact
through graphical icons, menus,
or other types of objects in
contrast to texts with electronic
devices.
Hosted services: provided over
the Internet where a computer is
configured to handle applica-
tions, IT infrastructure compo-
nents, and functions, covering of-
ferings, including web hosting,
infrastructure services, off-site
backup, and virtual desktops
customized to the needs of the
user.
Interoperability: allows data or
tools to work with resources other
than those they have been origi-
nally generated or implemented,
respectively, with minimal effort.
Molecular dynamics (MD): (com-
puter) simulations to study the
movement of atoms and mole-
cules by solving Newton’s equa-
tions of motion.
Replicability/reproducibility:
refer to the generation of the
same/original study results by (i)
using exactly the same protocol
such as the same input, original
source code, techniques, soft-
ware, settings; or (ii) following/
reimplementing the (often less-
detailed/automated) protocol or
algorithmic/workflow description
as given in the published study
(e.g., often different tools, soft-
ware, clusters are used). The as-
sociation/paring of the terms
Trends in Biochemical Sciences, November 2019, Vol. 44, No. 11 903
management should follow the Findable, Accessible, Interoperable, and Reusable (FAIR) principles
to maximize its potential (Boxes 1 and 2). For example, the worldwide Protein Data Bank (wwPDB)
consortium [24] is a prominent data resource that has obtained a central role in structural biology
and life science by following the FAIR principles. As such, all wwPDB members offer web-based mo-
lecular graphics to present the curated and deposited 3D structural coordinates in an intuitive and
comprehensive way. The Research Collaboratory for Structural Bioinformatics Protein Data Bank
(RCSB PDB) [25,26], for instance, uses the NGL viewer for a powerful web visualization [13,14] (Box
3). By providing analysis and visualization in an instant and easy-to-use fashion, the wwPDB has the
ability to reach out to a wider audience. Further, with predefined settings, the NGL viewer can high-
light prominent structural features such as a ligand-binding pocket of a receptor. Optionally, users
can visualize experimental structural data such as density maps, orientations, and contacts within
the assembly, or they can view B factors, thus facilitating critical reviewing of the structures even
before downloading them. Embedded visualization, online analytics, and application of cross-refer-
enced tools have consequently changed the habits of wwPDB users from just downloading structures
towards instant online visualization and analysis [27].
Advances in browser technologies have only recently opened up possibilities for web molecular
graphics and rendering techniques to allow interactive visualization of macromolecules as discussed
above [28]. As a result of a series of these technical developments (Box 3), even web-based visualiza-
tion of MD trajectories has become feasible. TheMegaMol framework for particle-based visualization
was the first to show the capability of web visualization of MD simulations; its client-server approach
for viewing MD trajectories mainly focuses on visualization research and prototyping [29,30]. The
JSmol viewer (https://sourceforge.net/projects/jsmol/) can visualize some trajectory files (e.g., .xyz
files) and can interpret structure files with multiple models (e.g., in .pdb files) as dynamic trajectories.
Similar to MegaMol, JSmol is, however, only capable of reading very few trajectory file formats and
demands expert knowledge for usage.
More recently, the MDsrv was the first user-friendly tool to stream and visualize MD trajectories inter-
actively within web browsers without requiring expert knowledge and specialized software [31]. To
interact with many different (currently 22) trajectory formats, the MDsrv utilizes MDTraj [32] and the
MDAnalysis [33] software packages. By integrating the NGL viewer for web-visualization like RSCB
PDB [13], the MDsrv can display even huge trajectory files in various representations. The MDsrv en-
ables efficient handling of requests for any trajectory frame by not reading the whole file into memory
but by transferring only the information requested for visualization [29]. MD trajectory frames
rendered into a suitable representation editable by the user, for example, a cartoon representation
for the secondary structure and a licorice representation to highlight specific residues or a ligand, can
then be shared and accessed via any modern web browser.
About this time, HTMoL, another web-based MD visualization tool, was presented which also facili-
tates streaming and visualization of MD trajectories on the web [34]. Unique to HTMoL is its imple-
mentation of a fast visualization by direct calling of the graphics processing unit (GPU) that enables
rendering and parsing of trajectories from the three most commonly used trajectory formats – Gro-
macs [35], Charmm [36], and Amber [37]. This is performed by utilizing the Node.js runtime engine to
transfer MD trajectory binary data through a WebSocket connection (Box 3). An Apache HTTP server
is then applied to share and access trajectories via any modern web browser.
In comparison to MDsrv, HTMoL has a higher frame rate for small to medium-sized systems, most
likely due to its direct GPU usage. This means a smoother and faster loading of the trajectory frames
of those sized systems prior to their visualization. HTMoL is currently limited to only three file types
and to a reduced set of structural representations [34], while MDsrv can currently utilize 22 trajectory
file types and more than 20 structural representations [13,31–33]. HTMoL and MDsrv are alike in that
they both require the users to set up their own servers, either within a private network or the public
cloud. We believe that for wider adoption of these tools, hosted services that can access data from
scientific data sharing resources (Box 2) and do not require individual researchers to set up servers
would be highly beneficial. Moreover, web-based MD visualization tools are still far behind the
reproducibility/replicability with
their definition (i) or (ii) depends
on the reference, author, or field
as a consistent and universally
accepted terminology is still
missing and its controversy is key
to ongoing discussions [72,73].
Trajectory: time evolution of an
object moving under the action of
given forces.
Visual analytics: scientific field
focusing on analytical reasoning
supported by interactive visual
interfaces.
Web Workers API: allows
browsers to run heavy calculations
without blocking the user
interface.
Web Graphics Library (WebGL):
JavaScript API for interactive
graphical rendering within a web
browser without the use of plug-
ins.
Worldwide Protein Data Bank
(wwPDB): archive of macromo-
lecular structures determined by
experimental techniques such as
NMR, cryo-electron microscopy
or X-ray crystallography.
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Key Figure
Visualization and Sharing of Molecular Dynamics (MD) Simulations on the Web
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Figure 1. MD trajectories have so far been translated into text, plots, figures, and videos for presentation and publication. Interactive visualization of MD
trajectories on the World Wide Web by MDsrv and HTMol, for example, opens up new possibilities for sharing. Sharing of MD simulations with colleagues
through interactive visualization promotes discussions and triggers new lines of investigations ultimately strengthening interdisciplinary research projects.
Moreover, interactive visualization may support the reviewing process of journals and funding agencies, ultimately contributing to a better understanding of
published MD simulation data and analyses. Interactive visualization may also broaden the outreach of MD simulations in society when used in teaching and
education. Adapted, with permission, from [76].
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capabilities of stand-alone viewer programs such as VMD [19] or others highlighted here [38] that inte-
grate manifold built-in analysis tools like root mean square deviation (RMSD), radius of gyration, ex-
tracting min/max coordinates/distances, heat maps, contact maps, energy plots and many more.
Despite their differences, MDsrv and HTMoL allow instant and interactive dynamic web-based visu-
alization of MD trajectories through intuitive graphical user interfaces (GUIs). After set up of the
server by the MD simulation distributer, the data can be streamed directly through the web without
the requirement to download any trajectory data or to install software by the user/observer. The tra-
jectories become immediately available in the browser as soon as a link served by the creator of MD
simulations (also known as MD simulation distributer) is clicked by the user/observer. In addition, the
MDsrv and HTMoL visualization can be embedded into any website to be combined with other user-
specified analysis tools.
Towards Common Platforms for Sharing and Visualization
Scientific data can be shared through centralized or decentralized solutions. Centralized sharing op-
tions provide a highly efficient way to gather and distribute research results via the web. The wwPDB
serves as a blueprint for centralized solutions to share structural information via the web [24]. Precisely
curated data are accurately and richly annotated by data-depositing authors with easy on-the-point
keywords to ensure findability by the broader community. Additionally, all data deposited to the
wwPDB are freely and openly accessible and reusable. Furthermore, a major reason for the success
of the wwPDB is that most journals require structural biologists to upload their structure information
to the database prior to publication of their manuscripts. This synergistic effect has led to exception-
ally high citation rates of publications, especially on novel structures deposited in the wwPDB [39].
A similar positive effect could also be expected for MD simulations if trajectories and related data
would become accessible and interoperable at the moment of publication (Box 1). In contrast to
Box 2. MD Data and Scientific Data Sharing Resources
Files from MD simulations can be divided into input files, used for production, and output files. Depending on
the software used such as GROMACS [35], NAMD [53], AMBER [37], DESMOND [54], or ESPResSo [55], many
different input and output file formats are required and generated which are often incompatible. Input files are
typically composed of starting structures, core force-field parameters, additional ligands, or other nonstandard
atomic parameters and finally operated by detailed, ideally automated, and shareable protocols. For repro-
ducibility/replicability, additional information about used software versions and computer/cluster systems
has to be provided in addition to metadata, like configuration files and workflow scripts. However, so far,
executable and easily reproducible protocols andmetadata to generate and analyzeMD studies are only rarely
made available. The output of MD simulations consists of raw unprocessed trajectories including coordinates
and velocities, energy, and log files. MD simulations belong to data-intensive sciences (also called e-sciences)
like proteomics, genomics, oceanography, astrophysics, engineering, web sciences, and more. Sharing of raw
or processed MD trajectory files is, accordingly, hampered by large file sizes. Nevertheless, scientific data
sharing resources offer the possibility to deposit data even as huge as trajectories [56].
In response to open science movements [57], numerous scientific general-purpose data repositories at scales
ranging from institutional to open globally scoped repositories emerged. Scientific data sharing resources
such as Dataverse [58], FigShare (http://figshare.com), Dryad [59], Mendeley Data (https://data.mendeley.
com), Zenodo (http://zenodo.org), DataHube (http://datahub.io), OSF (https://osf.io), or NOMAD (https://
nomad-coe.eu) accept a wide range of data types in a large variety of formats. The deposited data can be ac-
cessed globally through a unique, preserved DOI. Compared with well-curated, special-purpose archives like
the wwPDB, most scientific data sharing resources do not aim to integrate, harmonize, validate, or standardize
the deposited data. Since appropriate references and metadata are often not available, it is difficult to filter
suitable data from the huge variety of deposited files and databases. To overcome this challenge, the estab-
lishment of information platforms summarizing and integrating available data should be instrumental in
providing confidence in open source deposition concepts until global data standards are established. Web-
sites such as https://fairsharing.org/ or https://okfn.org/ are helpful resources recommending repositories
for scientific data, standards, and policies [60].
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Box 3. Technical Developments Enabling Web Molecular Graphics
Molecular graphics have been a part of the web since its early days (Figure I). Initially, browsers could not
display 3D content by themselves but relied on plugins [e.g., Chime (MDL Information Systems, Inc. https://
www.umass.edu/microbio/chime/abtchime.htm)] or extensions (Java as used by Jmol [61] and OpenAstex-
Viewer [62]) that had to be installed in addition to the browser. Lack of access to hardware accelerated graphics
and inflexible data streaming have been major limitations for web molecular graphics. In recent years, ad-
vances in browser technology have opened up new possibilities for web molecular graphics and rendering
techniques [28].
Modern browsers now include native support for GPU hardware acceleration through the Web Graphics Li-
brary (WebGL) Application Programming Interface (API) (https://www.khronos.org/registry/webgl/specs/
latest/). This enables web molecular graphics tools to provide fast 3D graphics on par with desktop programs.
In addition to GPU rendering, WebGL also includes support for handling binary data natively in the browser
which makes working with numerical and binary data much more efficient. Starting with GLmol (https://
github.com/biochem-fan/GLmol), the new browser capabilities have led to an explosion of web molecular
graphics tools, including PV (https://github.com/biasmv/pv), 3Dmol.js [63], NGL [13], Molmil [64], LiteMol
[65], and more (Figure I).
Nowadays, nearly all computers have multicore processors and the Web Workers API runs computations in
worker threads in parallel, leveraging the many cores of processors. As an additional benefit, the worker
threads perform tasks in the background without blocking the user interface. This is helpful for computationally
intensive tasks like calculating molecular surfaces and is employed, for example, by NGL and 3Dmol.js.
To provide real-time access to large amounts of data on demand, an efficient, low overhead data streaming
approach is often used. The WebSocket protocol (https://tools.ietf.org/html/rfc6455) enables this interaction
between a web browser and a web server and is muchmore efficient than the traditional HTTP protocol (as used
by MDsrv [31]). WebSockets are used by HTMol [34] and MegaMol [29,30] to stream MD trajectories to a web
browser.
A new generation of web applications is leveraging these tools enabled by the advances in browser technol-
ogies for modern computer-aided drug design [66] and general molecular sciences [22]. Additionally, a new
collaborative project, Mol* [67], was started to develop a common tool for web molecular graphics to better
meet visualization challenges.
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Figure I. Timeline (Center) of Relevant Web Browser Technologies (Bottom) and Popular WebMolecular
Graphics Tools (Top).
The listed web molecular graphics tools can be divided into a pre and post WebGL era (light green to
increasingly dark green). Pre WebGL: MDL Chime (MDL Information Systems, Inc. https://www.umass.edu/
microbio/chime/abtchime.htm), Jmol/JSmol [61], AstexViewer [62]. Post WebGL: GLmol (https://github.
com/biochem-fan/GLmol), Jolecule (http://jolecule.com/), PV (https://github.com/biasmv/pv), 3Dmol.js [63],
NGL Viewer [13], LiteMol [65], Molmil [64], and iCn3D [74] and Web3DMol [75].
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data uploaded to the wwPDB, MD simulations can accumulate huge trajectory files ranging from
gigabytes to terabytes, which may raise concerns about a sharable solution for storage and handling
(see Outstanding Questions). However, sharing of huge amounts of data is feasible as demonstrated
by other data-intensive science fields. The Galaxy Project [40] is a prominent example showing how
community fostered standards and guidelines promote efficient and accurate sharing and reuse of
huge genomic data [41].
Nevertheless, the establishment of centralized sharing platforms requires many efforts, guidelines,
community engagement, and a central dedicated and sustainably funded organization [42]. Commu-
nity engagement is crucial as any centralized organization has to be guided by the community. The
wwPDB has, for example, various task forces for validation, format development, and regarding new
experimental techniques [43,44]. Centralized, special-purpose MD platforms may accordingly be
considered a first step on the way towards the establishment of global MD platforms. Several such
platforms have already been created (Table 1), but only BIGNASim [45] and GPCRmd (http://www.
gpcrmd.org/) feature interactive visualization of trajectories. BIGNASim is a platform containing a
database system and analysis portal for MD simulations of nucleotides [45]. It includes a comprehen-
sive analysis tool package and a spartan interactive visualization of trajectories by JSmol, limited to
play and pause. Curated simulations by users can be up- and downloaded. Moreover, a reduced
version of BIGNASim can be installed as a local platform to serve sensitive or unpublished data via
Docker images by individual researchers/MD simulation distributers.
The GPCRmd is a comprehensive database and web platform for MD simulations of GPCRs and
related analysis (http://www.gpcrmd.org/). It uses the MDsrv for interactive visualization of trajec-
tories with predefined settings to highlight GPCR specific features (Figure 2). Linked to the MDsrv
are pharmacological, biochemical, or biophysical data like mutations or X-ray crystallography density
maps and an interactive, topic-specific Flareplot analysis (https://gpcrviz.github.io/flareplot/). The
platform has a descriptive, easily searchable framework and includes an application for simulation
setup and deposition, also available with unique idem/DOI. Similar to the Galaxy Project [40],
GPCRmd is discussed, designed, and influenced by a research community which makes the platform
frequently used, widely supported, and sustainable.
For researchareas andfieldswhere nocentralized sharingplatformsare available, individual researchers or
groups can enrich their own websites with embedded simulations (e.g., http://nglviewer.org/mdsrv/
examples). In contrast to the default settings of centralized options, sharing through decentralized solu-
tions allows the creatorofMDsimulations todefine studyspecificpre-settings.Analogously, user-specified
analysis tools canbe combinedwith interactive visualization in amodular fashion.As anexample, iBIOMES
facilitates searchability and findability by providing ametadata schema for indexing and summarizingMD
data in a web-searchable representation [46,47]. In summary, decentralized optionsmay be usedby scien-
tists preferring instant, independent and creative solutions for sharing and publication of MD trajectories.
Moreover, it may be the primary way to share trajectories with collaboration partners fostering critical dis-
cussions already on an early stage of the project.
Concluding Remarks and Future Perspectives
Visualization and sharing of MD trajectories can be considered initial steps towards a community
following the FAIR principles. We expect several lines of developments guiding this process, though
several issues remain to be resolved (see Outstanding Questions). Notably regarding shared visual-
ization in context of the FAIR principles, the data must be findable and accessible and sufficiently
interoperable to allow for visualization. Especially, findability suffers from poor description while reus-
ability suffers frommissing verification for completeness and coherence of all MD data. In the broader
context of making MD simulations reproducible, the interoperability and reusability aspects become
more important. Currently, there are no widely accepted guidelines for makingMDdata globally find-
able or accessible. A comprehensive and constantly developing discussion and description is needed
to examine if full FAIR compliance can be obtained for all MD data, whether it is needed and how
much it would cost.
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The availability of online tools for interactive visualization can set a novel standard for sharing of MD
trajectories: first, raw and unprocessed trajectories prior to extensive analysis can be shared within
workgroups to guide initial research, before sharing the MD outcome with collaborators and a
broader audience (Figure 1). This development accelerates as user-friendliness and acceptance of
tools for interactive visualization of MD trajectories improve and scientific data repositories become
standardized. Consciousness for interactive visualization and sharing options of MD simulations will
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Figure 2. Screenshot from GPCRmd (http://www.gpcrmd.org/).
The interactive visualization is shown on the left panel: in the upper part, the embedded MDsrv is showing the molecular dynamics (MD) trajectory together
with X-ray crystallography density maps. Below, a G protein-coupled receptor (GPCR)-specific selection mode can be used to visualize GPCR-specific
structural features. The analysis (right panel) is interconnected to the interactive visualization by the MDsrv. By clicking on a link within the Flareplot
(right upper part), the hydrogen bonding network between those residues is directly visualized in the MDsrv (left upper part). On the right lower panel,
the time-dependent development of a distance between two atoms clicked within the MDsrv is plotted.
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grow through appropriate workshops, social media discussions, scientific meetings, or simply by suc-
cessful integration into centralized MD platforms such as GPCRmd.
We believe a particularly important step will be the integration of interactive visualization of MD
trajectories into reviewing processes and ultimately journal policies that have a major impact on
the research behavior of individual scientists [48]. Recently established journal formats such as
ActivePapers [49] or the Living Journal of Computational Molecular Science (https://www.
livecomsjournal.org/) already foster interactive web-based publications. Nevertheless, journals will
gradually adapt their policies with authors increasingly sharing their trajectories and reviewers asking
for interactive visualization. A similar trend can be predicted for funding agencies exploring appro-
priate and effective ways to publish MD simulation projects. Specifically, centers for high-perfor-
mance computing would significantly gain visibility if results of funded research projects are pre-
sented in an interactive and intuitive way. First steps in adopting journal policies for MD are
presented by https://fairsharing.org or [50].
The benefits of interactive visualization and sharing of MD trajectories may have to overcome com-
mon resistance and reluctance in publishing complete data sets, specifically of raw data [41,51].
We believe that publishing complete datasets and trajectories will help the community to reinterpret
data, reevaluate outliers, and provide a more realistic picture of the complex and often nonergodic
nature of MD simulations, because we realize that although automatization of setups and analysis of
MD simulations facilitates application and analysis, it also entails the risk of misinterpretations by
newcomers. Adopting the FAIR principles by the MD simulation community may help to identify
setup issues and false interpretations already during the reviewing process and promote critical
discussions.
In summary, visualization and sharing of MD simulations may increase the reliability and understand-
ing of this technique and foster a more direct understanding of molecular dynamics. This develop-
ment will facilitate access and ultimately broaden the outreach of MD simulations in structural
biology, education, and society.
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Understanding the structure-function relationshipofproteins such asGprotein-coupled
receptors (GPCRs) requires detailed information on their three-dimensional (3D) structure
anddynamics. Recentprogress in the structural elucidationof receptor-Gproteinor -arrestin
complexes yields valuable starting points to studying their function and dynamics [24, 25]. I
investigated the dynamic process of β2 adrenergic receptor-G protein recognition and bind-
ing using molecular dynamics (MD) simulations [4]. MD simulation is a well-established
technique tomonitor the time-resolvedmotions of proteins and is used to investigate the dy-
namics of GPCRs [62, 63]. In order to start MD simulations, the structures that are often
incompletely resolved have to be further completed. Finally, the results from computational
analysis have to be subjected to experimental validation. To promote broad applicability of
that workflow, I automated critical steps such as modeling of missing segments or interactive
analysis and visualization of the results of MD simulations.
Web-tools allow researchers besides different methodological expertise to apply unfamil-
iar techniques on their biological systems of interest without the need to download software
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or databases. To facilitate usage, I included visualization allowing intuitive understanding
and analysis. We developed the NGL molecular web-viewer [5], which accesses hardware-
accelerated graphics throughWebGL.This andother recentdevelopments, reviewedbyMwa-
longo andothers [47, 48], openedupnewpossibilities forwebmolecular graphics and render-
ing techniques, superseding plugin- and Java-based viewers [49, 50] and making them com-
parable with desktop tools, such as PyMOL [51], VMD [52], or UCSF Chimera [53].
Here, I implemented and applied tools for interactivemodeling ofmissing segments into
single-particle cryo-electron microscopy (cryo-EM) density maps [6], for interactive analysis
of structure-functional dynamics [7], andmore general to promote interdisciplinary research
[8]. To allow non-expert users access to bioinformatics methods and biophysical techniques,
all tools were generated as web-services allowing interactive analysis and visualization.
1 Modeling of missing fragments into cryo-EM density
maps
Recently, the number and resolution of ternary GPCR complex structures obtained from
cryo-EM densities [64] have been rising significantly due to methodological and technolog-
ical developments [65, 66]. Therefore, easy to use tools for modeling into cryo-EM density
mapswere required. In recent years a number ofmodeling toolswere developed (Pathwalking
[31], EM-Fold [32], HADDOCK [33], MDFF [34], MAINMAST [35], and others, recently
discussed by Cassidy et al. [28]). These approaches aim to completely model structures into
densities or to fill in missing segments into structures that were initially only partially mod-
eled from known folds or homologous structures or to reconnect domains fitted into cryo-
EM density maps, where the protein has undergone a conformational change. To design an
easy to use web-tool, which allows interactive modeling of fragments into cryo-EM density
maps, the underlying algorithm and web-service design has to be fast, efficient and intuitive.
We selected a fragment-based approach for modeling fragments into structures by using
cryo-EMdensitymaps. It employs a fast hierarchical search algorithm to scan a huge database
containing currently more than 109 fragments [42] for suitable fragments by sequence sim-
ilarity to the missing segment and geometrical fit [44]. These, subsequently, are ranked ac-
cording to their fit into the protein density map [36]. We have shown that this approach al-
lows reliable prediction of the conformation of segments up to 14 residues length, evenwhen
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all fragments with identical sequence (90% threshold) were excluded from the database [36].
By reporting the PDB-structure fromwhich the fragment is selected the modeling approach
is transparent and reproducible.
As reliable results are provided in a fast and efficient manner, the algorithm is suitable to
be transferred into a web-service. I implemented the algorithm into a web-service where the
user can directly visualize the uploaded structures and densities in various file formats using
our powerful molecular web viewer NGL [5]. For that purpose, I integrated the modeling
workflow into the visualization graphical user interface of the server. This allows the visual-
ization of the density and structure already during setup and analysis of the fragment mod-
eling. I implemented the reading and visualization of a large variety of density map formats
to allow broad applicability. Further, I integrated an automated generation of comprehen-
sive and informative representations into theweb-serverworkflow to facilitate understanding
and applicability. The completed structure with the selected fragment can be downloaded
from the results table after interactive visualization and analysis in the viewer. The interactive
visualization is highly efficient to select the best suitable fragment, which is regularly found
within the first 5-10 results [36]. Despite advances in machine learning approaches in pattern
recognition, a visual-guided interactive selection of the best suitable hit by the user is still
more efficient and selective than an automated comparison and selection [67]. In the case
of interactive modeling into cryo-EM density maps, human interference turned out to be
specifically useful for lower or inhomogeneous resolutions or map fragmentation. For these
cases, I added an option so that users can decide in the context of the complete map through
the variation of the isolevel, if specific densitiesmight belong to thatmissing fragment or not.
In summary, I implemented the fast, efficient and intuitive web-tool FragFit, allowing
structural biologists to interactively model segments into cryo-EM structures without the
need to download advanced modeling and refinement software [6]. Resulting completed
structures are often the basis for further structure-functional studies.
2 Interactive analysis of MD simulations on the web
The tertiary structure of proteins such asGPCRs is the basis to study structure-function rela-
tionships, for example receptor-ligand interactions. However, experimentally derived struc-
tures only provide static snapshots but not the inherent dynamics of the receptor. GPCRs
exist in an equilibrium of different inactive or active conformations with different signal-
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ing properties that interchange within nanoseconds to hundreds of microseconds [3]. De-
spite the prominent role of dynamics [68–70], proteins are still visualized as static pictures
[71]. Even, MD studies mainly present their results as static text, figures, plots, or, at the
best, as videos. The output of MD simulations, trajectory files containing the path of single
molecules through space as a function of time, is therefore, only seen by theMD experts who
conducted the experiments. Visualization of MD trajectories and understanding of protein
dynamics by other users is hindered mainly by three obstacles: First, obstacles arise through
the need for installing and using available specialized expert software to visualize MD trajec-
tories on a local computer. Second, trajectories, which range from hundreds of gigabytes to
terabytes, have to be uploaded, downloaded, or, in general, transferred fromMD experts to
non-expert users. Third, the general lack of expert knowledge on how to process and analyze
MD simulation output data. In order to bring MD simulations into view, interactive 3D
web-visualizationwas chosen to share the simulated trajectories as ameans of intuitive and il-
lustrative communication with amore general audience and amultidisciplinary community.
For that purpose I developed theMDsrv [7], which uses theNGLviewer [5] for powerful
molecular web visualisation. With theMDsrv, it is possible to spontaneously access trajecto-
ries from computers that have previously not been set-up for that purpose as no download
and handling of data and software, requiring expert knowledge, is needed. Only the MD
expert has to install the MDsrv, which I made available as PyPi or Conda packages. I im-
plemented several preprocessing steps like trajectory concatenation, removal of the periodic-
boundary-condition (PBC), molecule centering, or superpositioning so that the expert can
even use raw, unprocessedMD data, as obtained from high-performance computing (HPC)
centers. This has so far not even been possible by powerful standalone desktop visualiza-
tion software. Second, theMDsrv has to be deployed by the expert into a web-service. I used
Apache2 (https://httpd.apache.org/) andmod_wsgi routines (https://modwsgi.readthedocs.io/)
to allow easy deployment of theMDsrv only within a few steps. In addition to default rep-
resentations, predefined features like buttons to zoom on certain receptor regions or spe-
cific residue representations, highlighting relevant aspects ofMD trajectories, can be defined
by the expert user as sessions. Those sessions guide the view of the observers/non-experts
(e.g. experimental collaborators) while still giving them all options for self-exploration and
changes of those predefined features. Finally, the URL to the MD session, which is auto-
matically generated by theMDsrv can be sent to a third party, requiring on their side only
a modern regular web browser, and thus promoting direct access to MD. This allows new
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possibilities for remote collaboration, exchange, and outreach [8].
As visualization of MD simulation data within the web has previously not been possi-
ble, several key features, like graphical user interface (GUI) options to e.g. play and pause
the visualization of the simulation, preprocessing options, or, in general, the handling and
visualization of MD data files had to be implemented. To ensure wide applicability, I inte-
grated the handling and visualization of manifold structure and trajectory file formats into
the MDsrv. By using available resources to reduce the amount of manual work tradition-
ally needed for ensuring functionality and sustainability, I employed and adapted powerful
software packages like MDTraj [72] and MDAnalysis [73] for data handling to extract the
coordinate changes from various trajectory file formats. Further, as MD belongs to the data-
intensive sciences, the transfer of complete trajectories through the web into the computer
memory of the user was, accordingly, not an option. Of major importance was therefore
to choose an efficient and suitable data transfer, like efficient compression formats and the
reduction to only those information which is needed to visualize the dynamics.
MDsrvwas designed so that it can be easily embedded into any website and also be con-
nected to static and dynamic analysis. Therefore, it has been immediately applied by the
GPCRmd [74], the first centralized, community-driven platform for GPCR simulations. It
allows not only the interactive visualization and analysis of MD data but also prompts novel
insights into the receptor pharmacology such as allosteric modulations of receptors by ions
or water molecules. Further, it promotes dynamic understanding by bringing experimen-
tally derived densities in visual comparison with the dynamic motions of the proteins. This
outcome is now presented in a comprehensive and most intuitive fashion through MDsrv
visualization. In general, interactive visualization and sharing of MD trajectories may help
to overcome common resistance and reluctance in publishing complete data sets, aid to rein-
terpret data, assist reviewing processes and enhance critical discussion on early project stages
already prior to publication, having a major impact on howMD simulation data will be pre-
sented in the future [8].
In conclusion, web-tools and -visualization provide great opportunities to overcome ex-
isting communication barriers between computer and experimental scientists, promoting
interdisciplinary research. This development may be generally fostered by the increased in-
terest in open science developments like the Findability, Accessibility, Interoperability, Re-
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ABSTRACT
SuperLooper2 (SL2) (http://proteinformatics.charite.
de/sl2) is the updated version of our previous web-
server SuperLooper, a fragment based tool for the
prediction and interactive placement of loop struc-
tures into globular and helical membrane proteins.
In comparison to our previous version, SL2 benefits
from both a considerably enlarged database of frag-
ments derived from high-resolution 3D protein struc-
tures of globular and helical membrane proteins, and
the integration of a new protein viewer. The database,
now with double the content, significantly improved
the coverage of fragment conformations and predic-
tion quality. The employment of the NGL viewer for
visualization of the protein under investigation and
interactive selection of appropriate loops makes SL2
independent of third-party plug-ins and additional in-
stallations.
INTRODUCTION
Structural biology is an established but still emerging re-
search field of life sciences, as reflected by the exponential
rise of atomic models deposited in the Research Collab-
oratory for Structural Bioinformatics Protein Data Bank
(RCSB PDB) (1). However, in more than one half of all
entries deposited in the RSCB PDB segments are missing
(2). These missing segments are often located in flexible and
functionally important regions of proteins such as loops or
turns, not resolved by X-ray crystallography or single parti-
cle cryo-electron microscopy. These regions have to be mod-
eled to obtain a more complete structural model for further
analysis of the structure, e.g. for molecular dynamics simu-
lations (3).
Loop regions are one of the most demanding regions in
homology modeling workflows. A prominent example are
G protein coupled receptors (GPCRs), which constitute the
largest protein family in the human genome. The number of
available templates for modeling of GPCRs has increased
dramatically in the last decade facilitating the generation
of homology models for structure-based drug design. The
common topology of the transmembrane-spanning regions,
even of distantly related GPCRs, allows homology model-
ing of these regions and docking of small rigid orthosteric
ligands with close to experimental accuracy. However, pre-
dictions of long or flexible loops remain unsolved problems,
as evaluated recently by the community-wide GPCR Dock
assessment (4). As the sequence similarity within loop re-
gions is generally much lower than within other parts of
proteins, specialized methods are required for modeling.
Loop modeling approaches can be divided into ab initio
(5–8), fragment-based, (9–12) or a mixture of both meth-
ods (13,14). Ab initio based methods utilize molecular me-
chanics force fields to determine possible loop conforma-
tions. These methods are generally CPU-intensive but ca-
pable of predicting currently unknown loop conformations.
Fragment-based methods on the other hand are less CPU-
intensive and thus faster, but depend on known structures
and precalculated fragment databases to find loop confor-
mations. It remains unclear which method provides the bet-
ter predictions. Some studies find that both methods per-
form on a similar level (9,12), while others describe advan-
tages to either ab initio (15) or fragment-based (16) methods.
As fragment-based methods generally provide results much
faster, they are well suited for web-based tools such as Su-
perLooper (17), allowing instant visualization and control
of the results.
The quality of fragment-based loop predictions using de-
pends on the completeness of the fragment database. Inde-
pendent studies have shown that the conformational space
for short loops up to 12–14 residues is covered by structural
fragments derived from the RCSB PDB (18,19). Enlarge-
ment of fragment databases may thus particularly enhance
prediction of longer loops. Depending on the method used,
also the prediction of shorter loops might benefit from a
larger pool of available templates, e.g. when the exact fit of
the stem atoms of the template loop to the gap is an evalua-
*To whom correspondence should be addressed. Tel: +49 30450524190; Fax: +49 30450524952; Email: peter.hildebrand@charite.de
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tion criterion. The database of globular and membrane pro-
teins has more than doubled since our previous publication
(17). In order to benefit from this enlargement of available
structures we updated our fragment database.
Fragment-based tools such as SuperLooper depend on
databases too large to distribute as stand-alone programs
(∼80 GB in the case of SL2). The rapid delivery of a large
number of possible loop conformation makes web-based
tools a perfect candidate. The database remains on a server
and the user is able to choose a suitable loop from listed re-
sults using a web-based molecule viewer. Here, we use NGL
(20) for protein and fragment visualization, which adopts
capabilities of modern web browsers, such as WebGL for
molecular graphics. NGL allows interactive display of even
large molecular complexes and is unaffected by the retire-
ment of third-party plug-ins such as Flash or Java-Applets.
This viewer offers comprehensive molecular visualization
through a graphical user interface so that life scientists can
easily access and utilize available structural data without
any further installations (20).
Thus, SL2 benefits from the significantly enlarged
database of fragments and new fast molecule viewer. Due
to the improved coverage of the conformational loop space,
the quality of prediction, measured by the backbone root
mean square deviation (RMSD), has improved by 20% on
average compared to our previous version (17). The new
version of our fragment-based web-application for loop
modeling SL2 thus has an improved performance in loop
prediction as well as an up-to-date visualization.
UPDATE OF THE LIP AND LIMP DATABASE
The loop database (LIP) is composed of all possible frag-
ments of 3–35 amino acids length extracted from the RSCB
PDB entries in December 2015. Here, not only loops
are considered but also fragments derived from secondary
structure elements like helices and -sheets. For each frag-
ment, the amino acid sequence, PDB identifier, chain iden-
tifier, residue number of stem atoms and a geometrical fin-
gerprint is stored.
Geometrical fingerprint matching is used as a criterion to
estimate the sterical fit of stem atoms of N- and C-termini
of each database fragment to the C- and N-terminal stem
atoms of a gap in a protein structure. The geometrical fin-
gerprints of both the stem atoms of each database fragment
and the stem atoms of the gap are composed of the dis-
tance between the N- and C-terminal stem atoms and three
angles defining their relative orientation (Figure 1). Com-
pared to our previous version, we slightly altered the geo-
metric fingerprint. Previously, we used a combination of two
distances and two angles for scoring, resulting in a higher
weighting of the fit of the residue where the angle was mea-
sured. In SL2, we solved this problem employing distance
and three angles.
Since the first release of SuperLooper in 2008, the num-
ber of entries deposited in the RSCB PDB has more than
doubled from 54 543 structures to 114 693 in 2015. A total
of 901 609 231 fragments with a length of 3 to 35 residues
was extracted from this enlarged pool of template structures
(Figure 2A). Because more short than long overlapping
fragments are extracted from a given template structure,
Figure 1. Schematic representation of the geometrical fingerprint: The ge-
ometrical fingerprint is characterized by the distance d between the N-
terminal C- and the C-terminal N atom and the following three angles:
 defined by the line between C(N), C(N) and d,  is spanned by the line
between N(C), C(C) and d,  is the angle between the two planes A (de-
fined by C(N), C(N) and N(C)) and B (C(C), C(N) and N(C)).
Figure 2. Length dependency of the number of fragments stored in our
previous (black) and present fragment (gray) database; (A) loops in pro-
teins (LIP), and (B) loops in membrane proteins (LIMP).
the number of fragments decreases linearly with length. For
loops with three amino acids, more than 30 million frag-
ments are stored in the database, for 35 amino acids 24 mil-
lion fragments are available. To benefit from the continuous
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mented that automatically adds novel fragments to the LIP
or LIMP database every three months.
Due to (partial) embedding into the lipid bilayer, loops
of membrane proteins have a more hydrophobic amino
acid composition compared to loops of globular proteins
(21). Tools developed for the prediction of loops connect-
ing transmembrane helices were indeed found to enhance
prediction of GPCR loops (22). In SL2, such loops can be
selected from LIMP, which is a collection of fragments ex-
tracted from loops of all helical transmembrane proteins.
Loops were defined as parts without regular fold, thus also
containing kinks, bulges or re-entrant loops (23). To allow
selection of membrane protein loops taking the lipid bilayer
into account, the extension of the lipid bilayer is indicated
by two parallel planes (as described below).
The number of membrane protein structures deposited in
the RCSB PDB rose from 805 (in 2008) to 2298 (in 2015) ac-
cording to the Protein Data Bank of Transmembrane Pro-
teins (24). As a result, the loops stored in LIMP doubled
from 179 580 to 378 839. For LIMP is composed mainly
of loop structures, the length distribution differs from LIP
where the fragments also include helical fragments and frag-
ments derived from -sheets. In LIMP (Figure 2B), few loop
templates are available for short loops of 3–5 amino acids
in length. The number of loops stored in LIMP increases
markedly to a maximum of 20 000 up to a length of 20
residues before it decreases again.
SEARCH PROCEDURE
To start the search the stem residues flanking the N- and C-
terminus of a missing (or existing) loop in a protein model
and the amino acid sequence have to be provided. As in
our previous version, the search procedure is based on a
stepwise approach which minimizes the calculation time.
Fragments with appropriate sequence length, and with ge-
ometrical fingerprints of the fragment and the gap match-
ing with an accuracy of at least 0.75 Å RMSD distance are
selected. This RMSD value is subsequently used to deter-
mine the top 1000 loop candidates. These loop candidates
are then rescored by the parameters ‘sequence similarity be-
tween missing segment and template loop’ and ‘fingerprint
matching of the template loop to the gap in the model.’
Only one representative of fragments with identical primary
structure and high tertiary structure similarity (with back-
bone RMSD < 0.5 Å) is kept in the results list to maximize
the conformational space of fragments used for further cal-
culations. The top 100 loop candidates are finally displayed
in the results list. Suitable candidates can be selected from
that list by visual inspection.
VISUALIZATION AND USER INTERFACE
For visual inspection of results, we employed the NGL
viewer which works without installation of additional plug-
ins (20). As a common graphical user interface for the
NGL viewer (Figure 3) the search mask and the results list
were implemented within JavaScript. A protein structure
uploaded via the file selection dialog is instantly loaded to
the NGL viewer. The stem residues of the gap in the protein
model must either be typed into the according search field or
can be selected by clicking them in the NGL viewer. The se-
quence of the missing segment must be typed or copied into
the search mask. If the membrane protein-specific LIMP
data base (Membrane DB) is not checked, the LIP data base
will be searched. After the submission button is pressed, the
search is started. Depending on the loop length, results are
expected to appear after few seconds or up to half a minute
in the results list.
The top hit will automatically be loaded into the gap of
the protein model depicted in the viewer window. Alterna-
tive loop conformations can be selected from the results ta-
ble containing the 100 best loop candidates. For each can-
didate, the score ranging from 0 to 0.455, the RCSB PDB
entry-code and sequence of the template protein, the num-
ber of clashes, and the sequence identity between target and
template are listed. If no appropriate loop is found, the
user can select ‘Decrease N-terminal stem’ or ‘Increase C-
terminal stem’ to add a residue to the loop and shift the
stem atoms of the gap, accordingly. As an additional vi-
sual control, for helical membrane proteins, the position
of the lipid bilayer can be calculated (’Calculate membrane
planes’), employing the web-service TMDET (25).
There is an option to display the complete list of loop
candidates at the same time as visualizing the conforma-
tion space of the loop. Loop candidates can be colored ac-
cording to score, sequence identity or clashes by selecting
the corresponding color scheme from the dropdown menu.
The completed structure (initial model plus selected loop)
can be downloaded by clicking the download button. Al-
ternatively, the complete list of loops can be downloaded
for further analysis.
TECHNICAL ASPECTS
Visualization is carried out by the NGL viewer (20). To use
the full feature set of the NGL viewer an up-to-date web
browser (tested on the recent versions of Firefox, Google
Chrome, Safari, IE and Edge) is recommended. The spe-
cialized graphical user interface is written in JavaScript. For
job handling a simple python job server based on the Flask
framework (http://flask.pocoo.org/) is used.
PERFORMANCE, LIMITATIONS AND OUTLOOK
The updated version of our fragment based web-application
tool for loop modeling, SL2, benefits from an enlarged frag-
ment database and a new user interface including an up-
dated protein viewer. As a result of the enlarged fragment
database the prediction quality has been further improved.
Using the same dataset (15) and validation procedure as in
our previous publication (17), an average gain in prediction
quality by 20% is observed for loops of 3–16 residues length
(Figure 4). A drop of the backbone RMSD between ex-
perimentally determined and modeled loops (only the top
hit was considered) starts to become evident for loops with
eight residues length. This implies that the coverage of pos-
sible loop conformations has been further optimized start-
ing with this length.
Despite the gain of prediction quality, the top hit results
obtained by SL2 sometimes deviate from the experimentally









B Leipzig user on 23 N
ovem
ber 2019
Nucleic Acids Research, 2016, Vol. 44, Web Server issue W393
Figure 3. Screenshot of the SL2 results page (NGL viewer). Structure of the human cytomegalovirus GPCR US28 (PDB-ID: 4xt1) in a gray cartoon rep-
resentation with top ranked loop (green) and calculated membrane planes. The list of loop candidates filling the gap 94 to 103 in the GPCR structure is
displayed as table on the right hand just below the search mask.
Figure 4. Comparison of benchmarks of our previous (17) (black rhom-
bus) and updated version SL2 (gray star) using a standard loop dataset
(15).
possible reasons for this. First, many loops are highly flexi-
ble or are even located in structurally disordered regions of
proteins (26,27). The conformations suggested by SL2 may
thus indicate alternative loop conformations not observed
by protein X-ray structure crystallography (e.g. Figure S6
in (28)). Second, as scoring of the loops mainly depends on
the stem residues, experimentally caused distortions of these
stem atoms may prevent selection of a specific conformation
(29). Prediction quality drops with loop length, mainly due
to the increased conformational space. A promising strategy
to enhance prediction quality of longer loops would be in-
clusion of additional experimental constraints such as mass
spectrometry (30,31) or electron density maps from single
particle cryo-electron microscopy (32).
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ABSTRACT
G-protein coupled receptors (GPCRs) are key play-
ers in signal transduction and therefore a large pro-
portion of pharmaceutical drugs target these re-
ceptors. Structural data of GPCRs are sparse yet
important for elucidating the molecular basis of
GPCR-related diseases and for performing structure-
based drug design. To ameliorate this problem,
GPCR-SSFE 2.0 (http://www.ssfa-7tmr.de/ssfe2/), an
intuitive web server dedicated to providing three-
dimensional Class A GPCR homology models has
been developed. The updated web server includes
27 inactive template structures and incorporates var-
ious new functionalities. Uniquely, it uses a finger-
print correlation scoring strategy for identifying the
optimal templates, which we demonstrate captures
structural features that sequence similarity alone is
unable to do. Template selection is carried out sep-
arately for each helix, allowing both single-template
models and fragment-based models to be built. Addi-
tionally, GPCR-SSFE 2.0 stores a comprehensive set
of pre-calculated and downloadable homology mod-
els and also incorporates interactive loop modeling
using the tool SL2, allowing knowledge-based input
by the user to guide the selection process. For vi-
sual analysis, the NGL viewer is embedded into the
result pages. Finally, blind-testing using two recently
published structures shows that GPCR-SSFE 2.0 per-
forms comparably or better than other state-of-the art
GPCR modeling web servers.
INTRODUCTION
G-protein coupled receptors (GPCRs) are the largest family
of integral membrane receptors consisting of more than 800
members in humans and clustering into five main groups
based on phylogenetic criteria (1,2). They transduce a wide
variety of extracellular signals to within the cell includ-
ing ions, hormones, neurotransmitters and sensory stim-
uli. Due to their fundamental role in signal transduction, a
large proportion of medical drugs target these receptors (3).
GPCR structural data are important for both understand-
ing the molecular mechanisms underlying diseases caused
by mutations in these receptors as well as for perform-
ing structure-based drug design. Despite recent advances
in stabilizing and crystallizing GPCRs, it is still difficult
to obtain experimental structures of them (4). Currently,
structural data of Class A GPCRs are restricted to around
30 members. All of these GPCR structures share a com-
mon molecular architecture of seven transmembrane he-
lices (TMHs). Hence, the deficit in experimental GPCR
structure data can be resolved by building molecular models
of GPCRs of unknown structure using homology modeling
techniques. Many researchers working on GPCRs are not
experienced homology modelers and are therefore unable
to benefit from the information that can be gleaned from
such three-dimensional (3D) models. Methods that pro-
vide high-quality homology models of GPCRs are there-
fore highly useful to such researchers. As a consequence,
various methodologies have been developed for modeling
GPCRs and provided for usage as web servers: GPCRM
(5), GoMoDo (6), GPCR-ModSim (7) and GPCR-SSFE
(8) employ homology modeling techniques whereas GPCR-
I-TASSER (9) is a threading assembly method. GPCRM
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employs a profile–profile comparison and multiple struc-
tural alignments for averaging the structure by Modeller.
The loops are refined by Modeller and Rosetta. GoMoDo
includes Modeller-driven single template homology model-
ing and offers small molecule docking blindly or by using
experimental information. GPCR-ModSim is designed to
combine automated modeling (Modeller based) and molec-
ular dynamics equilibration of GPCRs in different confor-
mational states. As a default the protocol uses a single tem-
plate approach, however multiple template based homology
modeling is possible by user selection for each topological
section of the GPCR. In contrast to these Modeller based
approaches, GPCR-I-TASSER relies on a hybrid protocol
to construct the GPCR models by integrating experimental
constraints from the GPCR-RD database and uses either a
threading or an ab initio TM helix assembly.
The first version of GPCR-SSFE was published in 2011,
based at that time on five crystal structures, providing an
automatic pipeline for Class A GPCR homology model-
ing and a comprehensive set of pre-calculated 7TMH ho-
mology models (5025) accessible via a web server (8). Tem-
plate selection is based on the structure–sequence relation-
ship and uses our published workflow whereby the template
for each TMH is selected individually thus allowing either
a single template or a fragment-based approach to be used
for model building (10). GPCR-SSFE’s models have been
frequently cited and used, for example, to help generate new
hypotheses on the enteroendocrine fat sensor GPR119 (11),
rationalize the design of potent CB1 antagonists (12) and
the server is linked as a partner tool on the GPCRdb web-
site (13).
Many new structural templates have been released since
the publication of the first version (including diverse GPCR
subtypes) necessitating an update to GPCR-SSFE. These
structures provide important insight into general and dis-
tinctive structural features (which were previously un-
known), shedding light on the variability of GPCR 7TMH
architecture. Moreover, the accuracy of homology models
is important for their successful usage e.g. in drug design
and consequently the increased number of templates results
in greater precision of homology model features, including
helix or loop properties. These improved models enable bet-
ter predictions and more accurate dockings of allosteric or
endogenous ligands into so far unsolved GPCR structures.
Here, we present an updated and extended version of the
web server (http://www.ssfa-7tmr.de/ssfe2). In comparison
to our previous version, GPCR-SSFE 2.0 benefits from a
considerably enlarged pool of templates (27 inactive crys-
tal structures in contrast to the five templates used in the
original version), provides models of the entire serpentine
domain by using an evaluated automated version of Super-
Looper2 (SL2) (14) for loop modeling and TMH template
selection now follows a fingerprint correlation scoring strat-
egy by using a sequence fingerprint database correspond-
ing to distinct structural features. This latter feature allows
the optimal template to be selected for each TMH using a
weighted structure-feature-matrix based on the presence or
absence of fingerprint features. For receptor and fragment
visualization, we use NGL (15,16), which adopts capabili-
ties of modern web browsers, such as WebGL for molecu-
lar graphics. GPCR-SSFE 2.0 performs comparably or bet-
Figure 1. An overview of the workflow used by GPCR-SSFE 2.0 for tem-
plate selection and homology modeling. A query protein sequence is first
verified for Class A GPCR membership. Upon passing this check, se-
quence alignment is performed using a HMMER3 derived hidden markov
model (HMM) profile. Alignment of the transmembrane helices (TMHs)
is used to identify matching fingerprint motifs from our database (see Fig-
ure 2). Template selection is performed separately for each helix using the
fingerprint scoring strategy and sequence similarity score. Once template
selection has been carried out for the 7TMHs and helix 8 (H8) modeling
is performed using Modeller. Where backbone clashes occur between two
helices, the second-best scoring template is chosen instead and Modeller is
re-run. PROCHECK is used to carry out quality checks with a Ramachan-
dran plot produced. SL2 is used to perform loop modeling with selection
of the loops being done interactively by the user. Both the TMH models
and entire models are available for download by the user.
ter than other published web servers for modeling Class A
GPCRs. Being a fragment-based approach, it has the ad-
vantage that it is able to capture structural features that
are not identified using single template sequence similarity
alone. GPCR-SSFE 2.0 stores a comprehensive set of pre-
calculated models comprising 1002 human, mouse and rat
GPCR sequences, providing Class A GPCR 3D structural
data to the wider GPCR research community.
MATERIALS AND METHODS
Technical features of the GPCR-SSFE 2.0 web server
An overview of the workflow used by GPCR-SSFE 2.0
is shown in Figure 1. GPCR-SSFE 2.0 was built by
combining an Apache web server (http://www.apache.org),
PHP Hypertext Pre-processor scripts (PHP5) and a rela-
tional database management system (MySQL 5.5). User-
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submitted job requests are subject to both client- and server-
side validation. Upon validation, the request is saved to
the MySQL database and a job with the ID of the corre-
sponding database record started. Each job utilizes a se-
ries of Python scripts as well as the following free bioinfor-
matics software and tools: Biopython (17) (sequence pars-
ing), HMMER3 (18) (sequence alignment), MODELLER
9.14 (19) (homology modeling), SL2 (loop modeling) (14)
and PROCHECK (20) (quality assessment). The web inter-
face is based on HTML 5, JavaScript and Cascading Style
Sheets (CSS) and is cross-browser responsive. The homol-
ogy model structures are displayed using the NGL viewer,
which allows interactive display of even large molecular
complexes and is unaffected by the retirement of third-party
plug-ins such as Flash or Java-Applets (15). This viewer can
easily access and utilize available structural data without
any further installations. Loop modeling is provided by a
customized SL2 web service, which is queried directly and
automatically by SSFE 2.0 using a Python script.
Fingerprint identification for improved template selection
The highest resolution structure of all Class A GPCRs hav-
ing an inactive crystal structure (totaling 27 at the time)
were superimposed using the highly conserved residues
found within the 7TMHs (as defined by the Ballesteros–
Weinstein nomenclature (21)) and manually inspected for
structural features that deviate from a regular -helical
backbone (kinks, bulges, etc) or which are not conserved in
all members (Figure 2). These features must correlate with
a corresponding sequence pattern (fingerprint) such as pro-
line distortions (22,23), serine/threonine residues modify-
ing proline-induced -helical kinks by forming side chain
hydrogen bonds with the helix backbone (24,25), glycine
patterns, conserved motifs, lack of conserved residues etc.
More than 150 fingerprint motifs are stored in our rela-
tional database. To ensure proper assembling of the TMH
fragment-based models, the superimposed Research Col-
laboratory for Structural Bioinformatics Protein Data Bank
(RCSB PDB) (26) co-ordinates were used for homology
modeling.
Sequence alignment and scoring strategy
The user uploads a Class A GPCR protein sequence in
FASTA format (see workflow in Figure 1) and on passing
the Class A GPCR sequence verification check, the server
creates a multiple sequence alignment (MSA) using a profile
hidden markov model (HMM). HMMER3 was used to gen-
erate the HMM from a MSA of 27 template structures plus
51 other class A GPCRs (18). The 51 GPCRs were selected
so as to maximize the coverage of the phylogenetic tree for
Class A GPCRS (1). After alignment, template selection is
carried out for each TMH based on an updated version of
our previously published workflow; extending on the struc-
tural feature workflows utilized in the original version of
GPCR-SSFE (10), we have now implemented a new scoring
strategy which uses a weighted structure-feature matrix to
calculate the best template per helix based on the presence
or absence of fingerprint features (e.g. proline distortions,
conserved motifs and TMH extensions) (Figure 2). Where
more than one template structure has the highest fingerprint
score, the structure with the highest sequence similarity to
the query protein is then chosen as the template. Where no
fingerprint features are identified in the query protein, the
template with the highest sequence similarity score out of
the pool of 27 is selected for homology modeling. Template
selection for helix 8 (H8) follows a different strategy. The
template structures were clustered into groups based on the
position of the junction between TMH7 and H8 when su-
perimposed (see Supplementary Data, Figure S1). The tem-
plate for H8 is selected from the cluster containing the tem-
plate(s) chosen for TMH7, with sequence similarity used as
the basis for selection. This ensures that clashes or large dis-
tances are not introduced between TMH7 and H8.
Modeling procedures
Initial modeling is performed for the 7TMHs and H8 using
Modeller 9.14. Three models are produced for each GPCR
but only the one with the lowest DOPE score (i.e. the most
energetically favorable model) is returned (27). If Modeller
reports backbone clashes between helices, the second-best
scoring template of one of these helices is selected instead
and the modeling repeated. Where multiple templates score
most highly for a particular helix, a homology model is built
using each set of templates. PROCHECK is used to per-
form stereochemical quality checking of the models with a
Ramachandran plot of each model being generated.
Loop regions are modeled using the SL2 interactive
web service (15). Loop candidates are selected from a pre-
calculated database currently containing more than 900 mil-
lion protein fragments with a residue length of 3–35 de-
rived from all entries of the RCSB PDB. Selection of the
loops is primarily based on target–template sequence sim-
ilarity and geometrical fit of stem atoms of the template
loop to the receptor (28). To facilitate selection of loops
by the user, a customized workflow was constructed for
GPCR-SSFE 2.0. The customized SL2 utilizes two loop
fragment databases, one containing only fragments from
GPCR structures and the other containing fragments de-
rived from all membrane protein (LIMP) entries deposited
in the PDB, including GPCRs. The semi-automated ap-
proach of SL2 was upgraded allowing fully automated pre-
diction of conformations of intra- and extracellular loops
(ECLs). For loops modeled by the SL2 workflow, 100 loop
candidates have been calculated from each of the GPCR
and LIMP databases ranging in length from the original
length of the loop up to symmetrical N- and C- terminal
extensions of length 1–3 (see Figure 3). Thus, up to 800
fragment candidates per loop are calculated. GPCR loop
templates are given five times higher scores. A list contain-
ing all candidates is sorted according to the score and re-
ranked using a sliding window of size 2 to favor a candidate
with less clashes if two results have a score differing <25%.
In general, only candidates with <10 clashes are allowed.
Afterward, the top five candidates for each loop are pro-
vided to the user for visual inspection. After selecting a set
of loops a complete receptor model comprising the entire
serpentine domain can be downloaded by the user.
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Figure 2. Fingerprint identification and scoring strategy used by GPCR-SSFE 2.0 for template selection. The set of available crystal structures (templates)
were superimposed using the most conserved amino acids in each of the 7TMHs. The structures were manually examined for structural features that
deviate from a regular -helical backbone (kinks, bulges, etc.) or which are not conserved in all members. The fingerprint features are stored in a relational
database. Here we show a subset of TMH2 template features in GPCR-SSFE 2.0–Sphingosine 1-phosphate receptor 1 (PDB ID: 3V2Y) has Pro 2×39
and Ala 2×53; Proteinase-activated receptor 1 (PDB ID: 3VW7) has Pro 2×39, Phe 2×53 and Pro 2×58; Muscarinic acetylcholine receptor M2 (PDB ID:
3UON) has Gly 2×54 and Asn 2×58 and bovine Rhodopsin (PDB ID: 1U19) has Pro 2×39, GG 2×56/7 and TTT 2×58–60. These fingerprint features
give rise to different helical conformations (straight and different degrees of kink). The aligned input query sequence is then checked against our database
of fingerprint features for any matches; in this case, it matches Gly 2×54 and Asn 2×58. The scores of the different templates are then calculated based
on the number of matching fingerprint features divided by the total number of fingerprint features that the template has in that helix. The highest scoring
template is then chosen for homology modeling (in this instance 3UON for TMH2).
GPCR-SSFE 2.0 WEB SERVER
Database of pre-calculated models
Using the modeling strategy outlined above, GPCR-SSFE
2.0 stores pre-calculated models for 1002 Class A GPCRs:
252 human (all non-olfactory), 432 mouse and 318 rat.
The sequences were downloaded from the GPCRdb in June
2016 (13). Results can be retrieved by either browsing or
searching the results. By navigating to the ’BROWSE’ menu
option, the user is presented with a list of 10 Class A GPCR
subgroups: Aminergic, Peptide, Protein, Lipid, Melatonin,
Nucleotide, Steroid, Alicarboxylic acid, Sensory and Or-
phan receptors. These subgroups correspond to the endoge-
nous ligand type (as used by the GPCRdb). Each sub-
group can be expanded by clicking on it, revealing further
subgroupings (receptor family and subtype) or (if the final
node is reached) a list of GPCRs within the subtype corre-
sponding to models from different species. Clicking on the
UniProt entry name (29) of a GPCR will take the user to the
results page for that particular receptor. Alternatively, users
may retrieve results by entering the UniProt entry name
onto the ’SEARCH’ webpage.
GPCR-SSFE 2.0 results page
The results returned by GPCR-SSFE 2.0 include: (i) the
templates used for analysis; (ii) the MSA of the 27 tem-
plates and the query sequence for each individual TMH and
H8; (iii) the MSA of the profile HMM GPCR sequences
and the query sequence, which spans the entire serpentine
domain; (iv) the HMMER2 e-value assigned to the full-
length MSA; (v) the template suggestions (and reasons) for
the seven TMHs and H8; (vi) the sequence similarity score
between the suggested template(s) and the query sequence;
(vii) the rationale for the selected templates such as matched
fingerprint motifs; (viii) an embedded NGL viewer display-
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Figure 3. Output of customized SL2 method for extracellular loop (ECL) 3
of thyroid-stimulating hormone receptor (TSHR). On the right, the TSHR
serpentine domain model is shown as cartoon representation in gray with
the modeled ECL3 loops as colored tubes (thicker lines indicate struc-
turally defined conformations like helices). N- and C-terminal extensions
of the loop sequence, which enlarge the gap into the transmembrane do-
main of the GPCR are indicated by a numbered bubble. On the left, the
modeled loop sequences are listed with their color code and the N- and
C-terminal extensions are annotated. The minimal loop length is indi-
cated by the red line. The table is extracted from the results page, provid-
ing information about the extension, the origin of the fragment (GPCR
and PDB ID:), the fitting score and sequence identity. The user can se-
lect the most suitable loop by visual inspection. For visualization pur-
poses only, the loops are elongated by 3 amino acids. Therefore, the loops
reach further into the transmembrane region, giving an impression of the
concatenated/complete structure.
ing the TMH homology model(s) of the query GPCR based
on the template suggestions; (ix) a link to the SL2 predic-
tions for the intra- and extracellular loops (see below for
more details); (x) a Ramachandran plot of each generated
TMH model and (xi) links to UniProt and the GPCRdb.
Files containing the sequence alignments, modeled PDB
structure(s), Ramachandran plot(s) and loop sequences are
made available for download.
SuperLooper2 results page
The NGL viewer is embedded in this page allowing the vi-
sual inspection of the loop predictions by SL2. For each
of the intracellular loops (ICLs) and ECLs, the five top-
scoring predictions are listed with the top hit for all loops
automatically being loaded into the gap of the protein
model. Alternative loop conformations can be selected from
the drop-down menu. For each candidate, the score, the
RCSB PDB entry-code and sequence of the template pro-
tein, the number of clashes and the sequence identity be-
tween target and template are listed in a table. If no suit-
able loop candidate was found, the gap remains open. The
completed structure (initial serpentine domain model plus
selected loops) can be downloaded by clicking the down-
load button. Side chains of the loops are included but re-
quire further optimization to select the most appropriate
rotamers. Clashes between sidechains in the loops and the
TMHs can be eliminated by carrying out energy minimiza-
tion on the entire structure using, for example, the Mod-
Refiner web server (30). Likewise, where the conserved cys-
teines in TMH3 and ECL2 are present in the sequence but
not in the model, minimization may shift their side chain
orientations to allow the conserved disulphide bridge to
form (functionality to deal specifically with this issue will
be implemented in the next web server update).
Submitting a modeling job to GPCR-SSFE 2.0
Where GPCR-SSFE 2.0 does not store modeling results
for a particular Class A GPCR, for example species not
stored in the database or newly identified orphan GPCRs,
users can submit their GPCR sequence to GPCR-SSFE 2.0
for analysis and homology model building. For such cases,
users should navigate to the ’RUN’ webpage and enter their
GPCR sequence (by either uploading a file or by copying
and pasting it) and email address (optional). Upon comple-
tion of homology modeling (taking ∼5 min for the TMHs
and a further 5–10 min for the loop modeling) the results
page is displayed (and where an email address was provided,
a web-link is emailed to the user). Results are stored on the
server for 7 days. The results page looks exactly like those re-
trieved when searching the database of pre-calculated mod-
els.
Performance
Since completion of the large-scale modeling and extension
of GPCR-SSFE 2.0, several new non-active Class A GPCR
structures have been published recently such as: human en-
dothelin type B (ETB) receptor; PDB ID: 5GLI (31) and
human CC Chemokine receptor 2 (CCR2); PDB ID: 5T1A
(32). These receptor structures therefore provide us with an
ideal means of assessing the performance of the models pro-
duced by GPCR-SSFE 2.0 as they were not included in the
pool of structural templates used by GPCR-SSFE 2.0 and
we can calculate the root-mean-square deviation (RMSD)
of our predicted models to the crystal structures.
Two Chemokine structures have already been published
and are included in our pool of templates (CCR5; PDB
ID: 4MBS and CXCR4; PDB ID: 4ODU), therefore tem-
plate selection and homology modeling of CCR2 should be
relatively straightforward. Indeed, for CCR2 we find that
GPCR-SSFE 2.0, GPCR-ModSim and GPCR-I-TASSER
all select a chemokine crystal structure as the best template
for homology modeling, resulting in comparable model ac-
curacies for both the transmembrane and full length models
(Table 1).
The ETB receptor’s closest homolog is the -type opioid
receptor (PDB ID: 4DJH) with 75% sequence similarity.
The multiple fragment-based approach utilized by GPCR-
SSFE 2.0 produced the most accurate model for the TMHs
compared to other state-of-the-art modeling servers tested
using default settings, all of which select a single template
for homology modeling (Table 1). Models produced using
the highest sequence similarity template per helix have sim-
ilar resolutions to the second best scoring server, GPCRM.
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Table 1. The RMSD of ccr2 human and ednrb human homology models compared to their crystal structures
Method of template selection and modeling Accuracy (RMSD)
CCR2 HUMAN1 EDNRB HUMAN2
GPCR-SSFE 2.0 0.72 Å (0.89 Å) 1.30 Å (2.33 Å)
GPCRM (Rosetta optimized) 0.72 Å (0.82 Å) 1.60 Å (2.36 Å)
Max %sequence similarity per helix + Modeller 0.72 Å 1.62 Å
GPCR-I-TASSER HGmod (2014) 0.73 Å (0.83 Å) 1.64 Å (1.91 Å)
GoMoDo 1.53 Å (1.72 Å) 1.78 Å (2.01 Å)
GPCR-ModSim 0.78 Å (0.92 Å) 1.97 Å (2.36 Å)
GPCR-SSFE 1.0 1.87 Å 2.01 Å
1RMSD between 5T1A and ccr2 human model in TMH region (left) and full length (brackets).
2RMSD between 5GLI and ednrb human model in TMH region (left) and full length (brackets).
However, when loops are included in the RMSD calcu-
lations for the ETB receptor, GPCR-I-TASSER and Go-
MoDo scored better (Table 1). For assessing the perfor-
mance of GPCR-SSFE 2.0 in building full length models,
we used the first suggested loop for each of the ICLs and
ECLs for calculating the RMSD (excluding loops from the
actual crystal structure of the tested protein). Nevertheless,
a particular strength of the loop modeling procedure im-
plemented in GPCR-SSFE 2.0 is that it is the first multi-
template based service which allows loops to be selected in-
teractively. Thus, utilizing their expert knowledge, experi-
mental data or similarity to crystallized GPCR structures,
the RMSD values for models built by GPCR-SSFE 2.0 may
be improved depending on the loops selected by the user.
An advantage of our fingerprint-based method is that se-
quence differences causing slight backbone changes such as
bulges or kinks are considered in more detail, which will be
discussed further in the following section.
Example
A case study that demonstrates the utility of our fragment-
based approach to homology modeling involves the thyroid-
stimulating hormone receptor (TSHR). A distinct feature of
TSHR compared to other Class A GPCRs is that in TMH5
it lacks the highly conserved proline in position 5×50 (mod-
ified Ballesteros–Weinstein nomenclature that considers the
structural alignment of bulges (33)) instead having an ala-
nine (Ala593) at this position. GPCR crystal structures that
have this conserved proline have a bulged TMH5 conforma-
tion causing a kink and twist toward the extracellular end of
the helix whereas those having a different amino acid at this
position have a regular -helical TMH5 e.g. the Sphingo-
sine 1-phosphate receptor 1 (alanine in position 5×50; PDB
ID: 3V2W (34)), the P2Y12 receptor (asparagine in posi-
tion 5×50; PDB ID: 4NTJ (35)) and the Lysophosphatidic-
Acid-Receptor 1 (threonine in position 5×50, LPAR1, PDB
ID: 4Z34 (36)). Mutagenesis studies have suggested that the
alanine at position 5×50 in TSHR most likely also causes a
regular -helix conformation in this receptor (37,38).
The fragment-based inactive TMH model of TSHR built
by GPCR-SSFE 2.0 uses 6 of the 27 different template
structures for model building (Supplementary Data, Table
S1). Figure 4 shows a comparison between this multiple-
template fragment model (shown in gray) with the best
matching single template TSHR model (shown in green)
based on the 2 adrenergic receptor ADRB2 (PDB ID:
Figure 4. Structural superposition of the multiple-template fragment-
based model (gray) with the best matching single template TSHR serpen-
tine domain model based on the 2 adrenergic receptor (PDB ID: 2RH1)
(green). The latter model has additional bulges in TMH2 and 5 and not
only has shifted locations of the highly conserved cysteine in TMH3 but
clearly has different orientations of the side chains V421 (position 1×39)
and L587 (position 5×44). Constitutively activating mutations by slight
hydrophobic alterations (V421I; l587V) (40) of these two positions are bet-
ter explained when these side chains point toward neighboring helices as
in the fragment-based model (gray) but are incompatible with them being
orientated toward the membrane as observed in the single template TSHR
model (green).
2RH1 (39)) with an overall sequence identity of 24%. Com-
parison of the two model structures reveals that the single
template model has additional bulges in TMH2 and TMH5
and clearly shows different side chain orientations of the
highly conserved cysteine in TMH3 as well as Val421 (posi-
tion 1×39) and Leu587 (position 5×44) (Figure 4). Conser-
vative hydrophobic substitution to isoleucine and valine at
these respective positions lead to constitutive activation of
TSHR (40) inferring that these side chains are unlikely to be
orientated toward the membrane as is the case with the sin-
gle template model. Thus, the activating roles of these mu-
tations are better rationalized by the structural data when
these side chains point toward neighboring helices as seen
in the fragment-based multiple template TSHR model (Fig-
ure 4). This clearly demonstrates the advantage of using a
multiple-template fragment-based approach in achieving an
improved accuracy over single template based methods or
those based on sequence similarity alone.
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Documentation
To aid usability of the web server, there is both a facts and
questions page as well as a tutorials page, linking to various
tutorial videos that are available on our YouTube channel.
CONCLUSIONS
GPCR-SSFE 2.0 is a web server dedicated to template se-
lection and homology modeling of GPCRs, which has been
updated to include the latest structural data and extended
with new components. It is user-friendly and allows non-
expert users to access 3D structural data that might oth-
erwise be unattainable; GPCR-SSFE 2.0 stores and makes
freely available, a comprehensive and up-to-date set of pre-
calculated homology models of human, mouse and rat
GPCRs. Template selection is done individually for each of
the 7TMHs and H8, flexibly allowing for both single tem-
plate models and fragment-models to be built, depending
on the similarity of a query sequence to the available tem-
plates. It uses a database of sequence fingerprint features
correlating with observed structural features in the tem-
plates to guide template selection. This allows sequence dif-
ferences causing slight backbone changes such as bulges or
differently oriented kinks to be considered in more detail.
Loop modeling results are now provided using SL2, with
the advantage of user-guided loop selection allowing their
knowledge-based input to drive the selection process, a lim-
itation of automatic methods of loop modeling. Up-to-date
visualization is provided by the NGL viewer. We demon-
strate that the models produced by GPCR-SSFE 2.0 are as
good or better than other published methods with the bene-
fit of being able to capture structural features that sequence
similarity alone is unable to do. In summary, compared to
other approaches the fingerprint-driven fragment approach
used by GPCR-SSFE 2.0 can achieve an improved accuracy
in the predicted TMH regions, which is essential for in silico
ligand docking and virtual screening.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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Supplementary Data
Supplementary Figure S1:  The decision process for selecting templates for homology 
modeling of helix 8 (H8). Transmembrane helix 7 (TMH7) and H8 of the 27 template 
structures are shown superimposed in the center of the figure. The structures were split into 
seven different groups (PDB IDs shown) based on the conformation of the TMH7-H8 
junction. The template selected for modeling TMH7 indicates the cluster that should be used 
for template selection of H8. For example, if 4DKL is selected for modeling TMH7, the 
structure in group 1 with the highest sequence similarity to H8 of the query protein is chosen 
for modeling H8. 
Supplementary Table S1: GPCR-SSFE 2.0 template suggestions for the Thyroid-stimulating
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53 AA2AR_HUMAN - 
4EIY
GC at position 3x24 to 3x25
TMH
4
50 OPSD_TODPA - 2Z73 P at position 4x60, highest sequence similarity
TMH
5
52 LPAR1_HUMAN - 4Z34 No P at position 5x50, no F at position 5x47, N 
at position 5x47, highest sequence similarity
TMH
6




No FXXCWXP motif at position 6x44 to 6x50, 
PXS at position 6x50 to 6x52, highest sequence 
similarity;
No FXXCWXP motif at position 6x44 to 6x50, 
PXS at position 6x50 to 6x52, highest sequence 
similarity;




50 OPSD_TODPA - 2Z73 Highest sequence similarity
H8 55 AA2AR_HUMAN - 
4EIY
Highest sequence similarity 
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A fragment based method for modeling of
protein segments into cryo-EM density
maps
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Abstract
Background: Single-particle analysis of electron cryo-microscopy (cryo-EM) is a key technology for elucidation of
macromolecular structures. Recent technical advances in hardware and software developments significantly
enhanced the resolution of cryo-EM density maps and broadened the applicability and the circle of users. To
facilitate modeling of macromolecules into cryo-EM density maps, fast and easy to use methods for modeling
are now demanded.
Results: Here we investigated and benchmarked the suitability of a classical and well established fragment-based
approach for modeling of segments into cryo-EM density maps (termed FragFit). FragFit uses a hierarchical strategy
to select fragments from a pre-calculated set of billions of fragments derived from structures deposited in the Protein
Data Bank, based on sequence similarly, fit of stem atoms and fit to a cryo-EM density map. The user only has to
specify the sequence of the segment and the number of the N- and C-terminal stem-residues in the protein. Using a
representative data set of protein structures, we show that protein segments can be accurately modeled into cryo-EM
density maps of different resolution by FragFit. Prediction quality depends on segment length, the type of secondary
structure of the segment and local quality of the map.
Conclusion: Fast and automated calculation of FragFit renders it applicable for implementation of interactive
web-applications e.g. to model missing segments, flexible protein parts or hinge-regions into cryo-EM density maps.
Keywords: Cryo-EM, Fragment based modeling, Flexible fitting
Background
Cryo electron microscopy (cryo-EM) is a key technology
for structural elucidation of molecular complexes. The
vast majority of published cryo-EM density maps is re-
solved at medium resolutions between 6 and 9 Å or
lower [1–3]. In these medium resolution maps, no side-
chains are resolved, but secondary structure elements or
backbone traces can be identified and modeled [4–6].
Recent technical advances in development of direct elec-
tron detectors significantly improved the resolution of
structures determined by cryo-EM [7, 8]. Near atomic
resolution of cryo-EM density maps now even allows de
novo modeling of well-resolved parts [9]. However, flex-
ible regions such as loops often remain unresolved [10].
In cases where conformational changes of proteins only
affect a substructure of the protein or a single domain
while the general fold remains unchanged, modeling fo-
cuses on the flexible hinge regions [11]. Approaches,
where defined structural elements are modeled into an
existing structural context are thus a regular part of the
workflow to calculate structural coordinates from cryo-
EM density-maps [10, 11]. Because of the wide range of
structural biologists working in the field of cryo-EM,
methods for modeling into cryo-EM density maps e.g. to
be integrated by easy to use web services such as SL2
[12] can greatly enhance researcher productivity. Here
we evaluate the applicability of a well established frag-
ment based modeling approach [12–14] for prediction of
protein segments into cryo-EM density maps. This novel
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method, termed FragFit, can be readily integrated into
modeling approaches where e.g.: (i) conformational
changes of proteins only affect a substructure of the pro-
tein or a single domain, while the general fold remains un-
changed [11], (ii) parts in a protein model are missing
[10], or (iii) where local flexibility does not allow unam-
biguous assignment of a single conformational state [15].
Several methods have been established for structure
prediction of protein segments, especially for the pur-
pose of loop modeling [13, 16, 17]. These methods can
be divided into forcefield- [17] and fragment-based ap-
proaches [13]. Forcefield-based methods have the gen-
eral advantage that, in principle, new polypeptide folds
can be predicted. These tools are, however, computa-
tionally expensive [18], and are thus usually not applic-
able for instant visual control of the results in interactive
web-applications. Fragment based methods allow for
comparably fast assessment of results because searches
leverage databases of pre-calculated fragments. The lat-
ter databases are typically either derived from third party
databases of protein structures such as the Protein Data
Bank (PDB) [12, 19] or from concatenating small frag-
ments in a structural database [20, 21].
The quality of classical fragment based modeling de-
pends on the algorithm used for fragment selection and
on the completeness of the fragment database [22]. Since
the number of conformations rises exponentially with
the length of the segment, quality of prediction generally
drops with segment length [23, 24]. Loops are structur-
ally highly heterogeneous and flexible. Nevertheless, it
has been suggested that the conformational space for
loops up to 12–14 residues is covered by structural frag-
ments derived from entries of the PDB [25, 26]. We
therefore used LIP a regularly updated fragment data-
base derived from the PDB for modeling of segments
into cryo-EM density maps [12]. The advantage of this
approach is that the segments derived from the PDB are
taken from structures that have already been subject of a
strict and independent quality control. To evaluate Frag-
Fit under realistic conditions we used experimentally de-
rived cryo-EM density maps, which naturally include
fragmentations and local variations in resolution, and ex-
cluded identical template fragments (with 90% sequence
identity or higher to the queried segment) from model-
ing. We find FragFit to be a useful tool for quick and re-
liable modeling of segments of up to 20–25 residues
length into cryo-EM density maps. Prediction quality de-
pends on segment length, secondary structure type of
the predicted segment and the local quality of the map.
Methods
To start a search, the amino acid sequence of the quer-
ied segment, the stem residues flanking the queried seg-
ment, the cryo-EM density map and its resolution must
be provided (Fig. 1). The sequence similarity and a geo-
metrical measure (termed geometric fingerprint) is used
to search for suitable fragments (‘FragSearch’) in the
fragment database derived from the RCSB PDB. These
fragments are subsequently re-scored by their fit to
preprocessed cryo-EM density maps to select for the
best fitting fragments (‘FragFit’). Besides providing
input arguments FragSearch and FragFit are fully au-
tomated procedures that do not require any interven-
tion by the user.
Fragment database and geometrical fingerprint
The fragment database LIP (‘Loops in Proteins’), which
we employed to search for suitable fragments in the first
prediction step (see Fig. 1a, ‘FragSearch’) contained about
9*108 protein fragments. The database was composed of
all overlapping fragments of 3–35 residues length ex-
tracted from about 100.000 entries of the PDB in June
2013. The number of fragments decreases linearly with
fragment length, from about 23 to 19 million for frag-
ments with 3 to 35 residues, respectively (see Add-
itional file 1: Figure S1). With a recent update (February
2017) the database contains now more than 109 protein
fragments, extracted from more than 126.000 entries of
the PDB. For each fragment the amino acid sequence,
PDB identifier, chain identifier and the residue numbers
of N- and C-terminal stem atoms is stored. In addition,
a geometrical fingerprint is calculated for the stem
atoms of each fragment (and also of the gap in the struc-
ture), composed of the distance d between the N- and
C-terminal stem atoms and three angles defining their
relative orientation (Fig. 1a, see Additional file 1: Figure
S2). Matching of geometrical fingerprints of fragment
and gap and sequence similarity (for details see [13]) are
used as evaluation criteria by FragSearch (Fig. 1a).
FragSearch
For detection of suitable fragments (FragSearch), we in-
tegrated the search algorithm of ‘SL2’ which is based on
a hierarchical approach that minimizes calculation time
(see [12–14]). First, fragments with the same number of
amino acids as the missing segment and with a similar
distance d of stem residues as in the gap (Δd < 0.75 Å)
are selected (see Additional file 1: Figure S2). Second,
these fragments are ranked by the RMSD-value of their
N- and C-terminal stem residues after superposition
with the respective stem residues of the gap. Third, frag-
ments whose incorporation would lead to clashes with
other atoms of the same protein chain are identified and
subsequently excluded. Moreover, fragments with identi-
cal primary structure or identical folds (with backbone
RMSD <0.5 Å) are deleted (see [13]) to maximize the
conformational space. In a fourth step, the top-1000 list
of suitable candidates is re-ranked by sequence similarity
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to the queried segment and matching of geometrical fin-
gerprints of fragment and gap (Fig. 1a). The top-100 list
of suitable candidates is subsequently evaluated by Frag-
Fit, which employs cryo-EM density maps as an add-
itional selection criterion.
FragFit
The geometrical fit of the shape of a fragment to a cryo-
EM density map is used to re-rank the top-100 list of
suitable fragments and select for ‘fitting fragments’
(Fig. 1c). This fit is measured by means of the Pearson
cross-correlation coefficient between structure-derived
(termed simulated density maps) and experimentally de-
termined cryo-EM density maps. This procedure assigns
a cross correlation value to each fragment, which is fi-
nally used for re-ranking of the top-100 list (Fig. 1c, ‘fit-
ting fragment’). For generation of the simulated density
maps for each suitable fragment (Fig. 1b, ‘map prepro-
cessing’) the ‘copy from pdb’ functionality implemented
in SPIDER was used [27]. The simulated density maps
were subsequently filtered to the resolution of the ex-
perimental cryo-EM density map using a Butterworth
Fig. 1 Workflow of FragFit. As input (top), (1) a PDB structure, (2) the stem atoms of residues flanking the queried segment, (3) the amino acid
sequence of the queried segment and (4) the cryo-EM density map with (5) its resolution must be provided. a Sequence similarity between fragment
and queried segment and matching of geometric fingerprints (Additional file 1: Figure S2) are used as evaluation criteria for FragSearch. b Cryo-EM
density maps are preprocessed to minimize calculation time and to reduce false positive predictions. For that purpose, a minimal box limited to the
maximum density of the missing segment is extracted and occupied densities are deleted. c Suitable fragments identified by FragSearch are re-scored
by the Pearson cross-correlation coefficient between simulated and experimentally determined cryo-EM density maps, which selects for the best fitting
fragments. All steps are presented in more detail in Additional file 1: Figure S6
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low pass filter. Since procession time of cryo-EM
density maps scales at least cubicly with image size, a
minimal box enclosing the density of the queried seg-
ment is extracted from the cryo-EM density map
(Additional file 1: Formula S1).
In the final preprocessing step, densities occupied by
other parts of the structure are deleted from the minimal
box (Fig. 1b). For that purpose, the part of the structure
located within the minimal box is converted into a
simulated density map with its intensity level adjusted to
the value of the experimental map by a standard
normalization (setting the average of the map to 0 and
the standard deviation to 1). With a simple arithmetic
operation, the simulated density map is subtracted from
the minimal box reducing the cryo-EM density to the
density of the missing fragment. Besides reducing
procession time, this step limits false positive predictions
by preventing placement of fragments into already
occupied densities.
Validation data set
For evaluation of FragFit, a test data set of cryo-EM
density maps and structure coordinates of eight different
macromolecular complexes selected from the EMDB [1]
was composed. This data set (Table 1) includes proteins
with different functions such as the ribosome, the prote-
asome and ion channels with resolutions ranging from
3.1 to 12 Å [7, 8, 28–33]. Using a sliding window of 5 to
35 amino acids length, a total of 20.000 different seg-
ments were assigned for evaluation. As for previous
evaluations of fragment based approaches, fragments
with sequence identities of more than 90% (for details
see [12, 14]) to the queried segments were excluded
from LIP prior calculations. This cut-off excludes identi-
cal structures, while keeping the conformational space
as large as possible, thus mimicking a real life situation,
where the best fitting fragment has to be selected from
millions of candidates. Further, to assess the quality of
FragSearch and FragFit (see Fig. 1) for prediction of dif-
ferent types of structural elements, helices, β-sheets and
loops were assigned by means of the DSSP algorithm
[34]. Finally, to estimate the impact of resolution on
FragFit prediction quality, simulated density maps with
resolutions ranging from 4 to 20 Å were used. Using
simulated instead of experimentally determined cryo-
EM density maps excludes bias by inhomogeneous reso-
lutions or map fragmentation. Simulated electron dens-
ity maps were calculated for the structure of the β2
adrenergic receptor–Gs protein complex (PDB-entry
code: 3SN6) [35] using the ‘pdb_sim’ functionality of the
NMFF program package [36]. As above, fragments with
sequence identities of more than 90% were excluded
from LIP prior calculations (for details see [12–14]).
Validation measures
The root mean square deviation (backbone-RMSD) was
used as primary measure of structural similarity between
an experimentally determined protein segment and its
predicted conformation after superposition of the corre-
sponding termini and stem atoms (Formula 1). Since
only the backbone atoms but not the side chains are pre-
dicted, solely the coordinates of backbone atoms were
used for evaluation. The difference of RMSD values of
FragSearch and FragFit (ΔRMSD) was used to evaluate
the gain in prediction quality, when cryo-EM density









Formula 1. Calculation of root mean square deviation
(RMSD).
N is the number of atoms, Xi and Yi are the coordi-
nates of the backbone atoms from both structures after
superposition of the corresponding termini and stem
atoms.
To provide a measure of similarity independent from
the number of compared atoms, that is, of fragment
length [37], the template modeling score (TM-score)
was employed to assess the ‘topological similarity’ of two
proteins (Formula 2a) [38]. The Method is described in
Table 1 Structures and cryo-EM density maps used for evaluation of FragFit
EMDB-entry code PDB-entry codes Biological system Resolution in Å Citation
1721 3J59,3J5A 70S ribosome 12.0 (Bock et al., [28])
1798 2XSY,2XTG 70S ribosome 7.8 (Ratje et al., [31])
2490 4CE4 Mitochondrial large ribosomal subunit 4.9 (Greber et al., [29])
2566 3J6B Mitochondrial large ribosomal subunit 3.2 (Amunts et al., [7])
5256 3IZX cytoplasmic polyhedrosis virus 3.1 (Yu et al., [32])
2325 3ZPZ GroEL/ES 8.9 (Chen et al., [33])
5776 3J5Q TRPV1 3.8 (Cao et al., [8])
1733 3C91 20S proteasome 6.8 (Rabl et al., [30])
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detail in ref. [38]. Shortly summarized, the TM-score
employs the length (‘L’) of the target protein and the
number of aligned residues in both protein segments
(‘Lali’) (see Formula 2a). The distance between each pair
of aligned residues is di, while d0 is a scaling value to
normalize this match difference. The expression ‘max’
denotes the maximum value after optimization of super-
position. A simplified variation of the TM-score was
used here (Formula 2b), since in our approach segments
of identical length (‘Lali’ = ‘L’) were used and no
optimization of superposition of fragments was per-
formed; only the stem residues were aligned. In
principle, the value of the TM-score ranges from 0 to 1





















Formula 2. a) General calculation of the TM-score, b)
simplified Version used here.
Results
To test the applicability of our fragment based approach
for modeling of loops, helices or β-sheets into cryo-EM
density maps, we evaluated the gain in prediction quality
of classical fragment modeling when cryo-EM densities
are employed as experimental restraints. For the initial
step of fragment-based prediction (FragSearch) we
employed the hierarchical search algorithm implemented
in SL2 and the fragment database LIP [12–14]. In a sec-
ond step we used the cross-correlation between simu-
lated and experimentally determined density maps for
re-scoring. The test data set includes functionally and
evolutionary distinct proteins, whose structures were elu-
cidated at resolutions between 3.1 Å and 12 Å by cryo-
EM. We find a significant improvement of prediction
quality depending on length and secondary structure of a
missing segment as well as on the quality (resolution, frag-
mentation, noise) of cryo-EM density maps.
Modeling accuracy of segments into cryo-EM density
maps
The top-100 list of fragments is obtained by FragSearch,
which uses the criteria sequence similarity and geomet-
rical fit of stem atoms (see Fig. 1a). This top-100 list is
re-scored by FragFit, which uses a cryo-EM density map
as additional restraint. That step significantly improves
prediction quality for all fragments longer than five resi-
dues (paired t-test with P ≤ 0.05). The absolute RMSD-
values range from 1.9 Å for fragments with five residues
length to 9.6 Å for fragments with 35 residues length
(Fig. 2a). Modeling, therefore, improves on average by
1–2 Å (ΔRMSD) for fragments of 8–16 residues length
and 2–3 Å (ΔRMSD) for longer fragments when cryo-
EM density maps are employed (Fig. 2c, grey bars).
Prediction quality depends on the secondary structure
type
Prediction quality depends on the secondary structure
type of the modeled segment. Helices, which become
visible even at medium resolution cryo-EM density maps
[5, 6], are found here as the secondary structure elements
with highest predictability (Fig. 2b). When compared to
other structural elements, the absolute RMSD value of
helices is lower. This difference is more articulate for lon-
ger fragments. Loops, which here also include structural
irregularities such as Pi-buldges or 3–10 helices, are pre-
dicted with similar accuracy as helices up to 16 residues
length, before prediction quality drops down to the level
of the β-sheets, which are generally most difficult to pre-
dict. The improvement of prediction of β-sheets and loops
with FragFit is similar or even more pronounced as for
helices up to a length of 25 residues but clearly drops for
longer segments (Additional file 1: Figure S3).
Prediction quality can be further enhanced when the
top-five hits are taken into consideration
When not only the top hit but the top-five hits of Frag-
Fit (and FragSearch) are considered for evaluation, the
performance is further improved by an additional aver-
age drop of the backbone-RMSD of about 1 Å (Fig. 2c).
This benefit is again particularly pronounced for longer
fragments. For fragments of e.g. 17 amino acids length,
the mean backbone RMSD to the original segment drops
from 7.2 Å (top hit FragSearch) and 5.0 Å (top hit
FragFit) to 3.9 Å (top-five hit FragFit). For fragments
of 27 amino acids length, the corresponding values
are 10.1 Å (top hit FragSearch), 7.2 Å (top hit FragFit)
and 5.6 Å (top-five hit FragFit). When additional hits are
taken into account (e.g. top-ten hits FragFit), no further
improvement is obtained (Additional file 1: Figure S4)
suggesting that the best solution is regularly found within
the top five results list.
Furthermore, a significant gain in prediction quality is
observed with FragFit when only those FragSearch top-
hits were considered with an RMSD above the mean
RMSD (indicated as double triangles in Fig. 2a). In those
cases, the gain in prediction quality measured by the
drop of the backbone-RMSD is about 2 Å larger as the
gain when all FragSearch top-hits were considered
(Fig. 2d). This result suggests that the gain in prediction
quality largely stems from down ranking of fragments
with non native conformations.
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FragFit selects for the right fold
The backbone-RMSD was used as a measure of struc-
tural similarity. Specifically, we measured the average
distance between the backbone atoms of a selected frag-
ment and the original protein segment after superpos-
ition of the corresponding termini and stem atoms (see
Methods). Using this measure, all atoms are taken into
account with equal weight. For high RMSD-values typic-
ally observed with longer fragments it, however, remains
unclear whether this value stems from similar structures
with local deviations (such as a kink) or completely dif-
ferent structures/folds.
To provide a second quality assessment for evaluation
of longer fragments, we employed the TM-score, which
is designed as a measure of similarity in structure or
fold. This measure is also considered to be rather inde-
pendent of protein length [39]. A TM-score > 0.5 indi-
cates a similar structure or fold. Our analysis of the TM-
score provides evidence that fragments with appropriate
structure are regularly identified by FragFit, especially
for fragments up to 25 residues length. For fragments
longer than 12 amino acids we find that the TM-score
between original and predicted fragment (top hit Frag-
Fit) is higher than 0.5 in 81% of predictions. In 82–93%
of predictions of fragments of 12–25 residue length
a similar structure is found. The number of
fragments with a score higher then 0.5-score drops
to values of 69–76% for fragments of 26–35 residue
length (Additional file 1: Figure S5). According to the TM-
score analysis, the conformation of fragments up to 25
residues length can be predicted with high accuracy.
Influence of resolution on fragment prediction quality
Assessment of the influence of resolution on fragment
prediction quality is complicated, because of local varia-
tions in structure resolution and fragmentation of cryo-
EM density maps. To estimate the influence of resolution
on prediction quality, we generated simulated density
maps from the X-ray structure of the β2 adrenergic
receptor-Gs protein complex (PDB accession code: 3SN6)
with resolutions ranging from 4 to 20 Å (Fig. 3). This
membrane protein complex contains 35% helices, 19.2%
sheets and 45.8% unassigned regions, such as loops or
kinks, thus representing the complete relevant spectrum
of protein secondary structures evaluated here. The ad-
vantage of using simulated instead of experimentally de-
termined cryo-EM density maps is that factors which
would influence this analysis such as noise or fragmenta-
tion are excluded. Of note, the PDB entry 3SN6 and all
fragments with a sequence identity of more than 90% have
been excluded from the fragment database.
Fig. 2 RMSD-based FragFit benchmarks. a Absolute backbone RMSD values of predicted fragment (top-hit) and original segment by FragSearch
(double triangle) or FragFit (black star). b Comparison of absolute backbone RMSD values of predicted fragment (top-hit) and original segment by
FragFit for the different structural elements helices (grey square), β-sheets (black rhombus) or loops (gray triangle). c Comparison of ΔRMSD (=RMSD
FragSearch – RMSD FragFit) of top hit (gray bar) and top five hits (blue bars). d Comparison of ΔRMSD of top hits (gray bars) and only those top-hits
were the RMSD of FragSearch is above the mean-value
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As with experimentally determined cryo-EM density-
maps the gain in prediction quality (ΔRMSD) increases
with fragment length (Fig. 3). Only for the highest reso-
lution maps of 4–6 Å, a minor improvement of predic-
tion quality is also seen for the short fragments of 5–7
residues length. A constant increase in prediction quality
up to ΔRMSD = 5 Å is seen for simulated density maps
of 4–12 Å resolutions for fragments of 8–35 residues
length. For the low resolution maps of 15 and 20 Å, a
minor gain in prediction quality is only observed for seg-
ments of at least 11 or 20 residues length, respectively. The
higher gain in prediction quality of simulated compared to
experimentally determined density maps shows how noise
and fragmentation of experimentally determined cryo-EM
density-maps complicates modeling. In summary, FragFit
performs very well over a wide range of resolutions but best
for high- and medium resolution maps.
Discussion
Using a representative data set of protein structures re-
solved by cryo-EM, we provide evidence that fragment
based approaches can be applied to model protein seg-
ments into cryo-EM density maps at high accuracy. Our
results are complementary to previous approaches using
cryo-EM density maps for rigid [40–42] or flexible fit-
ting [43–45] of existing structures, or for de novo mod-
eling of complete protein structures into high resolution
cryo-EM density maps [46]. One outstanding feature is
that FragFit, which uses the same hierarchical strategy to
find suitable fragments as SL2 [12–14], provides results
within one or few minutes even for long fragments (de-
pending on box size and running environment). This
renders FragFit applicable for web-based applications
providing easy access for structural biologists.
FragFit can be used to model or remodel parts of pro-
teins. It has been proven to guide modeling of poorly
resolved flexible loops in ribosome bound initiation
factor-2, which cryo-EM density map was resolved at
3.7 Å resolution. Initial models generated by FragFit
were verified or optimized by real-space refinement in
Phenix 1.10 [10]. Moreover, FragFit can be readily inte-
grated into modeling approaches, where conformational
changes of proteins only affect a substructure of the pro-
tein or a single domain, while the general fold remains
unchanged [11]. In these cases, flexible fitting of the
complete structure or complex is not required. Instead,
the structure can be dissembled into its different do-
mains which are rigidly fitted [40]. FragFit can then be
used to reconnect these domains or to re-model the
hinge regions. Since the fragments are taken from PDB
structures which have undergone several steps of quality
control, the fragments do not necessarily have to be re-
fined, only the side chain rotamers may have to be
edited. Moreover, automatically refinement tools as
Rosetta [47], or a short energy minimization might be
used to further improve the completed structure with
regards to the newly ligated backbone stem atoms, which
may suffer from small structural distortions due to geo-
metrical inconsistencies.
The accuracy of FragFit depends on the type of sec-
ondary structure and of the quality (resolution, fragmen-
tation, noise) of the map. The high reliability of
prediction of helices can be explained by the characteris-
tic sequence composition and geometry of α-helices,
that are often well defined and clearly visible in cryo-EM
density maps. By contrast, β-sheets and long loops, that
are stabilized by more complex tertiary or quaternary
structure interactions involving residues distant in pri-
mary structure, are much more difficult to model and to
identify even in medium resolution maps [48]. Despite
this fact, analysis of the TM-score suggests that FragFit
is also capable of modeling β-sheets and complex loop
Fig. 3 ΔRMSD between FragSearch and FragFit for simulated cryo-EM maps of different resolutions. The gain of FragFit over FragSearch is constant
for resolutions ranging from 4 to 12 Å for fragments of at least 12 residues length. Only a minor improvement of prediction quality is obtained with
resolutions of 15 Å or 20 Å for segments of at least 11 or 20 residues length, respectively
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structures, particularly when a homologous template
structure is available (Fig. 4b, c).
The gain in prediction quality is higher in those cases,
where FragSearch was unable to select the best fragment
(Fig. 2d, ΔRMSD FragSearch fails). Our analysis, therefore,
reveals that false positives are cleaned out from the top-
(Fig. 2d) and the top-five results list (Fig. 2c), when cryo-
EM density maps are used as restraints. An additional gain
in prediction quality is obtained, when the top-five results
list is taken into account. Visualization of the top-five frag-
ments is therefore expected to aid selection of the best fit-
ting fragment, particularly in case of fragmented maps or
maps with unassigned but not relevant densities. Fragmen-
tation might in several cases thus impact modeling quality
more than overall resolution. If noise or fragmentation is
absent, resolution of 12 Å would theoretically be sufficient
to guide the modeling process (Fig. 3). In this case, even
low resolution maps support modeling of segments longer
than 20 residues, suggesting that if the rough shape of the
queried segment is defined by the map the native conform-
ation could be selected from the ensemble of conforma-
tions suggested by FragSearch. Finally, fragmentation might
in part also refer to the presence of an ensemble of different
conformations rather than one well defined state. Loops of
proteins are often highly flexible and split up into various
substates with sub-micro second lifetimes [49]. In these
cases FragFit might be useful to contour the possible en-
semble of different conformations present in flexible pro-
tein regions.
Conclusion
In summary, FragFit has proven to be a valuable tool for
the modeling of protein segments into cryo-EM density
map. Particularly for longer segments, cryo-EM density
maps add additional restraint that improve classical frag-
ment based modeling. The low requirements in comput-
ing power recommend implementation of FragFit for
instant visualization in web-applications (runtime ap-
proximately within a few minutes, depending on the
running environment, fragment length and box size).
Visual control allows interactive selection of the most
appropriate fragment, which we consider as a necessary
step to select for the most appropriate conformation,
specifically when artifacts or map fragmentations
complicate fully automatic modeling. The database
LIP and the programs FragSearch and FragFit are ac-
cessible on request.
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SUMMARY
The crystal structure of the b2-adrenergic receptor
(b2AR) bound to the G protein adenylyl cyclase stim-
ulatory G protein (Gs) captured the complex in a
nucleotide-free state (b2AR-Gsempty). Unfortunately,
the b2AR-Gsempty complex does not provide a clear
explanation for G protein coupling specificity. Evi-
dence from several sources suggests the existence
of a transient complex between the b2AR and GDP-
bound Gs protein (b2AR-GsGDP) that may represent
an intermediate on the way to the formation of
b2AR-Gsempty and may contribute to coupling spec-
ificity. Here we present a structure of the b2AR in
complex with the carboxyl terminal 14 amino acids
from Gas along with the structure of the GDP-bound
Gs heterotrimer. These structures provide evidence
for an alternate interaction between the b2AR and
Gs that may represent an intermediate that contrib-
utes to Gs coupling specificity.
INTRODUCTION
G protein coupled receptors (GPCRs) constitute the largest
family of cell surface receptors that sense extracellular signals
and activate intracellular pathways (Lefkowitz, 2007). An
agonist-bound GPCR interacts with the guanosine diphosphate
(GDP)-bound Gabg heterotrimer, leading to GDP release and
guanosine triphosphate (GTP) binding, followed by functional
dissociation of the heterotrimer and activation of downstream
pathways. GPCRs typically have a preference for activating
one of three major G protein subfamilies that regulate distinct
cellular signaling pathways: adenylyl cyclase stimulatory G pro-
tein (Gs), Gi/o, or Gq/11. The structural basis for this coupling
preference is poorly understood. The b2-adrenergic receptor
(b2AR)-Gs structure was the first crystal structure of an intact
GPCR-G protein complex (Rasmussen et al., 2011). The A2A
adenosine receptor was subsequently crystallized in complex
with an engineered Gas subunit (Carpenter et al., 2016). More
recently, two family B GPCR-Gs complex structures, the
calcitonin receptor (CTR)-Gs complex and the Glp-1R-Gs
complex (Liang et al., 2017; Zhang et al., 2017), and four family
A-Gi/o complex structures, mOR-Gi, 5-HT1BR-Go, A1R-Gi, and
rhodopsin-Gi, were obtained by single-particle cryo-electron mi-
croscopy (Draper-Joyce et al., 2018; Garcı́a-Nafrı́a et al., 2018;
Kang et al., 2018; Koehl et al., 2018). The complex structures
solved so far all captured the nucleotide-free state, which has
the stability required for crystallography and cryo-electron mi-
croscopy. These structures reveal remarkable similarities in in-
teractions between nucleotide-free G protein and family A and
family B GPCRs. In all of these structures, the C terminus of
Ga (a5 helix) serves as the major conformational link between
the receptor and the nucleotide-binding pocket.
Several lines of evidence suggest the existence of an interme-
diate state between a GDP-bound G protein and its GPCR.
Recent single-molecule fluorescence resonance energy transfer
(FRET) studies show that the b2AR interacts with Gs in the pres-
ence of cytosolic concentrations of GDP (Gregorio et al., 2017).
Hydrogen-deuterium exchange and cross-linking studies also
provide evidence of specific interactions between the b2AR
and GDP-bound Gs (Chung et al., 2011). These studies suggest
that the b2AR may interact with the a5 helix of Gas in a different
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way in the GDP-bound state compared with the nucleotide-free
state. More recently, we used hydrogen-deuterium exchange
mass spectrometry (HDX-MS) and radiolytic X-ray footprinting
MS (XFP-MS) in a time-resolved manner to investigate the
sequence of events during GPCR-mediated GDP release. These
studies show that GDP release occurs within seconds of mixing
purified b2ARwith GsGDP, whereas formation of the stable b2AR-
Gsempty complex observed by crystallography takes much
longer (Du et al., 2019 [in this issue of Cell]). A recent study using
protein sequence analysis to understand GPCR-G protein
coupling specificity suggests that several residues on the a5 he-
lix are part of a G protein-specific bar code (Flock et al., 2017). Of
interest, H387Gas, R389Gas, Y391Gas, and E392Gas are all part of
the Gs-specific bar code. Although Y391Gas and H387Gas form
strong interactions with the core of the receptor in the b2AR-
Gsempty complex (Rasmussen et al., 2011) and the A2A-miniGs
complex (Carpenter et al., 2016), E392Gas and R389Gas are on
the opposite side of the a5 helix and largely solvent-exposed.
Although there are no specific interactions between the b2AR
and R389Gas or E392Gas in the nucleotide-free complex, their
high sequence conservation suggests that they may play a role
in complex formation and coupling specificity. Here we present
the structure of the b2AR in complex with a peptide representing
the C-terminal 14 amino acids of the a5 helix. This structure re-
veals an alternate conformation of the a5 helix bound to the cyto-
plasmic core of the active b2AR, where R389Gas and E392Gas
interact with the highly conserved DRY motif of the b2AR. Muta-
tion of R389Gas and E392Gas reduces the coupling efficiency,
suggesting that the observed complex may represent an inter-
mediate state in the process of Gs activation.
RESULTS
Identification of an Alternate Interaction between the a5
Helix and b2AR
This project began as an effort to develop a generally appli-
cable method to stabilize GPCRs in active conformations
for crystallography and was inspired by an active-state crystal
structure of opsin in complex with a peptide derived from the
C-terminal a5 helix peptide of the G protein transducin (Sche-
erer et al., 2008). Our attempts to crystalize the agonist-bound
b2AR with a synthetic peptide representing the a5 helix of Gs
failed. We had shown previously that fusion of the a5 helix of
Gas to the C terminus of b2AR increases agonist-binding af-
finity (Rasmussen et al., 2011), a property observed in the
b2AR-Gs complex, suggesting a functional interaction be-
tween the a5 helix and the core of the b2AR. We attempted
to crystallize a modified b2AR where the last 14 residues of
the Gas a5 helix (GsCT) were fused to the C terminus of the
b2AR; however, the resulting fusion protein failed to crystal-
lize, most likely because of flexibility of the link between the
b2AR and GsCT.
Figure 1. Design of the b2AR-T4L-GsCT-CC Construct and Overall b2AR-T4L-GsCT-CC Structure
(A) Topology map of the b2AR-T4L-GsCT-CC construct.
(B) Agonist competition studies show that b2AR-T4L-GsCT-CC and b2AR-T4L-GsCT exhibit higher affinity for the agonist isoproterenol (Iso) than b2AR-T4L or
b2AR (p < 0.0001) (n = 3). The differences between b2AR-T4L-GsCT-CC and b2AR-T4L-GsCT are not statistically significant (p = 0.13). Statistics comparisons
were performed by extra sum-of-squares F tests. Data are represented as mean ± SEM.
(C) Overall structure of b2AR-T4L-GsCT-CC.
(D) Structure alignment of the b2AR-T4L-GsCT-CC structure with the active b2AR structure (PDB: 3SN6).
(E) Alignment of the b2AR-T4L-GsCT-CC structure with the inactive b2AR structure (PDB: 2RH1). TM6 in b2AR-T4L-GsCT-CC is almost identical to its position in
the active structure and is 14 Å away compared with the inactive structure.
See also Figures S1, S2, and S3, and Table S1.
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To stabilize the interaction between GsCT and b2AR, GsCT
was fused to the C terminus of T4 lysozyme (T4L) and inserted
between TM5 and TM6 of the b2AR (Figure 1A). The linkers be-
tween TM5 and T4L, between T4L and GsCT, and between
GsCT and TM6 were optimized to yield a b2AR-T4L-GsCT
construct that had enhanced affinity for the agonist isoproterenol
(Iso) (Figure 1B; Figures S1A and S1B). Although we were able to
obtain crystals of this construct, the quality was not sufficient for
structure determination. To further stabilize the interaction be-
tween the b2AR and GsCT, a disulfide bond was introduced be-
tween L394Gas of GsCT and A2265.65 of TM5 (Figure 1A). The re-
sulting construct (named b2AR-T4L-GsCT-CC) showed a similar
increase in agonist affinity as observed for b2AR-T4L-GsCT,
which lacked the disulfide (Figure 1B), suggesting that the disul-
fide did not significantly change the interaction of the peptide
with the b2AR.
Crystals of b2AR-T4L-GsCT-CC were grown in lipidic cubic
phase, and the structure was determined by molecular replace-
ment at 3.7 Å resolution (Table S1). The fo-fc simulated anneal-
ing omit map clearly revealed the a helix-shaped densities for
TM6 and GsCT but with weak density for side chains other
than aromatic residues because of the limited resolution (Fig-
ures S2A and S2C). The model building of TM6 and GsCT
was guided by chemical restraints of an a helix and the position
of aromatic side chains, and the final model was well supported
by the 2fo-fc map (Figures S2B and S2D). There are two
molecules in the asymmetry unit, chain A and chain B. The re-
ceptors in these two molecules are almost identical, with a
root-mean-square deviation (RMSD) of 0.57 Å for all atoms
Figure 2. Identification of an Alternate Inter-
action between the a5 helix and b2AR
(A and B) Two different views comparing the
orientation of GsCT from the b2AR-T4L-GsCT-CC
structure (yellow) with GsCT from the b2AR-Gs
complex structure (cyan). In (A) GsCT is perpen-
dicular to the page and in (B) it is parallel.
(C) E392Gas interacts with R1313.50, and R389Gas
interacts with Y141ICL2 and T682.39 in the b2AR-
T4L-GsCT-CC structure.
(D) Y391Gas forms a cation-p interaction with
R1313.50, and H387Gas interacts with Y141ICL2 and
Q142ICL2 in the b2AR-Gs complex structure (PDB:
3SN6).
See also Figures S4 and S5.
(Figure S3A). We used chain A for the
following analysis. The receptor structure
is remarkably similar to its structure in
the b2AR-Gs complex; the RMSD is
0.81 Å for all atoms and 0.67 Å for Ca
carbons (Figures 1C and 1D). The major
differences come from the C terminus
of TM5 because TM5 directly links
to T4L, and the C-terminal residues
(K2275.66–K2325.71) are distorted. TM6
moves outward by 14 Å compared with
the inactive b2AR structure (PDB:
2RH1) (Figure 1E). This movement is
the same as in the b2AR-Gs complex (PDB: 3SN6) and 3 Å
more outward than Nb80-bound b2AR (PDB: 3P0G) or Gi-
bound mOR (PDB: 6DDE) (Figures S3B and S3C). Thus, b2AR
is stabilized in an active conformation in the b2AR-T4L-GsCT-
CC construct.
One surprising finding was that GsCT bound to active b2AR in
a different mode compared with the b2AR-Gs complex (Figure 2;
Figure S4). The positions of GsCT are slightly different between
chain A and chain B (Figure S4C). The N terminus of GsCT
(D381Gas) is displaced 13 Å toward helix 8 in chain A and 12 Å
in chain B (Figure S4C). The carboxyl terminus of GsCT is linked
to A226C at the cytoplasmic end of TM5 by an engineered disul-
fide bond and occupies a similar position as the C terminus of Gs
in the b2AR-Gs complex (Figure 2; Figure S4). The formation of
the bond is necessary to obtain diffraction-quality crystals; how-
ever, as noted above, the high-affinity state for agonists is not
dependent on disulfide formation (Figure 1B). Thus, although
the disulfide fixes the position of the C terminus of GsCT, we
expect that the peptide occupies a similar but less stable posi-
tion in the absence of the disulfide. Indeed, during molecular dy-
namics (MD) simulations, removal of disulfide bridges only
slightly increases the root-mean-square fluctuation (RMSF) of
GsCT (Figure S5A). The most significant difference between
GsCT in this structure and the same Gs segment in the b2AR-
Gs complex is that residues Y391Gas and H387Gas, which
interact with R1313.50, Y141ICL2, and Q142ICL2 in the b2AR-Gs
complex, are facing the solvent in the b2AR-T4L-GsCT-CC
structure. As a consequence of the rotation of the helix,
E392Gas and R389Gas, which face the solvent in the b2AR-Gs
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complex, interact with R1313.50 from the conserved DRY motif
(the ionic lock) as well as with Y141ICL2 and T682.39 from the re-
ceptor in the b2AR-T4L-GsCT-CC structure (Figure 2). Interest-
ingly, MD simulations suggest that the interactions in the
b2AR-T4L-GsCT-CC structure are nearly as stable as those in
the b2AR-Gsempty complex structure (Figures S5A–S5C), indi-
cating that the interaction pattern is unlikely to be a crystallo-
graphic artifact. The most stable interactions during simulations
include E392Gas and R1313.50; an interaction network of R389Gas
with T682.39, D1303.49, and I1353.54; interactions of Q390Gas with
I1353.54 and Q2295.67; and interactions between L393Gas and
T2746.36 and between L394Gas and K2706.32 (Figure S5C).
The Structure of the a5 Helix in the GsGDP Heterotrimer
The structure of b2AR-T4L-GsCT-CC suggests that bar code
residues E392Gas and R389Gas of the GDP-bound heterotrimer
may initially engage the b2AR and stabilize the ionic lock in an
open conformation and ICL2 in an a helix, with F139ICL2 posi-
tioned to engage Gas (Figure 2C). However, the orientation of
E392Gas and R389Gas in the GDP-bound Gs heterotrimer was
unknown because there was no available structure of this com-
plex. In the structures of GDP-bound heterotrimers for Gi (PDB:
1GP2) (Wall et al., 1995) and Gq (PDB: 3AH8) (Nishimura et al.,
2010), the C-terminal end of the a5 helix is not resolved. We
therefore solved the GDP-bound Gs heterotrimer structure at
2.8 Å resolution (Table S1). The overall structure is similar to
GDP-bound Gi and Gq (Figure 3A and 3B); however, the elec-
tron density of the Gas C terminus was good enough to allow
structure building of all a5 residues, including the last residue
L394Gas (Figures S2E and S2F). In the GDP-bound Gs struc-
ture, the a5 helix bends toward the aN-b1 loop. Y391Gas forms
a cation-p interaction with R38Gas and hydrogen bonds with
R42Gas, whereas H387Gas interacts with H41Gas through p-p
stacking and main-chain oxygen of R38Gas through a hydrogen
bond (Figure 3C). Therefore, it is unlikely that H387Gas and
Y391Gas (the two Gs bar code amino acids that engage the
b2AR in the structure of b2AR-Gs complex) would be free for
initial engagement with the b2AR because they are not
exposed on the protein surface. In contrast, R389Gas and
E392Gas (the other two Gs bar code amino acids) are sur-
face-exposed and, therefore, more available to form the initial
interaction with the b2AR (Figure 3C).
Comparison of GsGDP and b2AR-Gsempty reveals that the
a5 helix undergoes a large conformational change during forma-
tion of the nucleotide-free GPCR-G protein complex; the entire
helix straightens, moves 6 Å toward the receptor, and rotates
60 (Figure 3D; Dror et al., 2015). This structural change in-
volves disrupting an extensive network (1,100 Å2) of hydropho-
bic and polar interactions between the a5 helix and the rest of the
Ras domain. It is unlikely that this change is accomplished in a
single conformational rearrangement and probably involves at
least one conformational intermediate.
R389Gas and E392Gas Are Essential for Efficient
Complex Formation
To further assess whether the binding mode captured in the
b2AR-T4L-GsCT-CC structure might represent a physiologically
relevant state, we examined the functional effect of mutations
in bar code residues R389Gas and E392Gas (Gs R389A/E392A),
which interact with the b2AR in b2AR-T4L-GsCT-CC, and
H387Gas and Y391Gas (H387A/Y391A), which interact with the re-
ceptor in the nucleotide-free b2AR-Gs complex. To monitor Gs
coupling to the b2AR, we labeled C2656.27 on the cytoplasmic
end of TM6 with monobromobimane. We have shown previously
that, uponGs coupling to the b2AR, the outward displacement of
TM6 leads to a decrease in bimane fluorescence intensity and a
redshift in the wavelength of maximum emission (lmax) (Yao
et al., 2009). As shown in Figure 4A, the changes in bimane fluo-
rescencewere smaller for GsR389A/E392A comparedwith wild-
type Gs. Gs R389A/E392A was also less effective at triggering
GDP release and stabilizing high-affinity agonist binding than
wild-type Gs (Figure 4B and 4C). We also observed impaired in-
teractions between the b2AR and Gs H387A/Y391A that were
similar to or smaller than what was observed for Gs R389A/
E392A (Figure 4).
Similar results were obtained when Gs residues R389Gas and
E392Gas were mutated individually and in combination in a
construct where the 21 C-terminal residues of Gas were fused
to the C terminus of b2AR (b2AR-C-terminal peptide [cpep])
Figure 3. The Structure of the a5 Helix in GsGDP
(A) Alignment of GsGDP with Gi1
GDP (PDB: 1GP2).
(B) Alignment of GsGDP with GqGDP (PDB: 3AH8). The overall structures are
similar, but the C-terminal end of the a5 helix was not resolved in Gi1
GDP
or GqGDP.
(C) Y391Gas and H387Gas on the a5 helix interact with R38Gas, H41Gas, and
R42Gas on the aN-b1 loop. The cation-p interaction is indicated by a green
arrow, and hydrogen bonds are indicated by green dashes.
(D) Conformational changes in the GsCT in going from the GsGDP structure
(orange) to the b2AR-Gsempty complex structure (cyan; PDB: 3SN6) involve
disrupting an extensive network of hydrophobic and polar interactions be-
tween the a5 helix and the rest of the Ras domain.
See also Figure S2 and Table S1.
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(Figure S6A). As reported previously, b2AR-cpep exhibits
a higher affinity for the agonist Iso compared with b2AR (Ras-
mussen et al., 2011). For the b2AR-cpep fusion, we observed
impaired Iso affinity by introducing R389A and E392A mutations
separately and in combination compared with the native cpep
(Figures S6B–S6E). The R389T and E392T mutants were also
Figure 4. R389Gas and E392Gas Are Essential for Efficient Complex Formation
(A) Fluorescence spectra of the monobromobimane-labeled b2AR in the presence of 1 mMwild-type (WT) Gs, 1 mMR389A/E392A Gs, or 1 mMH387A/Y391A Gs.
Each spectrum represents an average of 3 independent spectra.
(B) The b2AR triggered tritium labeled guanosine diphosphate (3H-GDP) release of WT Gs, R389A/E392A Gs, or H387A/Y391A Gs (n = 3). The statistically
significant differences (*p < 0.05) between the WT and mutant are indicated.
(C) Isoproterenol competition curves of the b2AR reconstituted into high-density lipoprotein (HDL) particles, either as receptor alone or in the presence of WT Gs,
R389A/E392A Gs, or H387A/Y391A Gs. The values and statistics of the agonist competition curves are shown in the inset. Data are given as mean ± SEM from
4–6 independent experiments performed in duplicate or triplicate. Statistics comparing WT and mutant Gs were performed by extra sum-of-squares F test. The
differences between WT Gs and R389A/E392A Gs are statistically significant (p < 0.0001), and so are the differences between WT Gs and H387A/Y391A Gs (p <
0.0001). However, the differences between R389A/E392A Gs and H387A/Y391A Gs are not statistically significant (p = 0.13).
See also Figure S6.
Figure 5. Interaction between the b2AR
and R389Gas and E392Gas May Initiate GDP
Release
(A) Interaction between the b2AR and R389Gas
and E392Gas would affect interactions between
H387Gas, Y391Gas, and the aN-b1 loop. These
changes could be propagated to the P loop and
b6-a5 loop through the b1 strand and a5 helix.
(B) H387Gas interacts with H41Gas from the b1
strand; Q390Gas interacts with T242Gas at the
a2-b4 loop.
(C) Effect of the Gas H387A/Q390A mutation on
basal GDP release of Gas. The WT and mutant
are statistically different (p < 0.0001). Statistics
comparing H387A/Q390A with WT Gs were per-
formed by the extra sum-of-squares F test, where a
model of individually best-fit values of dissociation
rate (Koff) of the two different datasets was
comparedwith a model where the parameters were
shared among the datasets. The data are given as
mean ± SD of three independent experiments.
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tested because MD simulations suggested that Ala might still
mediate weak hydrophobic interactions with b2AR. E392T and
the R389T/E392T combination displayed marginally larger im-
pairments of agonist affinity than their Ala counterparts.
Our results are in agreement with previous studies. Mutations
of E392Gas impair cyclic AMP (cAMP) accumulation following Iso
stimulation of the b2AR (DeMars et al., 2011), with the less
conserved, non-polar mutations completely abolishing cAMP
accumulation. Using a FRET-based system for monitoring inter-
actions between the C-terminal peptide of Gs and the trans-
membrane core of the b2AR, the E392Q mutation significantly
reduced interactions between the tethered C-terminal peptide
and the b2AR (Semack et al., 2016). Finally, flexible docking
methods predicted an intermediate complex where E392Gas
from GsCT forms a hydrogen bond with R1313.50 from the highly
conserved DRY motif (Rose et al., 2015).
In the b2AR-T4L-GsCT-CC structure, R389Gas interacts with
Y141ICL2 through a cation-p interaction and forms a hydrogen
bond network with Y141ICL2, D1303.49, and T682.39 (Figure 2C).
Of interest is that Y141ICL2 is a target of the insulin receptor tyro-
sine kinase (Baltensperger et al., 1996). Phosphorylation on
Y141ICL2 leads to a super-sensitization of the receptor with
respect to Gs-mediated signaling. Upon insulin-induced phos-
phorylation on Y141ICL2, b2AR exhibited an increased ability to
activate adenylyl cyclase in response to Iso, which was through
the Gs-mediated signaling pathway (Valiquette et al., 1995).
Based on interactions in the nucleotide-free b2AR-Gs complex,
the molecular mechanism of the phenomenon is unclear,
whereas the b2AR-T4L-GsCT-CC structure provides a plausible
explanation. When Y141ICL2 is phosphorylated, the negatively
charged phosphate group would enhance the interaction be-
tween Y141ICL2 and R389Gas.
Interaction between the b2AR and R389Gas and E392Gas
May Initiate GDP Release
Our mutagenesis studies, together with previously published
work, suggest that R389Gas and E392Gas are involved in func-
tionally important interactions with the b2AR that are not evident
in the structure of the b2AR-Gsempty complex. Coupling to the
b2AR leads to changes that propagate through the b1 strand
to the P loop and the a5 helix to the TCAT motif in the b6a5
loop (Figure 5A). In the GDP-bound Gs, the C-terminal end
of the a5 helix is bent toward the aN helix and is stabilized in
this position by interactions between Y391Gas, H387Gas, and
I383Gas and the aN-b1 junction as well as by interactions be-
tween Q390Gas and T242Gas at the N-terminal end of the b4
strand (Figure 5B). These interactions would be expected to
stabilize the GDP-bound Ras domain, and disrupting these inter-
actions might initiate GDP release through conformational
changes propagating through the a5 helix and the b1 strand.
Figure 6. Proposed Process of GPCR-G Protein Complex Formation
(A) Before formation of the b2AR-Gs protein complex, the a5 helix of GsGDP is bent, with H387Gas and Y391Gas interacting with the Ras domain, whereas E392Gas
and R389Gas are surface-exposed.
(B and C) Straightening of the a5 helix (B) is required for an early interaction with the b2AR, which involves E392Gas and R389Gas andmay initiate GDP release (C).
The b2AR-T4L-GsCT-CC structure may represent this intermediate state.
(D) Relatively large conformation changes between GPCR and Gs are required to change from the intermediate state shown in (C) to a nucleotide-free complex
(PDB: 3SN6). H387Gas and Y391Gas interact with b2AR in this state (enlarged window on top of D).
See also Figure S5.
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As discussed below, interactions between the b2AR and
E392Gas and R389Gas may stabilize a straightened conformation
(Figures 6A–6C) of the a5 helix, disrupting these interactions and
initiating GDP release. In support of this hypothesis, mutation of
two of these C-terminal amino acids (H387A/Q390A) results in a
4-fold increase in basal GDP release compared with wild-type
Gas (Figure 5C).
DISCUSSION
We present evidence that the a5 helix interacts with the b2AR in
two completely different orientations, each involving two Gs bar
code amino acids identified by Flock et al. (2017): through
E392Gas and R389Gas in a proposed intermediate state and
through Y391Gas and H387Gas in the fully coupled nucleotide-
free state (Figure 2). We speculate that the initial interaction be-
tween an agonist-bound b2AR and GDP-bound Gs occurs
through contacts observed in the b2AR-T4L-GsCT-CC struc-
ture. We were able to build a clash-free model of b2AR-GsGDP
that maintained this interaction pattern. The model requires
straightening of the distal a5 helix (Figures 6A–6C; Figures
S5D–S5F), which is known to be flexible and dynamic based
on HDX-MS studies (Chung et al., 2011). The changes in
the a5 helix required to make a clash-free model with GsGDP
are much smaller than those observed in the nucleotide-free
b2AR-Gs complex (Figure S5G). The model was stable during
1.5-ms MD simulations (Figure S5A). Formation of this intermedi-
ate b2AR-GsGDP complex would disrupt the interactions be-
tween the end of the a5 helix and the aN-b1 junction (Figures
5A and 5B) that stabilize the GDP binding pocket, initiating
GDP release and facilitating the larger conformational changes
observed in the structure of b2AR-Gsempty (Figure 6D). We
cannot be certain that the structure represented in Figure 6C is
sufficient to trigger rapid GDP release; however, as discussed
by Du et al. (2019), GDP release would be complete long before
formation of the b2AR-Gsempty complex. The transition from the
GDP-bound complex to the nucleotide-free complex observed
in the b2AR-Gsempty complex (Figures 6C and 6D) would require
a relatively large conformational rearrangement of Gs on the
b2AR. This may explain the slow conformational changes in
the C-terminal half of the a5 helix and N-terminal end of ICL3
observed by HDX-MS (Du et al., 2019). This structural rearrange-
ment would be facilitated by the flexible nature of GsCT following
disruption of interactions with the Ras domain.
The proposed intermediate complex may contribute to G pro-
tein coupling specificity. Although the interactions between
E392Gas and R389Gas and the conserved D3.49 and R3.50 of the
ionic lock might suggest that this binding mode could be
observed with most family A GPCRs, the orientation of the pep-
tide requires the large outward movement of TM6 observed in
the b2AR-Gs and A2A-Gs structures (Carpenter et al., 2016;
Rasmussen et al., 2011). Recent structures of Gi-coupled re-
ceptors (mOR-Gi, 5-HT1BR-Go, A1R-Gi, and rhodopsin-Gi) are
notable for a much smaller outward displacement of TM6 (Fig-
ure 7; Draper-Joyce et al., 2018; Garcı́a-Nafrı́a et al., 2018;
Kang et al., 2018; Koehl et al., 2018).
In summary, here we present an active structure of the b2AR
stabilized only by 14 amino acids from GsCT. The structure
may represent a conformational intermediate in the formation
of the nucleotide-free b2AR-Gs complex and sheds light on
the dynamic process of G protein activation.
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Charité and the Einstein Center Digital Future (to P.W.H. and B.K.K.);
computing resources by Norddeutscher Verbund für Hoch- und Höchstleis-
tungsrechner (to P.W.H.); the German Academic Exchange Service (DAAD)
(to D.H.); and the NIH (R01GM083118 to B.K.K.). B.K.K. is a Chan Zuckerberg
Biohub investigator and an Einstein BIH visiting fellow. D.H. thanks Shoji
Maeda, Hideaki Kato, Antoine Koehl, and Kaavya Krishna Kumar for helpful
comments regarding data processing and refinement and Hideaki Kato for
running KAMO. The authors thank the Gauss Center for Supercomputing
e.V. (www.gauss-centre.eu) for funding this project by providing computing
time on the GCS Supercomputer SuperMUC at Leibniz Supercomputing
Centre (www.lrz.de).
AUTHOR CONTRIBUTIONS
X.L. designed, cloned, and screened b2AR-T4L-GsCT-CC constructs with
help from H.L. and X.X. X.L. and X.X. jointly performed b2AR-T4L-GsCT-CC
expression, purification, crystallization, data processing, structure determina-
tion, and refinement as well as bimane studies and radioligand binding of b2AR
rHDLs in complex with Gs and Gs mutations. D.H. established the biochem-
istry of GsGDP, expressed and purified the protein, performed crystallization tri-
als, identified initial crystals of GsGDP suitable for diffraction studies, pro-
cessed data, and determined and refined the GsGDP structure. P.A. helped
with protein purification, optimized the GsGDP crystals, performed data collec-
tion, and helped with data processing. Y.D. performed GDP release assays of
Gs and Gs mutations. J.K.S.T. and R.G.-G. performed and analyzed MD
simulations supervised by P.W.H. X.S. helped with b2AR-T4L-GsCT-CC
expression. K.H. performed automatic data collection of b2AR-T4L-GsCT-
CC crystals. J.M.M. generated mutations of b2AR-cpep constructs and char-
acterized the mutants in competition binding experiments. X.L. and B.K.K
wrote the manuscript. B.K.K. coordinated the experiments and supervised
the overall research. All authors contributed to editing of the manuscript.
DECLARATION OF INTERESTS
B.K.K. is a co-founder of and consultant for ConfometRx, Inc.
Received: October 3, 2018
Revised: February 25, 2019
Accepted: April 9, 2019
Published: May 9, 2019
REFERENCES
Abraham, M.J., Murtola, T., Schulz, R., Páll, S., Smith, J.C., Hess, B., and Lin-
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and Virus Strains
E. coli cells BL21(DE3) CWBIO CW0809S
E. coli cells TOP10 CWBIO CW0807S
E. coli cells Rossetta 2 (DE3) EMD Millipore 70954
E. coli cells DH10Bac Invitrogen 10361012
Chemicals, Peptides, and Recombinant Proteins
Benzamidine Sigma Cat#B6506
Leupeptin Sigma Cat#L2884
n-dodecyl-beta-D-maltopyranoside (DDM) Anatrace Cat#D310
Lauryl Maltose Neopentyl Glycol (MNG) Anatrace Cat#NG310
Cholesterol hemisucinate (CHS) Sigma Cat#C6512
ANTI-FLAG M1 Agarose Affinity Gel Sigma-Aldrich Cat#A4596
1-Oleoyl-rac-glycerol (monoolein) Sigma Cat#M7765
Cholesterol Sigma Cat#C8667
POPG Avanti Cat# 840457
FLAG peptide Sigma-Aldrich Cat# F3290
Alprenolol Sigma-Aldrich Cat# A8676
BI-167107 Custom N/A
Isoproterenol Tocris Cat# 1747
GDP Sigma Cat# 7127
ESF921 culture medium Expression Systems Cat# 96-001
Monobromobimane Invitrogen Cat# M1378
FBS VWR Cat#97068-085
PNGase F New England Biolabs Cat# P0708
Lambda Protein Phosphatase (Lambda PP) New England Biolabs Cat# P0753
TCEP Sigma-Aldrich Cat# C4706
Antarctic Phosphatase New England Biolabs Cat# M0289
CIP New England Biolabs Cat# M0290
DpnI New England Biolabs Cat# R0176
Dihydroalprenolol hydrochloride, Levo-[ring, propyl- 3H(N)] PerkinElmer Cat# NET720001MC
Polyethylenimine Sigma Cat# 408727
cOmplete, EDTA-free Protease Inhibitor Cocktail Roche Cat# 30307800
CK28 beads Bertin Cat# 03961CK28
GF/B unifilters, Whatmann PerkinElmer Cat# 6005177
Deposited Data
b2AR-T4L-GsCT-CC structure This paper PDB: 6E67
GsGDP structure This paper PDB: 6EG8
Experimental Models: Cell Lines
Insect cell line Sf9 Expression Systems N/A
Insect cell line High Fives (Tni) Expression Systems N/A
BHK-21 cell line ATCC Cat# ATCC CCL-10
Recombinant DNA
pfastbac-wtb2AR This study N/A
pfastbac-mutb2AR This study N/A
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents should be directed to and will be fulfilled by the lead contact, Brian. K. Kobilka
(kobilka@stanford.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human b2AR-T4L-GsCT-CC was expressed in Sf9 cells infected with recombinant baculovirus (pFastBac, Invitrogen). Human Gas
and Gbg were expressed in HighFive insect cells. Human Gas C3S was expressed in Rosetta 2 (DE3) cells.
METHOD DETAILS
Design of b2AR-T4L-GsCT-CC construct
b2AR-T4L-GsCT-CC construct was designed to insert both T4L andGsCT in ICL3 of b2AR (Figure 1A). The 3 linkers: linker 1 between
TM5 and T4L, linker 2 between T4L and GsCT, linker 3 between GsCT and TM6 were optimized to generate the final crystallization
construct (Figure S1A).
Molecular cloning and protein expression
a5 helix was inserted to a b2AR-T4L construct in pfastbac using a site-directed mutagenesis method (Liu and Naismith, 2008). The
same method was applied to generate constructs with different linker length. Baculoviruses were prepared according to protocol
(Bac-to-Bac, ThermoFisher). For protein expression, typically 20 mL P2 viruses were added to 1 l Sf9 cells with a density of around
4 million per mL. 10 mM alprenolol (MP biomedicals, LLC) was added into the medium to enhance protein expression and the cells
were harvested 48 h after infection.
Single point competition binding for construct screening
The constructs were screened based on the expression level and agonist affinity (Figure S1B). Cell membranes containing different
constructs were incubated with either 1 nM 3H-dihydro-alprenolol (DHA) alone or with both 1 nM DHA and 50 nM isoproterenol. The
binding count with DHA alone represented the expression level of the construct. The relative decrease of binding count in presence of
50 nM isoproterenol was an indication of agonist affinity. The construct with high expression level and high agonist affinity was
chosen for the following studies. A final construct was chosen after several rounds of linker optimization.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
pfastbac-Gas/bg This study N/A
Pfastbac-mutGas/bg This study N/A
pET28a-ApoA1 Denisov et al., 2004 Addgene Plasmid# 20060
pET28a-Gas C3S This study N/A
pVLdual_Gbg C68S This study N/A
pcDNA3.1(+)-b2AR This study N/A
pcDNA3.1(+)-b2AR-cpep This study N/A
pcDNA3.1(+)-b2AR-cpep mutants This study N/A
Software and Algorithms
COOT Emsley et al., 2010 http://www2.mrc-lmb.cam.ac.uk/personal/
pemsley/coot
XDS Kabsch, 2010 http://xds.mpimf-heidelberg.mpg.de/
Phaser McCoy et al., 2007 http://www.ccp4.ac.uk
Phenix Adams et al., 2010 https://www.phenix-online.org
PyMOL Schrodinger https://www.pymol.org/2/
KAMO Yamashita et al., 2018 https://github.com/keitaroyam/yamtbx
Prism v.6.0 GraphPad Software https://www.graphpad.com
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Radioactive ligand binding
Membrane preparation and DHA-binding were performed as previously described (Swaminath et al., 2002).
For experiments with b2AR-cpep constructs, the b2AR-cpep construct described previously (Rasmussen et al., 2011) was subcl-
oned into pcDNA3.1(+) and mutants generated by site-directed mutagenesis. For each b2AR-cpep construct, one 150 mm dish of
BHK cells, seeded the day before at a density of 2.5 x106 cells, was transfected by adding 15 mg plasmid-DNA and 38 mg polyethy-
lenimine (from 2mg/mL stock) into a volume of 1 mL OptiMEM and incubating for 20 min at RT before adding the mixture to the cells.
48 h after transfection cells were washed once and detached in DPBS supplemented with 2 mM EDTA. After centrifugation, the cell
pellet was resuspended in 1 mL lysis buffer (10 mM Tris, pH 7.5 supplemented with cOmplete Protease Inhibitor) and homogenized
using a Precellys homogenizer with CK28 beads for 10 s at 5000 rpm. The lysate volume was increased to 3 mL and centrifuged at
1500 rpm at 4C for 10 min. The membrane-containing supernatant was isolated and supplemented with Tris pH 7.5 and MgCl2 to
constitute a membrane-suspension of 3.2 mL in 75 mM Tris, pH 7.5 and 12.5 mM MgCl2 (binding buffer).
To initiate competition binding experiments, 100 mL of themembrane-suspension wasmixedwith 20 mMGTPgS, 1.25 nM [3H]DHA,
0.4 mg/mL BSA and varying concentrations of isoproterenol to a final volume of 250 mL binding buffer in 96-deepwell plates. After
shaking at 600 rpm for 1.5 h at RT, the receptor-bound radioligand was separated by filtration over GF/B unifilter plates using a
96-well FilterMate harvester (PerkinElmer). The filters werewashed rapidly three timeswith a total of 2.5mL of ice-cold binding buffer,
and radioactivity determined in a MicroBeta2 scintillation counter after addition of 40 mL of MicroScint O (PerkinElmer). Isoproterenol
competition binding curves from 4-6 independent experiments were fitted by non-linear regression (GraphPad Prism) to a two-site
binding model where the low-affinity binding site was kept constant to that of b2AR alone.
For experiments with G proteins, purified b2AR was reconstituted into high-density lipoprotein (HDL) particles constituting apoli-
poprotein A1 andmixture of POPG: POPC lipid with 3:2 (mol:mol) ratio (Whorton et al., 2007). For competition binding, membranes or
HDL particles containing receptors or receptor-G protein complexes were incubated for 1 h with 1 nM DHA and increasing concen-
tration of isoproterenol (Sigma). Membranes were harvested with a 48-sample semi-automated harvester (Counter Rack Systems,
Brandel). Competition curves were fitted by non-linear regression to a one-site bindingmodel using GraphPad prism. Statistics com-
parisons were performed by the extra sum-of-squares F test.
Protein purification and crystallization of b2AR-T4L-GsCT-CC
Protein purification was performed according to previously described methods (Kobilka, 1995) with some modifications. The cell
membranes were washed extensively with washing buffer (20 mM HEPES, pH 7.5, 100 mM NaCl, 400 nM BI-167107) for 3 times
to exchange the ligand from alprenolol to BI-167107. 100 mM copper phenanthroline (CuP) was added to catalyze the disulfide
bond formation between A226C (b2AR) and L394C (GsCT). After reacting for 40 min at room temperature, the oxidized membrane
was centrifuged for 20min at 18,000 rpm and resuspended with solubilization buffer (20 mMHEPES, pH 7.5, 100mMNaCl, 1%DDM
and 200 nM BI-167107). Solubilized receptors were enriched and purified by M1 Flag affinity chromatography (Sigma), during which
detergent was gradually exchanged from DDM to MNG-3. The receptors were eluted and deglycosylated with PNGaseF (New En-
gland Biolabs) overnight at 4C. A final SEC purification was performed to remove aggregated protein. SEC pure protein was concen-
trated by Amicon centrifugal filters (50 KD cutoff, Millipore) to around 50mgmL-1. If not used immediately, the protein was flash frozen
in liquid nitrogen and stored at 80C.
Purified b2AR-T4L-GsCT-CC chimera protein wasmixedwithmonoolein (Sigma) containing 10% (w/w) cholesterol (C8667, Sigma)
and 2% (w/w) POPG (840457, Avanti) in 2:3 protein solution to lipid ratio (w/w) using the previously reported two-syringe mixing
method (Caffrey and Cherezov, 2009). LCP mixing and dispensation was performed by an LCP crystallization robot (Gryphon, Art
Robbins Instruments). In short, 96-well glass sandwich plates were filled with 25 nL to 30 nL of protein-lipid mixture overlaid with
1 mL precipitant solution. The well diffracting crystals were grown in 100 mM Bis-tris, pH 7.0, 75 mM to 125 mM NH4AC, 50 mM
to 75 mM KF, 38% to 42% PEG400, 6% Ethylene Glycol and 1.5% 1,2-propanediol (Sigma). Crystals appeared after 1 day and
grew to full size in about 1 week.
G protein expression and purification for crystallography
Human Gas subunit mutated at position 3 (C3S) with an amino-terminal 6x histidine tag followed by a rhinovirus 3C protease side
were expressed in Rosetta 2 (DE3) cells (EMDMillipore) using pET28a. Cells were grown in Terrific Broth to OD600 of 0.6, and protein
expression was induced by addition of 0.5 mM IPTG. After 15 h of incubation at room temperature, cells were harvested and resus-
pended in lysis buffer (50 mM HEPES pH 7.5, 100 mM sodium chloride, 1 mM magnesium chloride, 50 mM GDP, 5 mM beta-mer-
captoethanol, 5 mM imidazole, and protease inhibitors). Cells were disrupted by sonification using a 50% duty cycle, 70% power
for four times 45 s. Intact cells and cell debris were subsequently removed by centrifugation and the supernatant was incubated
with Ni-NTA resin for 1.5 h at 4C. The Ni-NTA resin was washed multiple times with lysis buffer in batch and then loaded into a
wide-bore glass column, and protein was eluted with lysis buffer containing 200mM imidazole. The eluted protein was dialyzed over-
night in dialysis buffer (20 mM HEPES pH 7.5, 100 mM sodium chloride, 1 mM magnesium chloride, 20 mM GDP, 5 mM beta-mer-
captoethanol, and 5mM imidazole). The amino terminal histidine tag was cleaved by adding 1:1000 w/w 3C protease into the dialysis
bag. Uncleaved protein, cleaved histidine tag, and 3C protease were subsequently removed by incubation with Ni-NTA resin for
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45min at 4C. The resin was loaded into awide-bore glass column and the flow-through containing theGa subunit was collected. The
protein was concentrated and run on a Superdex 200 10/300 GL column in SEC buffer (20 mMHEPES pH 7.5, 100 mM sodium chlo-
ride, 1 mM magnesium chloride, 20 mM GDP, and 5 mM beta-mercaptoethanol).
The Gbg heterodimer was expressed in Tni cells using a baculovirus generated by the BestBac (Expression systems) method. We
used one virus containing the genes for Gb1 andGg2 (C68S) subunits. The sequence for the Gb subunit contains an amino terminal 6x
histidine tag followed by a rhinovirus 3C protease sequence, allowing us to cleave off the histidine tag after purificiation.Hi5 cells were
infected at a density of 3.03 106 cells/ml and incubated at 27C for 48 h. After centrifugation, cells were resuspended in lysis buffer
(10mMTris, pH 7.5, 5mMbeta-mercaptoethanol, and protease inhibitors). Intact cells and cell debris were subsequently removed by
centrifugation. Ni-NTA resin was added to the supernatant and stirred for 1.5 h at 4C followed bymultiple washes of the Ni-NTA resin
in batch with wash buffer (20 mM HEPES pH 7.5, 100 mM sodium chloride, 5 mM beta-mercaptoethanol, 20 mM imidazole and pro-
tease inhibitors). The resin was collected into a wide-bore glass column, and the protein was eluted with wash buffer supplemented
with 200 mM imidazole. To cleave off the amino terminal histidine tag, 3C protease (1:1000 w/w) was added and the sample dialyzed
overnight in 20 mMHEPES pH 7.5, 100 mM sodium chloride, and 5 mM beta-mercaptoethanol. The cleaved histidine tag, uncleaved
fractions, and 3C protease were removed by incubation of the sample with Ni-NTA resin for 45 min at 4C. The slurry was loaded into
a glass column and the flow-through containing the Gbg heterodimer was collected. Lambda protein phosphatase (2000 units, NEB),
calf intestinal phosphatase (10 units, NEB), and Antarctic phosphatase (5 units, NEB) were added together with 1 mM manganese
chloride, followed by a 1 h incubation at 4C. The protein was concentrated and further purified by size-exclusion chromatography
using a Superdex 200 10/300 GL column in SEC buffer (20 mM HEPES pH 7.5, 100 mM sodium chloride, and 5 mM beta-
mercaptoethanol).
For formation of the Gs heterotrimer, Gas and Gbgwasmixed at a molecular ratio of 1:1 followed by a 15min incubation at RT. The
formed heterotrimer was isolated by size-exclusion chromatography using a Superdex200 10/300GL column and SECbuffer (20mM
HEPES pH 7.5, 100 mM sodium chloride, 20 mMGDP, 1 mMmagnesium chloride, and 5 mM beta-mercaptoethanol). The Gs hetero-
trimer was concentrated to 9-10mg/mL andmixed with 1mMGDP. For crystallization, 1 mL of protein wasmixed with 1 mL of the well
buffer containing 17.5%(w/v) PEG 3350, 0.1M magnesium chloride. Crystals were grown at 20C in a 24-well plate using hanging-
drop vapor-diffusion and flash-frozen in liquid nitrogen.
Data collection and processing
Diffraction data of b2AR-T4L-GsCT-CC crystals were collected at SPring-8 beamline BL32XU by using the multiple small wedge
scheme implemented in ZOO systemdeveloped at SPring-8 (K.H., unpublished data). A total of 158 small wedge datasets were auto-
matically collected with 10 per crystal, using 103 15 mm focused beam. Absorbed dose for each data collection was set to 15 MGy
at thewavelength of 1.0000 Å. KAMO (Yamashita et al., 2018) was used for automatic data processing. 42 isomorphous crystals were
manually selected based on R-merge and merged together with xscale (Kabsch, 2010) to generate the final 3.7 A dataset.
Diffraction data of Gs-GDP crystals were collected at the Advanced Photon Source beamline (23IDD) with a wavelength of
1.0332 Å, oscillation width of 0.1-0.2, and an exposure time of 0.1-1 s. Data processing was performed using KAMO (Yamashita
et al., 2018) and data from 6 isomorphous crystals were merged together to generate the final 2.8 Å dataset.
Structure determination and structure refinement
The b2AR-T4L-GsCT-CC structure was solved by molecular replacement using Phaser (McCoy et al., 2007). The searching models
include active-state b2AR (PDB ID: 3SN6, chain R) and T4 lysozyme (PDB ID: 2RH1, residue 1002-1161). a5 helix wasmanually fit into
the fofc density in Coot (Emsley et al., 2010). Rigid body refinement was performed in Phenix (Adams et al., 2010), with b2AR, T4L and
a5 helix as separated rigid body groups. Restrained refinement with phenix.refine andmanually building in Coot were performed iter-
atively to yield the final model. Due to the relatively low resolution of the diffraction data, the electron densities were poor for many
side chains. For residueswith weak side chain density, if we saw continuous density with the shape of the side chain at 0.5 sigma, and
the side chain points to a similar direction as the high resolution model (4LDE, 3SN6), we chose to keep the side chain. Otherwise, the
side chain was removed. The final model was validated by Molprobity (Chen et al., 2010).
The Gs-GDP structure was solved by molecular replacement using Phaser (McCoy et al., 2007). The search models include the b1
and g2 subunits from aGi heterotrimer (PDB ID: 6CRK) and Gas (PDB ID: 1AZT, chainB). In the searchmodel of Gas, the aN (residues
35-41) and the switch II loop (residues 222-243) were deleted due to the expected conformational differences in these regions be-
tween the search model and the Gs heterotrimer. Following the determination of the initial structure by molecular replacement, rigid
body refinement was performed with phenix.refine (Adams et al., 2010), followed by restrained refinement and manual rebuilding in
Coot (Emsley et al., 2010). After iterative refinement andmanual adjustments, the finalmodel was validated byMolprobity (Chen et al.,
2010) to determine Ramachandran statistics.
All the structural figures were prepared with PyMOL (The PyMOL Molecular Graphics System, Schrödinger, LLC.). The model of
TM6 andGsCT in b2AR-T4L-GsCT-CC structure andGsCT in Gs-GDP structure were confirmed by Fo-Fc simulated omit map calcu-
lated by phenix (Adams et al., 2010), during which the region of interest was omitted and starting temperature was set to 3000 K.
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G protein purification for activity assay
Gprotein expression and purification were performed as previously describedwithminormodification (Rasmussen et al., 2011). Cells
membranes were prepared and solubilized with sodium cholate. The solubilized G proteins were enriched by Ni affinity chromatog-
raphy (Sigma), during which detergent was exchanged from sodium cholate to 0.02% n-Dodecyl-b-D-maltoside (DDM). Ni column
purified G protein was further purified with MonoQ column (GE). In order to control the amount of free detergent in final G protein
stock, elution fromMonoQ column was diluted to0.5 mg/mL before concentrated to approximately 20 mgmL-1 with a 30 kDa mo-
lecular weight cut off concentrator (Millipore). The concentrated protein was aliquoted, flash frozen in liquid nitrogen and frozen at
80C before use.
Bimane assay
Bimane labeling and fluorescence spectroscopy were performed as previously described (Yao et al., 2009). In short, M1 purified
b2AR was mixed with 100 mMmonobromobimane and incubated on ice for 3 h. The fluorophore-labeled receptor was then purified
with alprenolol affinity resin to isolate functional protein. The purified protein was concentrated to 200 uM, flash frozen with liquid
nitrogen and stored at 80C.
Fluorescence spectroscopy experiments were performed on a DUEL-FL Fluorometer (Horiba). The excitation and emission band-
pass was set to 0.5 nm, the final receptor concentration was around 200 nM. The reaction buffer contains 20 mM HEPES, pH 7.5,
100 mM NaCl, 0.02% DDM, 0.002% CHS, 0.3 mM GDP, 1.2 mM ISO. All experiments were performed at 20C.
GDP release assay
[3H]GDP was purchased from Perkin Elmer (NET966250UC) with specific activity of 40 Ci/mmol. To prepare [3H]GDP-bound Gs mu-
tants, 200 nM purified Gas subunit of each G proteins was first mixed with 75 nM [3H]GDP for 1 hr at room temperature in the buffer
containing 20 mM HEPES, pH 7.5, 100 mM NaCl, 0.1% DDM, 100 mM TCEP and 2 mMGDP, and then 2 mM purified Gbg was further
added for incubation of 10 min. 50 mM (final) BI-167107-bound b2AR or the corresponding DDM buffer of same volume was further
added to initiate GDP release in the presence of 1 mMGDP. The reaction mixture was aliquoted at indicated time points, and imme-
diately loaded onto calibrated G-50 columns. The follow-through was collected with 1 mL buffer (20 mM HEPES, pH 7.5, 100 mM
NaCl, 0.1% DDM), and Gs-bound [3H]GDP was measured with scintillation counter (Beckman) after adding 15 mL scintillation fluid.
The initial sample represents [3H]GDP binding capacity of Gs before initiation of GDP release. Each measurement was performed in
triplicate.
For spontaneous GDP release assay on Gas alone, 1mM final GDPwas added to trigger GDP release and eachmeasurement was
performed in triplicate. Comparisons between release datasets were fitted to a one-phase decay model and taken from the p value
that is less than 0.0001, and it was calculated by means of the F-statistic based on the differences in the sum of squares.
Molecular dynamic simulations
A list of all simulations performed in this work is given in Figure S5B. VMD1.9 (Humphrey et al., 1996) and the Schrödinger software
(Sastry et al., 2013) were used for protein preparation, modeling, and set-up of initial structures. All atoms different than protein, b2AR
ligand (i.e., 3P0G), or crystallization water were removed from the crystal structure. Internal protein cavities were solvated using the
DOWSER software (Zhang and Hermans, 1996) to model unresolved water molecules. For the setup of set 1-4 see table Figure S5B.
No changes to the protein sequence were made for simulation sets 1, whereas stabilizing mutations T96M, T98M, E187N, C226A of
b2AR andC394L of GaCTwere changed back to its native form for simulation sets 2-3. The intracellular TM5 & TM6 regionwas adop-
ted from receptor coordinates of PDB: 3SN6 in set 3, where the TM5 carboxyl terminus is undistorted. For set 4, receptor and GsCT
(381-394) coordinates were taken from PDB: 3SN6 with the missing ECL2 residues extracted from b2AR-T4L-GsCT-CC. The
CHARMM-GUI builder (Jo et al., 2008) or the g_membed (Wolf et al., 2010) tool from Gromacs v5 (Abraham, 2015) were used to
model and embed the receptor into a pure 1-palmitoyl-2-oleyl-sn-glycero-3-phosphocholine (POPC) bilayer of approximately
903 90 Å2. b2AR D79 and E122 were protonated whereas all titratable residues of the receptor were left in the dominant protonation
state at pH 7.0. b2AR residue C483 was palmitoylated in all system.
Systems were then solvated, neutralized, and the ionic strength adjusted. All system were then geometry-optimized, and equili-
brated with harmonic positional restraints applied to lipids and Ca atoms of the protein that were sequentially released in a series
of equilibration steps. Simulations were performed using Gromacs v5 (Abraham, 2015) in combination with either CHARMM36
(Klauda et al., 2010) or Amber ff99SB (Lindorff-Larsen et al., 2010) and Slipids (Jämbeck and Lyubartsev, 2012) force fields to repre-
sent protein and lipids, and Amber or CgenFF (Vanommeslaeghe et al., 2010) general force field to describe the b2AR ligand (i.e.,
P0G), with partial charges generated from AM1-BCC calculations (Jakalian et al., 2002).
VMD1.9 (Humphrey et al., 1996), NGL (Rose and Hildebrand, 2015), and MDsrv (Tiemann et al., 2017) were used to visualize/
analyze all MD simulations.
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QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification and statistical analyses of data are described in Method Details.
DATA AND SOFTWARE AVAILABILITY
Data Resources
The coordinates and structures factors of b2AR-T4L-GsCT-CC and GsGDP structures have been deposited in Protein Data Bank
under accession number 6E67 and 6EG8, respectively.
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Supplemental Figures
Figure S1. Design and Optimization of the b2AR-T4L-GsCT-CC Construct that Led to the Crystal Structure, Related to Figure 1
(A) The sequences for linker 1 (between TM5 and T4L), linker 2 (between T4L and GsCT) and linker 3 (between GsCT and TM6) that were tested for stability and
agonist affinity. The chosen linkers are labeled with a red star.
(B) A single point competition-binding assay was used to screen different b2AR-T4L-GsCT constructs. The dark blue or dark purple columns showbinding counts
of the antagonist [3H]-dihydro-alprenolol (DHA) from Sf9 membranes expressing either b2AR-T4L (blue) or different b2AR-T4L-GsCT constructs (purple), re-
flecting expression level. The light blue or light purple columns show the binding counts of the sampleswith both 1nMDHA and 50 nM Iso. The relative decrease of
DHA binding counts in light color columns represents the agonist affinity of the sample. In this figure, construct 5 (labeled with red star) has the highest expression
level and largest fractional decrease in the presence of the agonist. The data are given as mean ± SD (n = 2).
Figure S2. Electron Densities of Key Structural Elements, Related to Figures 1 and 3
(A) The fo-fc simulated annealing omit map of TM6 at 2.0s in the b2AR-T4L-GsCT-CC structure.
(B) The 2fo-fc maps of TM6 at 0.8s in the b2AR-T4L-GsCT-CC structure. The positions of TM6 suggest b2AR-T4L-GsCT-CC captures an active b2AR structure.
(C) The fo-fc simulated annealing omit map of GsCT at 2.0s in the b2AR-T4L-GsCT-CC structure.
(D) The 2fo-fc maps of GsCT at 0.8s. The density maps suggest overall shape of alpha helix.
(E) The simulated annealing fo-fc omit map of C terminus of a5 helix (residues 385 to 393) contoured at 2.0s in GsGDP structure.
(F) The 2fo-fc map of residues 385-393 contoured at 0.8s in GsGDP structure.
Figure S3. The b2AR-T4L-GsCT-CC Structure Captures the b2AR in an Active State, Related to Figure 1
(A) Alignment of receptor structures in chain A and chain B, the receptor structures are similar in chain A (green) and chain B (orange).
(B) Alignment of receptor structures in b2AR-T4L-GsCT-CC (chain A) and NB80 bound b2AR structure (red) (Protein Data Bank accession number 3P0G).
(C) Alignment of receptor structures in b2AR-T4L-GsCT-CC (chain A) andGi bound mOR structure (blue) (Protein Data Bank accession number 6DDE). TM6 shows
more outward displacement in b2AR-T4L-GsCT-CC structure than the other two structures.
Figure S4. GsCT Binding Mode in the b2AR-T4L-GsCT-CC Structure, Related to Figure 2
(A) Overall view of the interactions between the b2AR (light red) and GsCT (cyan) in b2AR-Gs complex structure (Protein Data Bank accession number 3SN6).
(B) Overall view of the interactions between the b2AR (green) and GsCT (yellow) in b2AR-T4L-GsCT-CC structure.
(C) The amino terminus of GsCT in chain A (yellow) and chain B (purple) are 13.3Å and 11.8Å displaced toward helix 8 compared to its position in b2AR-Gs
complex (cyan), respectively.
(D) Interactions between the b2AR (light red) and GsCT (cyan) in the b2AR-Gs complex structure (Protein Data Bank accession number 3SN6). H387Gas and
Y391Gas interact with b2AR.
(E) Interactions between the b2AR (green) and GsCT (yellow) in chain A of b2AR-T4L-GsCT-CC structure. R389Gas and E392Gas interact with b2AR.
(F) Interactions between the b2AR (light green) and GsCT (purple) in chain B of b2AR-T4L-GsCT-CC structure.
Figure S5. The Alternative Binding Mode Supported by Molecular Dynamics Simulations and Structural Rearrangements of a5 during
Formation of the b2AR-GsGDP Intermediate Complex, Related to Figures 2 and 6
(A) GsCT dynamics during Molecular Dynamics (MD) simulations, shown by average Root-Mean-Square Fluctuation (RMSF, boxplot with median) over all
replicas of simulations.
(B) A list of simulations performed in this study (time per replica).
(C) Prominent interactions between the b2AR and GsCT during MD simulations (observed in at least 2/3 of the simulation time in set 2,3).
(D) Prior to b2AR-Gs protein complex formation, the a5 helix of GsGDP is bent with H387Gas and Y391Gas interacting with the Ras domain while E392Gas and
R389Gas are surface exposed.
(E) Views of G-protein rearrangements required for clash-free interactions with the b2AR, with lower panels rotatd 90 relative to the upper panels. To proceed
from unbound (D) to the b2AR - GsGDP intermediate (F), a5 GsGDP needs to straighten (a- > b) and rotate (b- > c). These structural rearrangements allow E392Gas
and R389Gas to engage the b2AR, and release H387Gas and Y391Gas from their interaction with R38Gas and H41Gas, reducing the affinity of Gs for GDP (c- > F).
(F) In the b2AR-T4L-GsCT-CC structure, which may represent an early b2AR- GsGDP intermediate, b2AR engages E392Gas and R389Gas. The b2AR - GsGDP
intermediate was modeled with a5 helix tilted, rotated, and aligned to the b2AR-T4L-GsCT-CC structure. In this clash free model, the GsGDP-aN is parallel to the
membrane. In two independent MD simulations of 1.5 ms, this model displays a high structural stability, as shown by its low mean Ca Root Mean Square
Fluctuations (RMSF) (A).
(G) Comparison of the a5 helix structures in the GsGDP crystal structure (orange), the b2AR - Gsempty crystal structure (3SN6, cyan) or the b2AR - GsGDP inter-
mediate model (purple).
Figure S6. Mutations of R389Gas and/or E392Gas Decrease Agonist Affinity in a b2AR-cpep Fusion Protein in Cell Membranes, Related to
Figure 4
(A) Cartoon of the b2AR-cpep constructs used to assess the effects of R389Gas and E392Gas mutations.
(B) Agonist competition curves of R389Gas/E392Gas doublemutations in b2AR-cpep. Constructs were tested in competition binding experiments between Iso and
[3H]-dihydroalprenolol in GTPyS-treated BHK cell membranes.
(C) Agonist competition curves of R389Gas single mutations in b2AR-cpep.
(D) Agonist competition curves of E392Gas single mutations in b2AR-cpep.
(E) The values and statistics of the agonist competition curves shown in (B), (C), and (D). Competition binding curves for the b2AR-cpep fusion protein andmutants
were fitted to a two-site binding model where the Iso binding affinity to the low-affinity binding site was constrained to that of WT b2AR alone (pIC50 low site =
5.59). (n/a, not applicable since one-site model). Statistics comparing the b2AR-cpep fusion protein with R389 and/or E392mutants were performed by the extra
sum-of-squares F test where a model of individually best-fitted values of pIC50 or the high-site fraction of the two different datasets was compared to a model
where the parameters were shared among the datasets. Data are given as mean ± SD from 4-6 independent experiments.
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ABSTRACT: Given the need for modern researchers to produce open,
reproducible scientific output, the lack of standards and best practices for
sharing data and workflows used to produce and analyze molecular
dynamics (MD) simulations has become an important issue in the field.
There are now multiple well-established packages to perform molecular
dynamics simulations, often highly tuned for exploiting specific classes of
hardware, each with strong communities surrounding them, but with very
limited interoperability/transferability options. Thus, the choice of the
software package often dictates the workflow for both simulation
production and analysis. The level of detail in documenting the workflows
and analysis code varies greatly in published work, hindering reproducibility
of the reported results and the ability for other researchers to build on these
studies. An increasing number of researchers are motivated to make their
data available, but many challenges remain in order to effectively share and
reuse simulation data. To discuss these and other issues related to best practices in the field in general, we organized a workshop in November 2018
(https://bioexcel.eu/events/workshop-on-sharing-data-from-molecular-simulations/). Here, we present a brief overview of this workshop and topics
discussed. We hope this effort will spark further conversation in the MD community to pave the way toward more open, interoperable, and reproducible
outputs coming from research studies using MD simulations.
■ INTRODUCTION
Molecular simulations have become increasingly powerful and
accessible in recent years, due in part to the rise of HPC1−3 and
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GPU-powered clusters and powerful desktop computers4 as well
as the development of user-friendly software to setup
simulations.5,6 The underlying physical models and methods
have also improved over the years to address ever more complex
biological and chemical questions.7,8 Finally, the number of
users and available tools is continuously increasing, as is the
amount and complexity of workflows and produced outputs.9,10
In this context, defining best practices related to documentation
of protocols and code used to generate and/or analyze
Molecular Dynamics (MD) simulations is becoming more
important than ever.11 A set of guidelines for reporting results
obtained using molecular dynamics techniques and an
opportunity to share data, similar to what structural biologists
have achieved with the worldwide Protein Data Bank12
(wwPDB), should generally help to improve the quality,
reproducibility, statistics, and reuse of the published results.
Here, we would like to focus on the term reproducibility. The
definition of reproducibility and its distinction from replicability
can vary between disciplines,13−15 but in this context, we will
broadly define reproducibility as the ability to reimplement the
workflows of published work and obtain similar behavior for
observables of interest as well as define the appropriate way to
measure/calculate and report these observables.16 Reproduci-
bility is a long-standing issue for molecular modeling17 and a key
step toward better reproducibility and improved collaboration is
making data more accessible and workflows interoperable. This
can help reduce the entry barrier for the newcomers, but it could
also help the existing practitioners to focus on answering
scientific questions rather than wasting time in redeveloping
existing sets of parameters or translating files formats to pass
from one software to another. To reach this goal, it is now
necessary to overcome several difficulties:
• First, there is now a multitude of package-specific file
formats and object models. This variety, although
increasing the efficiency for each package, introduces
limitations in the interoperability and creates friction for
users juggling with various software to generate and
analyze their data.
• Second, there is still a lack of exhaustive documentation
related to new software development. The proliferation of
various libraries and toolkits definitely opens up new
avenues of research, but documenting the entire workflow
from building a molecular model and parametrization to
data analysis and visualization has become more complex.
The method sections in publications often lack sufficient
details to successfully reimplement the protocol or repeat
the study from scratch, and default parameters to run a
simulationmay vary from one software version to another.
• Last but not least, there is no consensus to share data. The
recent years have seen developments of different open
data platforms, but the (ever-increasing) size of the
generated trajectories makes it difficult to share
simulation data efficiently. The absence of appropriate
infrastructure, guidelines, and incentives further compli-
cate the situation.18,19
In general, we are witnessing a growing effort to make science
more open by researchers themselves and increasingly so by
funders and journals.20,21 Soon, it may be mandatory to share
data and deposit models obtained from hybrid/integrative
approaches combining molecular modeling and experimental
results.22 Finding a way to consistently share data, workflows,
and protocols will be thus necessary to ensure an efficient
information exchange. Defining best practices and coming up
with solutions should be a community effort to achieve the best
outcome for everyone involved. In an effort to start a discussion
around these questions, we organized a BioExcel workshop on
Sharing Data f romMolecular Simulations (SDMS) in Stockholm,
November 2018. In this paper, we present a summary of
discussions broadly focused on four topics:
• Standardization of file formats
• Streamlining molecular simulation data
• Tools for trajectory file sharing
• Reproducibility of molecular simulations
Each topic was introduced by two researchers and then openly
discussed by all participants. All the presentations and the
discussions were recorded and are accessible here: https://
bioexcel.eu/sdms18-recordings/. The slides for the majority of
the talks can be found here: 10.5281/zenodo.2652703.
■ STANDARDIZATION OF FILE FORMATS
While in structural biology the established PDB file format was
stable for decades,12 the MD simulations field has a tendency to
produce a multitude of input/output formats each related to one
MD package.1,23−27 With the rapid growth in complexity, size,
and number of macromolecular structures led by advances in
experimental techniques, even the canonical PDB format is now
evolving to allow rendering and analyzing larger files with a gain
in performance.28 This evolution may also encourage the MD
community to update its file formats to deal with larger andmore
heterogeneous data.
A new jointly developed format would need to be modular
and flexible enough to not only take into account current but
also anticipate future needs. Here arises a first question: What
are the current and future needs of the MD community for such
a format?While particle coordinates are the current main feature
both for input and output standards, other features need to be
discussed such as physical/chemical descriptions of the model,
experimental data used to create the model, technical details
related to the simulation (such as algorithms used, sampling
method, and force field). Different formats may be used as
templates such as MMTF,28 MMCIF,29 JSON (http://www.
json.org/), and TNF.30 At this workshop, we all agreed that it
would be a great advance if this new standard can follow the
FAIR principle:31 Findable, Accessible, Interoperable, and
Reproducible/Reusable. Many details remain to be discussed,
and the standardization question cannot be solved in one
workshop with only a small sample of the MD community; it
needs to be discussed by all the main software developers joined
with users to ensure usability. To do so, another workshop will
be held soon in New York to further discuss the question of file
format and MD package interoperability: https://molssi.org/
2019/07/29/molssi-workshop-molecular-dynamics-software-
interoperability/.
For further details and discussions, interested readers can
watch associated videos from the 2018 workshop:
• Introduction of the topic by Mark Abraham (https://
youtu.be/2S3qjBIE6Y4)
• Preliminary talk I by Erik Lindahl (https://youtu.be/
Hvy8-gyTmj8)
• Preliminary talk II from Alexandre Bonvin (https://
youtu.be/48Eb2MLHoYU)
• Breakout discussions presented by Phillip Stansfeld,
Mikael Trellet, Daniel Smith, and Johanna Tiemann
(https://youtu.be/4fnV5EFXDpc)
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■ STREAMLININGMOLECULAR SIMULATIONS DATA
The MD simulation is often not a means and an end in itself but
instead is run as part of a larger workflow. Such workflows
involve joining together the output of many independent
programs, such as those used for parametrizing molecules, those
for performing molecular dynamics, and those for trajectory
analysis. Managing the data movement between different
programs in this workflow is challenging for several reasons:
1. The file formats used by different programs in the
workflow may be incompatible, thereby preventing
certain combinations of tools from being used together.
2. The features and force fields supported by different
programs in the workflow may be incompatible, thereby
forcing researchers to choose algorithms and force fields
based on software compatibility rather than for good
scientific reasons.
3. Different programsmay implement features or force fields
in different ways, thereby meaning that the results of
running the workflow will depend on the exact
combination of programs (and possibly program
versions) used. It is generally not possible to mix-and-
match different programs and get the same results.
These challenges have forced researchers to develop work-
flows using specific software packages and specific force fields.
This creates divisions within the community and makes it
difficult to write workflows that function equally well across a
number of force fields and a number of different software
packages.
One of the solutions to this problem is the development of
programs that convert/handle molecular information between
the different file formats such as VMD,32 cpptraj,33 MDAnal-
ysis,34,35 mdtraj,36 LOOS,37,38 and many others for trajectory
analysis and TopoGromacs,39 CHARMM-GUI,40 CHAM-
BER,41 ParmEd (http://parmed.github.io/ParmEd/html/
index.html#), InterMol42 (https://github.com/shirtsgroup/
InterMol), and others for topology generation and editing.
The aim of these programs is to translate as much information as
possible from onemolecular file format into another. One recent
example is BioSimSpace (https://biosimspace.org/), which
provides wrappers that simplify the generation of the command
files that are used to control the running of simulations. This
allows researchers to write workflows that are independent of
the choice of the underlying packages used to perform the
simulation. BioSimSpace aims to run all stages of the workflow
using the simulation software installed on the researcher’s
computer that is compatible with the force field chosen for the
specific calculation.
While translators and program wrappers like ParmEd and
BioSimSpace solve some of these problems, they are not a
universal solution. They do not solve the issue that different
simulation programs use different algorithms (or interpretations
of algorithms, for example, different implementations of
thermostats or integrators) or that different programs store
and represent molecular information in different ways (e.g.,
SHAKE information for constraining bonds is represented in the
molecular topology in GROMACS, while it is a simulation
command parameter in NAMD and AMBER). This means MD
properties/observables computed with one package will be
systematically different by an often small but statistically
significant amount from those computed with a different
package as shown for free energy calculations.43 Thus, the
version and name of the MD program used to produce a
simulation result will affect that result and must be reported
accordingly. Furthermore, MD simulation outputs are mainly
trajectories which (1) represent ensemble averages and (2) are
chaotic in that small differences in initial conditions cause large
differences in the subsequent dynamics (“butterfly effect”). This
adds another layer of complexity and needs also a consensus on
how to further analyze/process these trajectories to provide the
final quantities of interest.
The recordings of this session can be found here:
• Introduction to the topic by John Chodera (https://
youtu.be/6xOfN0y_uoQ)
• Preliminary talk I by Philip Stansfeld (https://youtu.be/
YPYeujSD-6Y)
• Preliminary talk II by ChristopherWoods (https://youtu.
be/w1d1xtbGhHc)
• Breakout discussions presented by Christian Blau,
Christopher Woods, Jonathan Barnoud, and Mark
Abraham (https://youtu.be/Z-JfBU3Emug)
■ TOOLS FOR TRAJECTORY FILE SHARING
The benefits of sharing data together with the peer-reviewed
publication, preprint, or as a self-standing research output seem
to be manyfrom receiving additional credit for one’s work to
improving reproducibility, reusability, or offering potentially
new avenues of research.20,44 Some disciplines, such as protein
crystallography or genomics, have open data practices well
integrated into their workflow, with metadata being collected
throughout the workflow, and those practices are a de facto
standard in scholarly communication. However, data sharing in
theMD community still has not becomewidely adopted because
best practice guidelines or journal recommendations on how to
share MD simulations are yet to be established and adopted by
the whole community. Making data sharing a standard practice
in the field faces both technical and cultural challenges, although
these are currently being tackled by some ongoing initiatives and
solutions.20,45,46 Thus, the development of best practices and
guidelines for simulation data sharing will be of tremendous
value, especially if created with the FAIR principles in mind.31
To do so, we need to address several important questions
regarding what data should be shared, how and where.
Answering to the what data question would need longer
discussions not limited to a small group of individuals but
involving the whole community and especially all the MD
packages (another workshop will be held soon to help starting to
answer to this question: https://molssi.org/2019/07/29/
mo l s s i -wo r k s hop -mo l e c u l a r - d yn am i c s - s o f tw a r e -
interoperability/). The emergence of dedicated tools is now
helping to answer to the how question. Software such as
MDsrv,47 HTMoL,48 Mol* (https://molstar.org), and Mol-
mil49 are now taking advantage of the WebGL API for sharing
trajectories through interactive visualization on the web.50
Other fields of research can help us to answer to the where
question. Existing databanks, such as wwPDB51 and Galaxy
(https://usegalaxy.org), have been recognized by the scientific
community. However, the establishment of an analogous,
specialized platform for MD data, poses a great challenge,
given the current lack of long-term support for the infrastructure
projects of this kind. It is not clear yet who should be responsible
for building such platform and how this infrastructure could be
funded in a sustainable way, preferably without relying on short-
term research grants, to cover the costs of development,
maintenance, and data hosting. In the meantime, community-
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driven, special-purpose platforms like the GPCRmd (http://
www.gpcrmd.org), Lipidbook52 and NMRlipids45 (http://
nmrlipids.blogspot.com), Ligandbook,53 MoDEL,54 and
BIGNASim55 lead the way, providing specialized platforms for
deposition and analysis of G protein-coupled receptors
(GPCR), lipids, small molecules, proteins, and nucleic acids,
respectively. General data sharing resources like Zenodo
(https://zenodo.org), FigShare (https://figshare.com), Open
Science Framework (https://osf.io), and others also provide an
opportunity for every researcher to deposit their simulation files
and trajectories. Nevertheless, those resources may, sometimes,
not provide enough space to sustainably store MD simulations
outputs (with file size limits ranging between 5 and 50 GB).
To establish an efficient sharing culture, a systematic approach
to developing tools and sharing guidelines is necessary, with the
participation of the entire community in such activities and
efforts. An open and inclusive discussion about best practices in
data sharing and identification of short-term solutions based on
the currently available frameworks and tools, as well as
developing a strategy and requirements for future solutions
bespoke to the MD community and their needs is necessary.
More details about the discussions taking place at the workshop
can be found in the following videos:
• Introduction to the topic by Daniel Smith (https://youtu.
be/mvesL9Y_9xU)
• Preliminary talk I by Johanna Tiemann (https://youtu.
be/VOT6fEc7Iuc)
• Preliminary talk II by Jana Selent (https://youtu.be/
TVS75j48mQ8)
• Breakout discussions presented by John Chodera, Kar-
men Čondic-́Jurkic,́ Samuli Olllila, and Lucie Delemotte
(https://youtu.be/UIs1isntUPY)
■ REPRODUCIBILITY OF MOLECULAR SIMULATIONS
MD simulations are chaotic, and as such, the definition of
reproducible results is nontrivial. First, the distinction between
repeatability (by the same team and the same computational
setup), replicability (by a different team and the same
computational setup), and reproducibility (by a different team
and with a different experimental setup) should be made.14
Differences in outputs from these three perspectives may
indicate different types of errors (bugs in software, human
errors, or different choices along the workflowchoice of code,
force field, system setup, and more). The variability of
parameters and dependence of the final results on both software
and hardware makes it complicated (but also often unnecessary)
to achieve the exact replication/repetition of any given setup,
and untangling all the effects would be a difficult task. Focusing
on a set of observables that can be calculated and preferably
validated against experiments might be a better way of
approaching reproducibility in this particular field. Similarly,
focusing at observables which, despite the underlying chaoticity
of the detailed dynamics, are reproducible without too large
variation might be beneficial. Reaching an agreement on which
observables we should aim to reproduce and how to properly
calculate and report these values is thus desirable. For this,
educational efforts are needed: best practice dissemination in
terms of calculating statistical properties, for example, are
crucial.16 Coming up with standard benchmarks would also
help, where the performance of different software/force field
combinations for selected tasks could be compared.
In practice, data sharing would help with replicability and
reproducibility. Practical challenges come from the size of data
sets. However, one can envision sharing at least minimal data
sets to improve the following:
• Methods reproducibility. Provide sufficient details to
replicate the study; this is in principle already done in
publications, but authors, reviewers, and editors should
pay special attention to the question, and direct sharing of
all input files should be mandatory,
• Raw data reproducibility. Share a minimum amount of
data in the form of MD simulation snapshots or, even
better, whole trajectories on existing data sharing
repositoriesZenodo, Figshare, OSF.
• Results and inferential reproducibility: Share among other
analysis code, pipeline/workflow and example used.
Inspiration can be found in other research fields (e.g.,
genomics56 or proteomics57), and existing dedicated initiatives,
like MemProtMD58 (http://memprotmd.bioch.ox.ac.uk), the
NMRlipids project (www.nmrlipids.blogspot.fi), and GPCRmd
(http://www.gpcrmd.org), show that small groups of people
focused on a specific topic can create the necessary structure to
share even large data sets in an efficient way. For further details
and discussions interested readers can watch associated videos:
• Introduction to the topic by Karmen Čondic-́Jurkic ́
(https://youtu.be/lUTQgOXDEP8)
• Preliminary talk I by Helmut Grubmüller (https://youtu.
be/cliVmGlrKag)
• Preliminary talk II by Samuli Ollila (https://youtu.be/
46s33SonsiU)
• Breakout discussions presented by Mikael Trellet,
Alexandre Bonvin, Mark Abraham, and Christopher
Woods (https://youtu.be/ex0_bqmJwE8)
This article summarizes the discussions started during the
workshop held in Stockholm in November 2018. As may be
noted by the reader, these discussions have not solved the issues
about sharing data that our field is facing. Of course, this has
never been the goal of such a small workshop. This workshop
was intended to start asking relevant questions. Thus, this
document (and the videos associated) can be seen as a roadmap
for future developments. It is now crucial to build a community
responsible for transforming these ideas into actions. This
community needs to represent a diversity of perspectives by
including both MD users and developers, newcomers, and more
seasoned practitioners, PhD students and postdocs, who are
performing MD simulations on a daily basis, and PIs, who may
hold the bigger picture views. As a community building effort, we
are planning to regularly organize more specific workshops
aiming to address some of the issues raised in this article or to
expand the scope of newly recognized problems. Of course, the
structure of the workshops limits the number of participants but
care will be taken to ensure the aforementioned diversity of
perspectives and roles in the field. In an effort to include as many
users as possible in this discussion, the best practices guidelines
that will emerge from these workshops will be submitted to the
Living Journal of Computational Molecular Science (http://
www.livecomsjournal.org/). This journal “...provides a venue
where authors can submit living documents that are updated on
an ongoing basis as websites or Wikipedia articles could be, but
which still have clear authorship and provide a mechanism for
authors to get publication credit for their work.”59 Hence,
researchers interested to help us shape new practices to share
data will be able to provide their feedback or directly contribute
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to the forthcoming document (as per the general idea laid out
here: https://livecomsjournal.github.io/about/paper_code/).
We hope that our work will act as a first step in a community-
driven process of defining best practices for tool development
and application in the molecular dynamics field.
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S.; Domanśki, J.; Dotson, D.; Buchoux, S.; Kenney, I.; Beckstein, O.
MDAnalysis: a Python Package for the Rapid Analysis of Molecular
Dynamics Simulations. SciPy 2016, 98−105.
(36) McGibbon, R. T.; Beauchamp, K. A.; Harrigan, M. P.; Klein, C.;
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